data_1zuv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1zuv _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 97.9 m -38.96 127.56 1.61 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 128.486 2.715 . . . . 0.0 112.129 -173.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.5 t 1.34 -85.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 130.191 3.396 . . . . 0.0 112.192 -159.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -130.98 30.04 4.63 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.345 2.258 . . . . 0.0 109.771 142.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.97 -15.86 0.04 OUTLIER Glycine 0 CA--C 1.536 1.375 0 N-CA-C 116.656 1.422 . . . . 0.0 116.656 168.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -133.18 174.49 10.32 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 119.937 1.869 . . . . 0.0 113.662 -173.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.0 m -97.46 166.76 13.06 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.322 1.049 . . . . 0.0 111.638 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -50.68 149.58 13.68 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.94 2.427 . . . . 0.0 111.4 157.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.6 m -68.25 80.06 0.24 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.209 1.403 . . . . 0.0 111.583 -174.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 150.22 -14.81 0.98 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.723 1.63 . . . . 0.0 114.428 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.7 mtt -106.27 174.91 5.68 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.905 1.853 . . . . 0.0 111.754 175.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.5 m -126.27 130.4 50.81 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.389 1.876 . . . . 0.0 111.374 -172.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.9 t -84.0 114.82 21.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.467 0.707 . . . . 0.0 110.57 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.2 p -66.4 163.95 17.24 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -5.4 21.72 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 169.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.79 -8.87 58.61 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.152 0.887 . . . . 0.0 112.321 163.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.07 4.44 90.25 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.626 1.108 . . . . 0.0 113.701 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -109.82 148.95 30.56 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.098 1.359 . . . . 0.0 110.784 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.1 t -91.59 150.41 21.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.749 1.22 . . . . 0.0 113.153 -169.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.57 -156.69 24.59 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.01 0.814 . . . . 0.0 113.548 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -139.6 161.32 37.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.468 1.907 . . . . 0.0 112.153 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.2 -179.96 51.77 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.802 1.191 . . . . 0.0 112.798 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.7 -1.6 8.71 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.125 2.55 . . . . 0.0 115.802 -166.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.59 -6.04 58.48 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.194 0.998 . . . . 0.0 110.798 171.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -138.15 -53.47 0.63 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.104 1.762 . . . . 0.0 111.479 -165.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 63.9 m . . . . . 0 CA--C 1.541 0.608 0 C-N-CA 125.625 1.57 . . . . 0.0 113.746 176.914 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 120.842 0.353 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.3 m -62.63 135.72 57.52 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.947 0.88 . . . . 0.0 111.483 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.46 69.88 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.782 1.633 . . . . 0.0 110.381 -164.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 47.97 25.31 0.75 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.864 -155.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 128.84 -13.95 6.05 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.582 1.086 . . . . 0.0 115.544 162.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.79 171.77 7.34 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.198 1.799 . . . . 0.0 110.79 175.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 67.8 m -145.25 153.96 53.16 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.567 0.747 . . . . 0.0 112.157 -169.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.42 172.93 15.34 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.94 3.094 . . . . 0.0 112.229 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.6 m 42.4 41.69 2.34 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.603 1.961 . . . . 0.0 115.495 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.61 26.84 17.08 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.807 1.67 . . . . 0.0 114.438 -174.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.1 mtt -70.0 170.79 10.62 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.782 1.291 . . . . 0.0 110.76 172.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -122.77 140.52 52.81 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.027 1.731 . . . . 0.0 110.448 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t -71.56 116.94 12.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.488 1.115 . . . . 0.0 110.868 173.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.8 p -70.52 161.77 30.01 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.518 1.127 . . . . 0.0 113.133 172.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -14.67 9.49 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.415 1.486 . . . . 0.0 114.212 166.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -78.5 -11.76 59.97 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.238 1.015 . . . . 0.0 113.047 170.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.6 16.68 67.84 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-N 118.674 0.67 . . . . 0.0 113.732 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -119.32 143.63 47.28 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.576 1.551 . . . . 0.0 111.977 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.5 m -77.4 151.94 34.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.598 1.159 . . . . 0.0 112.663 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.6 -170.41 43.49 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.656 1.122 . . . . 0.0 111.24 174.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -119.4 145.65 46.04 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.698 1.199 . . . . 0.0 111.061 -173.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.98 -173.88 24.84 Favored Glycine 0 CA--C 1.542 1.74 0 N-CA-C 115.932 1.133 . . . . 0.0 115.932 166.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -71.88 12.53 0.57 Allowed 'Trans proline' 0 CA--C 1.541 0.847 1 C-N-CA 125.881 4.387 . . . . 0.0 116.282 -161.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.59 -11.87 6.71 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 167.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -88.26 -58.06 2.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.501 1.52 . . . . 0.0 109.272 168.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.9 m . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 126.572 1.949 . . . . 0.0 110.872 177.019 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.9 mp0 . . . . . 0 CA--C 1.539 0.552 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.1 m -62.88 131.28 48.22 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.161 0.981 . . . . 0.0 110.458 168.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.473 ' C ' ' H ' ' A' ' 7' ' ' GLY . 21.9 t -74.09 77.36 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 128.746 2.819 . . . . 0.0 109.893 -169.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 52.94 1.32 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.99 1.716 . . . . 0.0 114.532 -158.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 5' ' ' VAL . . . 151.47 -20.71 0.93 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-O 118.264 -1.298 . . . . 0.0 114.285 174.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -90.48 170.38 10.26 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 119.453 1.626 . . . . 0.0 111.875 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.7 m -141.73 -179.73 1.04 Allowed Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 126.245 1.818 . . . . 0.0 107.935 174.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.79 152.1 18.11 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.96 2.44 . . . . 0.0 113.997 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.7 m -68.38 93.25 0.47 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.724 0.81 . . . . 0.0 111.302 -172.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.19 -8.95 4.12 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 126.021 1.772 . . . . 0.0 114.287 -169.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.55 176.04 0.1 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 129.468 3.107 . . . . 0.0 118.413 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.7 m -135.85 111.95 9.66 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.728 2.011 . . . . 0.0 108.476 143.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.0 t -60.92 116.92 4.84 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.15 -0.969 . . . . 0.0 110.239 169.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.1 p -68.08 159.18 31.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.828 0.851 . . . . 0.0 113.183 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -54.2 -27.26 33.04 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.52 1.128 . . . . 0.0 112.581 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 34.1 m0 -76.47 -2.53 32.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.593 1.557 . . . . 0.0 112.253 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.89 23.08 67.52 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.295 -0.725 . . . . 0.0 112.686 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.41 148.4 44.45 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.6 1.56 . . . . 0.0 112.695 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.4 m -86.51 153.29 21.96 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.07 1.748 . . . . 0.0 114.247 -178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.05 -161.92 31.87 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 127.044 2.259 . . . . 0.0 110.556 -177.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.11 157.95 43.79 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.846 2.458 . . . . 0.0 108.37 174.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.24 -174.68 18.43 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.809 1.195 . . . . 0.0 113.154 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.46 -14.8 40.73 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.95 2.434 . . . . 0.0 114.29 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.3 tptp -78.87 -4.22 48.58 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.172 1.389 . . . . 0.0 111.832 174.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -137.32 -54.92 0.7 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.537 1.535 . . . . 0.0 110.684 -158.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.2 m . . . . . 0 CA--C 1.544 0.737 0 C-N-CA 125.156 1.382 . . . . 0.0 113.191 169.683 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 . . . . . 0 CA--C 1.541 0.607 0 CA-C-O 120.965 0.412 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 m -66.0 146.66 54.43 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.605 -0.684 . . . . 0.0 111.262 170.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.1 t -50.73 -69.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.093 1.757 . . . . 0.0 109.73 -173.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -138.41 21.67 2.75 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 127.591 2.356 . . . . 0.0 111.201 142.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.62 -24.36 0.3 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.856 1.217 . . . . 0.0 113.809 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.3 169.86 14.25 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.476 1.11 . . . . 0.0 112.837 165.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.1 m -137.39 176.39 2.79 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 128.733 2.813 . . . . 0.0 108.845 173.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -52.88 168.82 0.43 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.653 2.902 . . . . 0.0 115.431 175.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.9 p -54.69 106.03 0.19 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.261 1.824 . . . . 0.0 111.632 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.57 9.18 64.95 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.402 -1.221 . . . . 0.0 114.578 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 54.0 mtt -110.92 166.93 10.64 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.364 1.466 . . . . 0.0 112.067 172.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.7 m -134.32 143.35 47.65 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.906 2.082 . . . . 0.0 111.006 -173.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.6 t -84.81 115.81 22.94 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.626 1.57 . . . . 0.0 111.793 177.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.1 t -70.72 159.49 34.38 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 172.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -48.35 -24.22 1.16 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.555 2.342 . . . . 0.0 113.538 168.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -83.55 -4.47 58.58 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.132 1.773 . . . . 0.0 113.172 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.42 13.05 68.75 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.102 0.858 . . . . 0.0 114.433 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -122.0 153.33 38.71 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.677 1.591 . . . . 0.0 112.336 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.4 m -88.39 158.13 18.49 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.557 1.543 . . . . 0.0 113.426 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.22 -165.1 38.01 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -137.37 163.82 30.1 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.859 0.863 . . . . 0.0 111.185 -175.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.34 -170.25 52.16 Favored Glycine 0 CA--C 1.539 1.547 0 N-CA-C 114.756 0.663 . . . . 0.0 114.756 172.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.35 13.4 0.55 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 124.708 3.605 . . . . 0.0 115.469 -166.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.27 9.95 7.99 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.363 1.065 . . . . 0.0 112.44 169.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -138.69 -50.78 0.55 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 125.749 1.62 . . . . 0.0 110.862 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.1 m . . . . . 0 CA--C 1.539 0.526 0 C-N-CA 123.759 0.824 . . . . 0.0 109.026 161.359 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.407 ' OE2' ' OH ' ' A' ' 20' ' ' TYR . 6.3 mp0 . . . . . 0 CA--C 1.548 0.871 0 CA-C-O 122.082 0.944 . . . . 0.0 112.263 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 41.2 m -65.23 102.27 0.64 Allowed 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.529 -1.357 . . . . 0.0 108.003 157.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -4.57 -88.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 130.641 3.577 . . . . 0.0 112.515 -156.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 67.9 mmt-85 -130.16 41.19 3.44 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.051 0.941 . . . . 0.0 109.526 143.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 157.67 -10.12 0.23 Allowed Glycine 0 CA--C 1.534 1.25 0 N-CA-C 116.254 1.262 . . . . 0.0 116.254 163.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -121.65 178.79 4.69 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 119.839 1.819 . . . . 0.0 112.883 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 39.8 m -127.59 166.78 21.05 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 124.651 1.18 . . . . 0.0 110.586 173.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.67 149.85 13.19 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.432 2.755 . . . . 0.0 112.537 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.7 m -69.49 76.27 0.4 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.542 1.537 . . . . 0.0 111.682 -171.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.38 -17.07 1.14 Allowed Glycine 0 CA--C 1.537 1.432 0 C-N-CA 126.249 1.881 . . . . 0.0 114.231 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.1 mtt -86.43 -168.59 2.29 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.674 1.737 . . . . 0.0 112.261 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.76 160.9 41.08 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.651 2.381 . . . . 0.0 110.159 162.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.1 t -98.24 120.78 39.24 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.402 1.881 . . . . 0.0 112.044 -173.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.1 t -76.43 159.19 30.67 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -7.92 7.07 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 160.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -71.59 -10.34 59.62 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.38 1.072 . . . . 0.0 112.436 164.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.63 13.8 82.0 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.492 1.044 . . . . 0.0 113.723 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.407 ' OH ' ' OE2' ' A' ' 3' ' ' GLU . 17.9 m-85 -130.27 164.12 25.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.444 1.898 . . . . 0.0 111.495 -178.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 78.0 m -94.32 158.24 15.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.823 1.249 . . . . 0.0 113.83 -172.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.57 -156.18 26.92 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.175 1.369 . . . . 0.0 111.102 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.7 tptt -138.34 164.47 29.21 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.839 1.656 . . . . 0.0 111.662 171.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.06 -176.18 31.59 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 124.119 0.866 . . . . 0.0 114.263 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.31 18.57 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.861 1 C-N-CA 125.745 4.296 . . . . 0.0 115.087 -168.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.49 6.46 6.92 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.889 1.276 . . . . 0.0 112.447 170.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -134.28 -48.88 0.78 Allowed 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 128.049 2.54 . . . . 0.0 109.911 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.1 m . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 125.696 1.598 . . . . 0.0 111.565 173.373 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 . . . . . 0 CA--C 1.545 0.75 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.5 m -47.18 140.9 4.83 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.032 1.733 . . . . 0.0 112.094 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.8 t -30.44 -70.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 128.377 2.671 . . . . 0.0 112.908 -152.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -123.01 21.12 9.87 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.194 1.798 . . . . 0.0 110.415 138.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.07 -21.34 0.5 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.975 1.274 . . . . 0.0 114.985 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -98.78 -178.29 3.92 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.188 1.395 . . . . 0.0 111.971 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.9 m -130.95 170.43 11.24 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.737 1.215 . . . . 0.0 112.026 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.98 177.0 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 125.231 3.954 . . . . 0.0 115.386 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.7 p -53.86 90.83 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.107 2.163 . . . . 0.0 113.764 -174.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.77 -1.52 75.12 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.255 1.407 . . . . 0.0 114.661 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.29 170.27 16.87 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.369 1.585 . . . . 0.0 110.795 175.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.1 m -134.4 137.3 43.96 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.532 1.533 . . . . 0.0 110.805 -168.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 32.2 t -86.83 115.39 24.22 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.14 1.376 . . . . 0.0 110.865 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.4 t -74.44 164.88 26.08 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.628 0.728 . . . . 0.0 112.745 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -45.44 -23.13 0.18 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.948 2.499 . . . . 0.0 114.373 158.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -66.6 -16.67 64.35 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.621 1.568 . . . . 0.0 112.54 173.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.18 10.11 86.47 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.629 1.109 . . . . 0.0 113.14 -167.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -121.4 153.57 37.65 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.88 1.672 . . . . 0.0 111.269 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.1 m -84.01 155.5 22.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.116 0.967 . . . . 0.0 113.58 -177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.52 -155.44 15.77 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.142 1.829 . . . . 0.0 110.244 174.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -145.02 161.68 38.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.706 1.602 . . . . 0.0 109.965 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.79 -172.38 35.53 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.486 0.954 . . . . 0.0 115.486 172.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.19 -0.7 0.68 Allowed 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 126.11 4.54 . . . . 0.0 117.96 -172.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.412 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -125.74 9.74 7.68 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.39 0.995 . . . . 0.0 112.636 175.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -136.91 -47.07 0.59 Allowed 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 125.218 1.407 . . . . 0.0 112.409 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.441 0 CA-C-N 118.153 0.433 . . . . 0.0 110.432 159.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 CA--C 1.54 0.569 0 CA-C-O 121.801 0.81 . . . . 0.0 111.854 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.9 m -57.45 138.67 54.78 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 157.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.2 t -31.88 -68.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 128.261 2.624 . . . . 0.0 112.461 -158.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -123.32 19.11 9.8 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.491 1.916 . . . . 0.0 110.423 134.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.23 -26.78 0.32 Allowed Glycine 0 CA--C 1.54 1.597 0 C-N-CA 125.309 1.433 . . . . 0.0 114.806 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -85.23 -179.01 6.91 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.748 1.619 . . . . 0.0 111.633 172.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.7 m -134.49 142.66 43.59 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.158 0.983 . . . . 0.0 111.258 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -80.4 174.89 10.78 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.764 2.976 . . . . 0.0 111.584 172.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.1 m 37.74 46.99 0.78 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 127.672 2.389 . . . . 0.0 115.599 167.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.03 11.3 54.61 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-O 118.346 -1.252 . . . . 0.0 115.843 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.3 mmt -72.68 172.28 10.98 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.264 2.032 . . . . 0.0 112.206 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m -122.12 137.67 54.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.935 2.094 . . . . 0.0 111.006 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -86.87 117.77 25.82 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.945 0.898 . . . . 0.0 111.309 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.0 p -75.26 159.81 31.09 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.309 1.044 . . . . 0.0 113.29 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -59.2 -13.58 7.99 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.031 1.732 . . . . 0.0 113.961 167.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -75.56 -9.33 58.48 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.838 1.255 . . . . 0.0 112.45 171.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.93 9.82 86.66 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.064 0.84 . . . . 0.0 113.106 -169.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -107.49 145.83 32.58 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.655 1.582 . . . . 0.0 111.872 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.9 t -96.42 143.83 27.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.238 1.015 . . . . 0.0 111.691 -175.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.68 -160.42 29.63 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.891 -0.506 . . . . 0.0 112.918 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -132.82 163.1 29.82 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.45 1.5 . . . . 0.0 111.999 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.65 177.68 31.05 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.64 1.114 . . . . 0.0 113.947 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.01 8.87 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 124.551 3.5 . . . . 0.0 115.246 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 tpmp? -123.78 10.21 8.94 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.309 0.959 . . . . 0.0 112.144 169.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -125.37 -55.26 1.55 Allowed 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 126.608 1.963 . . . . 0.0 110.04 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 64.1 m . . . . . 0 CA--C 1.536 0.412 0 C-N-CA 124.049 0.939 . . . . 0.0 110.847 167.216 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 CA--C 1.539 0.529 0 CA-C-O 121.707 0.765 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.6 m -56.16 133.67 52.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 161.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.1 t -19.95 -76.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 129.2 3.0 . . . . 0.0 113.173 -160.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -122.41 25.14 9.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.804 2.042 . . . . 0.0 109.88 139.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.03 -6.92 0.45 Allowed Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.216 1.389 . . . . 0.0 115.45 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -114.13 -178.08 3.29 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.229 2.212 . . . . 0.0 112.38 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.5 m -144.75 159.93 48.97 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.661 1.584 . . . . 0.0 110.342 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.04 166.96 28.06 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.135 2.557 . . . . 0.0 113.123 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.5 m -56.63 92.71 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.12 2.168 . . . . 0.0 113.117 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.76 -8.5 6.46 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.415 1.483 . . . . 0.0 113.954 -176.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -122.03 165.54 15.87 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.56 1.944 . . . . 0.0 111.26 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.6 m -142.27 157.44 44.83 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.834 1.654 . . . . 0.0 111.047 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.3 t -83.53 118.92 24.11 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.621 0.768 . . . . 0.0 111.175 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 90.2 p -72.09 165.52 24.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.493 1.139 . . . . 0.0 113.225 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.477 ' CD ' ' H ' ' A' ' 17' ' ' GLN . 5.7 mp0 -60.04 -17.13 36.8 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.355 1.862 . . . . 0.0 113.046 173.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -81.82 -7.61 59.62 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.322 1.449 . . . . 0.0 113.292 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.37 12.27 84.38 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 118.959 0.8 . . . . 0.0 113.336 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -105.07 146.03 29.67 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.791 1.637 . . . . 0.0 111.518 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.8 t -85.41 157.82 20.39 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.503 0.721 . . . . 0.0 112.095 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.36 -171.45 38.23 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.662 1.125 . . . . 0.0 111.921 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.89 175.77 9.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.176 0.988 . . . . 0.0 112.04 174.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.25 177.55 45.94 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.676 1.131 . . . . 0.0 111.755 -165.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.98 5.47 3.48 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.624 2.216 . . . . 0.0 116.097 -164.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -90.69 -8.22 50.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.265 0.939 . . . . 0.0 111.304 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -130.92 -51.27 1.04 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.754 2.422 . . . . 0.0 111.283 -168.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -148.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.453 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.4 pm0 . . . . . 0 N--CA 1.468 0.472 0 CA-C-O 121.538 0.685 . . . . 0.0 111.783 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.9 m -61.34 148.1 42.55 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.911 0.484 . . . . 0.0 111.442 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t -49.09 -66.61 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.906 1.682 . . . . 0.0 109.907 -173.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -138.3 19.24 2.76 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.023 2.129 . . . . 0.0 111.721 140.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.91 -19.36 0.2 Allowed Glycine 0 CA--C 1.532 1.12 0 N-CA-C 115.162 0.825 . . . . 0.0 115.162 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -99.87 173.79 6.51 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.209 1.404 . . . . 0.0 110.777 165.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.9 m -139.48 154.12 71.24 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.086 1.354 . . . . 0.0 110.939 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.45 170.45 15.95 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.553 2.835 . . . . 0.0 112.914 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.1 p 54.47 30.65 13.26 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 173.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.29 30.48 58.24 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.606 1.098 . . . . 0.0 113.399 -171.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.8 mmt -72.19 168.17 18.79 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.611 1.206 . . . . 0.0 109.782 163.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.0 m -124.13 130.85 53.24 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.081 1.752 . . . . 0.0 110.13 -173.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.9 t -73.1 102.32 3.53 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.978 0.911 . . . . 0.0 112.287 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.1 p -61.91 171.48 1.67 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 175.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -67.82 -11.27 58.2 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.246 1.418 . . . . 0.0 113.744 166.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -79.26 -4.45 50.75 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.183 0.901 . . . . 0.0 112.535 168.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.54 18.99 77.51 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.828 0.74 . . . . 0.0 112.741 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.71 146.58 46.3 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.936 1.694 . . . . 0.0 112.007 -176.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.1 m -84.09 157.46 21.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.844 1.658 . . . . 0.0 112.341 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.05 -172.55 39.09 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 128.05 2.738 . . . . 0.0 107.278 -174.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -132.39 163.68 28.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.047 1.424 . . . . 0.0 110.885 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.37 -165.98 36.07 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 114.882 0.713 . . . . 0.0 114.882 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.88 8.46 1.32 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 125.04 3.827 . . . . 0.0 115.722 -165.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.45 5.9 9.59 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.555 1.07 . . . . 0.0 113.41 168.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -133.45 -52.4 0.88 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.521 1.528 . . . . 0.0 111.733 -173.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 CA--C 1.537 0.462 0 C-N-CA 122.675 0.39 . . . . 0.0 110.031 162.47 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 CA--C 1.541 0.618 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.5 m -66.58 99.69 0.61 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 163.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t 2.73 -90.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 131.257 3.823 . . . . 0.0 111.547 -162.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 75.7 mmt-85 -131.06 41.97 3.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.774 1.23 . . . . 0.0 109.283 141.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.02 -16.36 0.08 OUTLIER Glycine 0 CA--C 1.538 1.486 0 N-CA-C 117.169 1.628 . . . . 0.0 117.169 165.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -130.77 175.77 8.76 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 120.583 2.191 . . . . 0.0 113.248 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.8 m -119.95 166.6 14.53 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 123.894 0.878 . . . . 0.0 111.018 173.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -51.57 149.85 17.46 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.27 2.647 . . . . 0.0 112.816 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.0 m -69.83 76.22 0.46 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.546 1.538 . . . . 0.0 111.206 -175.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 151.13 -19.84 0.95 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 126.113 1.816 . . . . 0.0 113.93 -171.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.5 mmt -86.5 -167.29 1.82 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.307 1.843 . . . . 0.0 111.575 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 p -147.43 162.17 39.55 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.494 1.918 . . . . 0.0 110.749 161.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.7 t -102.04 114.11 27.93 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.169 1.788 . . . . 0.0 111.997 -171.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.4 t -65.77 147.55 53.2 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.153 0.581 . . . . 0.0 111.747 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.5 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -60.74 -8.44 2.98 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.951 1.7 . . . . 0.0 114.666 175.134 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -90.7 -2.43 57.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.098 1.359 . . . . 0.0 113.792 168.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.4 18.14 31.77 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.287 -1.285 . . . . 0.0 115.542 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -127.77 152.86 47.23 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.283 1.541 . . . . 0.0 112.707 -175.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.8 m -91.11 155.97 18.24 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.57 -161.22 35.01 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.187 1.375 . . . . 0.0 111.251 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -134.77 161.72 34.39 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.76 1.624 . . . . 0.0 112.082 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.46 176.02 35.74 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.962 1.268 . . . . 0.0 112.701 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.44 -2.82 10.6 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.467 2.778 . . . . 0.0 115.257 -169.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -81.27 -16.95 51.05 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.449 1.099 . . . . 0.0 110.672 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -123.81 -42.79 2.16 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 129.014 2.926 . . . . 0.0 111.43 -167.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.2 m . . . . . 0 CA--C 1.541 0.625 0 C-N-CA 125.339 1.455 . . . . 0.0 113.268 -179.35 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 121.645 0.736 . . . . 0.0 112.617 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.0 m -54.25 129.28 34.62 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.994 0.918 . . . . 0.0 109.48 162.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.2 t -22.47 -74.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 128.833 2.853 . . . . 0.0 113.163 -158.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -122.87 23.44 9.38 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.765 2.026 . . . . 0.0 110.077 138.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.33 -5.05 0.2 Allowed Glycine 0 CA--C 1.536 1.356 0 N-CA-C 116.171 1.229 . . . . 0.0 116.171 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -115.01 167.87 10.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.694 1.747 . . . . 0.0 112.056 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 72.9 m -152.73 173.01 4.92 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 125.912 1.685 . . . . 0.0 110.066 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -58.39 -178.0 0.11 Allowed 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 125.797 4.331 . . . . 0.0 118.894 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.6 m -43.8 105.18 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 129.016 2.926 . . . . 0.0 114.299 -178.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.74 33.26 86.31 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 123.885 0.755 . . . . 0.0 113.356 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.01 167.89 0.14 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.721 1.608 . . . . 0.0 114.985 170.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -134.69 88.29 2.42 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.002 156.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.2 t -50.55 112.51 0.71 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.186 0.995 . . . . 0.0 110.359 173.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.7 t -61.22 152.38 29.01 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.987 0.915 . . . . 0.0 111.119 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -64.1 -18.27 64.25 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -90.66 3.67 53.54 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.672 1.989 . . . . 0.0 111.929 175.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.36 6.89 47.09 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-O 118.109 -1.384 . . . . 0.0 115.831 162.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -114.62 152.77 31.31 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.638 1.719 . . . . 0.0 113.765 -169.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.6 m -79.37 152.28 30.49 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.67 -175.76 31.9 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 127.218 2.342 . . . . 0.0 109.514 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -141.65 158.15 44.18 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.927 2.091 . . . . 0.0 109.351 -175.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.44 -176.56 24.35 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 123.82 0.724 . . . . 0.0 114.67 171.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.45 -1.61 8.51 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.415 3.41 . . . . 0.0 115.854 -166.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -115.99 7.01 14.24 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.83 1.252 . . . . 0.0 111.847 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -120.39 -52.16 2.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 126.721 2.009 . . . . 0.0 109.905 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.2 m . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 164.739 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.479 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.7 pm0 . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 121.217 0.532 . . . . 0.0 111.836 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.0 m -64.81 139.53 58.77 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.214 0.606 . . . . 0.0 110.74 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.0 t -52.77 -66.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.262 1.825 . . . . 0.0 111.287 -165.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.3 mmt-85 -129.68 16.97 5.83 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.476 1.91 . . . . 0.0 110.269 151.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.98 -23.25 2.28 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.933 1.73 . . . . 0.0 113.007 -176.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.17 157.95 33.79 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.035 0.918 . . . . 0.0 112.225 168.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.5 m -149.24 -179.12 0.91 Allowed Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 130.0 3.32 . . . . 0.0 107.461 174.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -55.81 177.97 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.637 3.558 . . . . 0.0 117.774 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.2 m -53.77 121.77 8.57 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.851 1.66 . . . . 0.0 111.607 174.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.46 4.67 80.81 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.624 -1.098 . . . . 0.0 115.349 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.81 165.89 0.17 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 176.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.9 m -136.69 99.29 4.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.481 154.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.0 t -51.41 113.08 0.86 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.3 1.04 . . . . 0.0 110.66 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.3 t -67.6 160.51 27.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.294 1.438 . . . . 0.0 113.435 -169.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -57.86 -20.49 36.79 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.273 1.029 . . . . 0.0 112.712 161.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.43 ' CD2' ' HE2' ' A' ' 26' ' ' LYS . 6.1 m-90 -79.18 -2.39 40.69 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.441 1.496 . . . . 0.0 112.987 170.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.36 18.69 79.01 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.405 1.002 . . . . 0.0 113.877 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -121.44 155.45 34.84 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.849 1.66 . . . . 0.0 113.022 -172.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.98 152.42 28.0 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.288 1.835 . . . . 0.0 112.304 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.91 -170.79 30.68 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.645 1.117 . . . . 0.0 111.104 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -146.8 165.67 28.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 129.879 3.272 . . . . 0.0 109.698 -172.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.56 -170.29 38.43 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.505 1.05 . . . . 0.0 112.943 -171.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.56 3.04 7.18 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.617 2.878 . . . . 0.0 115.648 -171.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.43 ' HE2' ' CD2' ' A' ' 18' ' ' TRP . 1.6 ttpm? -98.19 11.69 36.98 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 119.534 1.061 . . . . 0.0 111.823 172.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -147.24 -53.02 0.21 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.898 2.479 . . . . 0.0 110.179 -164.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.453 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.7 pm0 . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 121.587 0.708 . . . . 0.0 111.797 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.3 m -64.0 154.84 32.95 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.689 0.796 . . . . 0.0 111.005 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.9 t -45.7 -67.21 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.987 1.715 . . . . 0.0 110.191 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -138.49 23.18 2.72 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.246 2.218 . . . . 0.0 110.907 139.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.78 -11.14 0.2 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.1 0.857 . . . . 0.0 114.957 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -105.89 165.69 11.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.561 1.944 . . . . 0.0 111.312 170.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.3 m -155.56 178.52 1.63 Allowed Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 127.079 2.152 . . . . 0.0 109.24 -170.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -57.54 178.71 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.941 3.761 . . . . 0.0 118.137 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.9 m -42.87 109.13 0.12 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 128.214 2.606 . . . . 0.0 114.0 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.19 29.12 74.51 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.235 -0.759 . . . . 0.0 114.041 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.72 168.7 0.4 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 170.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -132.73 106.27 7.66 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 113.377 -1.738 . . . . 0.0 108.712 147.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.1 t -54.68 117.48 3.41 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.336 -0.852 . . . . 0.0 110.569 170.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 t -64.95 164.1 13.29 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.05 0.94 . . . . 0.0 113.091 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -60.51 -18.92 55.04 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.672 1.989 . . . . 0.0 111.5 168.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 30.5 m0 -90.97 0.75 57.46 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.739 2.016 . . . . 0.0 113.391 172.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.98 25.21 69.73 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.858 -0.968 . . . . 0.0 114.24 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -120.01 152.69 37.12 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.909 1.684 . . . . 0.0 112.527 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.3 m -81.86 151.05 27.5 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.148 1.379 . . . . 0.0 113.072 -177.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.48 -165.23 32.86 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.539 2.018 . . . . 0.0 108.471 -174.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.75 160.79 42.85 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.588 1.955 . . . . 0.0 108.907 177.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.35 -169.81 26.59 Favored Glycine 0 CA--C 1.543 1.796 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 171.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -54.64 -10.13 2.23 Favored 'Trans proline' 0 CA--C 1.538 0.713 1 C-N-CA 126.101 4.534 . . . . 0.0 119.143 -170.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.438 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -119.14 12.34 12.63 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.87 1.214 . . . . 0.0 112.636 176.138 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -129.96 -70.48 0.64 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 127.346 2.258 . . . . 0.0 108.085 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.539 0.548 0 C-N-CA 124.111 0.964 . . . . 0.0 113.331 170.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.6 mp0 . . . . . 0 CA--C 1.542 0.656 0 CA-C-O 121.102 0.477 . . . . 0.0 112.213 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.9 m -69.51 156.76 38.37 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.794 -0.566 . . . . 0.0 110.774 163.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.4 t -49.18 -70.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.272 1.829 . . . . 0.0 109.613 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -141.92 17.28 2.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 127.717 2.407 . . . . 0.0 111.916 145.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 171.38 -17.84 0.06 OUTLIER Glycine 0 CA--C 1.532 1.106 0 N-CA-C 115.455 0.942 . . . . 0.0 115.455 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -121.76 179.43 4.49 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.136 1.374 . . . . 0.0 111.821 168.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.51 -173.51 0.36 Allowed Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 127.384 2.274 . . . . 0.0 109.105 173.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.02 151.97 15.17 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.063 2.508 . . . . 0.0 113.792 174.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.9 m -72.12 30.07 0.05 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 -159.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -130.45 -4.78 4.32 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 127.391 2.424 . . . . 0.0 115.029 165.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -179.67 0.15 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.055 2.542 . . . . 0.0 117.452 -176.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.07 96.08 2.83 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.493 1.117 . . . . 0.0 110.206 146.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.7 t -49.82 115.02 1.21 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.234 1.014 . . . . 0.0 111.899 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.6 t -70.04 152.56 44.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.81 1.244 . . . . 0.0 111.081 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -6.12 7.61 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 171.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -6.51 50.12 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.542 1.137 . . . . 0.0 113.159 163.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.96 23.94 60.76 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.996 0.816 . . . . 0.0 113.493 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -126.8 159.02 35.05 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.393 1.877 . . . . 0.0 112.467 -174.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.0 m -115.05 165.83 12.47 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.05 1.34 . . . . 0.0 113.218 -175.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.48 -170.65 24.33 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 -162.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -139.48 161.99 36.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.527 2.331 . . . . 0.0 109.872 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.27 -174.63 28.74 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 123.936 0.779 . . . . 0.0 113.35 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -57.96 -16.11 25.03 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 124.011 3.141 . . . . 0.0 117.551 -169.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.79 -7.14 59.53 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.544 1.066 . . . . 0.0 111.359 178.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -134.08 -58.76 0.85 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.991 2.116 . . . . 0.0 110.198 -160.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.0 m . . . . . 0 CA--C 1.539 0.546 0 C-N-CA 126.781 2.032 . . . . 0.0 113.008 -177.506 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.7 pm0 . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.4 m -34.17 119.76 0.42 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 128.939 2.896 . . . . 0.0 112.406 -168.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.2 t 0.92 -85.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 130.18 3.392 . . . . 0.0 112.426 -160.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -130.94 32.59 4.3 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.608 2.363 . . . . 0.0 109.171 140.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 164.37 -11.96 0.08 OUTLIER Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.864 1.697 . . . . 0.0 115.76 172.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -121.94 174.46 6.88 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.333 1.853 . . . . 0.0 113.456 -172.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.1 m -150.58 175.74 2.67 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 126.912 2.085 . . . . 0.0 109.188 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -57.39 178.41 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 125.129 3.886 . . . . 0.0 118.577 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -50.52 120.14 4.39 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.647 1.579 . . . . 0.0 112.364 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.78 32.33 74.18 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 118.761 -1.022 . . . . 0.0 113.808 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.37 166.86 2.1 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 169.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.8 m -133.81 94.26 3.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.648 1.979 . . . . 0.0 107.421 152.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -50.42 113.3 0.85 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.868 0.867 . . . . 0.0 109.381 170.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.5 t -64.95 159.45 22.89 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.023 0.916 . . . . 0.0 112.53 -169.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.447 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -48.82 -26.1 2.22 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.903 2.481 . . . . 0.0 113.552 169.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -100.23 3.33 43.53 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.728 2.011 . . . . 0.0 112.664 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.31 8.61 58.6 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.955 -1.47 . . . . 0.0 115.661 169.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -118.59 158.67 24.99 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.617 2.209 . . . . 0.0 113.328 -172.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.5 m -89.47 156.07 18.9 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -167.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.56 -166.43 27.75 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 128.07 2.747 . . . . 0.0 109.596 -175.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.39 170.26 21.79 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.996 1.318 . . . . 0.0 110.895 163.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 126.69 172.19 13.25 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.612 1.577 . . . . 0.0 112.63 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.24 -23.03 16.85 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 124.575 3.517 . . . . 0.0 117.545 -169.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.8 -4.54 11.6 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.487 1.115 . . . . 0.0 113.607 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -76.36 -55.9 5.13 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.634 1.174 . . . . 0.0 109.23 155.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.4 m . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 125.499 1.52 . . . . 0.0 112.962 -179.205 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 . . . . . 0 CA--C 1.545 0.769 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 62.7 m -45.72 140.93 3.17 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.749 1.62 . . . . 0.0 112.091 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t -33.23 -67.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 127.931 2.492 . . . . 0.0 112.877 -155.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -124.16 19.66 9.07 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.402 1.881 . . . . 0.0 110.517 138.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.4 -19.2 0.81 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.732 1.158 . . . . 0.0 115.053 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.5 ptp85 -96.78 177.3 5.69 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.45 1.5 . . . . 0.0 111.559 172.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -137.57 169.37 13.25 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.798 1.239 . . . . 0.0 112.459 -172.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.23 167.99 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.613 3.542 . . . . 0.0 114.842 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 m -38.68 96.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.388 2.675 . . . . 0.0 114.628 -174.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.71 3.39 90.53 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 118.268 -1.296 . . . . 0.0 115.8 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.2 mmt -78.27 173.46 12.26 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 120.19 1.995 . . . . 0.0 112.716 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.9 m -119.3 136.28 54.32 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.609 2.364 . . . . 0.0 109.722 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.6 t -75.9 113.91 13.93 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.945 0.498 . . . . 0.0 109.738 166.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.2 t -62.35 151.28 37.2 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.996 0.903 . . . . 0.0 110.359 167.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.411 ' CD ' ' H ' ' A' ' 17' ' ' GLN . 17.8 mp0 -72.7 -4.93 34.24 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.557 1.543 . . . . 0.0 111.33 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -75.47 -11.19 59.98 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.486 1.914 . . . . 0.0 113.597 162.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.53 9.91 48.94 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.457 1.504 . . . . 0.0 115.195 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -131.07 147.18 52.59 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.928 1.864 . . . . 0.0 113.193 -171.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 82.6 m -82.99 149.51 26.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -169.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.02 -160.3 33.18 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.074 1.321 . . . . 0.0 111.827 176.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.6 tptt -135.94 162.1 33.78 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.395 1.478 . . . . 0.0 112.165 176.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.05 178.73 36.03 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.761 1.172 . . . . 0.0 113.862 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.34 19.29 0.53 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 125.271 3.981 . . . . 0.0 114.697 -170.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm -121.42 4.44 10.21 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.325 1.85 . . . . 0.0 111.616 169.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -130.14 -63.34 0.91 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.815 2.446 . . . . 0.0 108.876 -177.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.1 m . . . . . 0 CA--C 1.545 0.76 0 C-N-CA 125.11 1.364 . . . . 0.0 113.56 174.245 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 CA--C 1.551 0.994 0 CA-C-O 123.018 1.39 . . . . 0.0 114.129 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 62.2 m -58.21 116.82 3.81 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.607 -1.308 . . . . 0.0 108.185 148.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -4.67 -81.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 131.056 3.742 . . . . 0.0 113.67 -160.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -129.27 22.38 5.63 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.114 2.165 . . . . 0.0 109.807 147.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.6 -14.38 0.07 OUTLIER Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.543 1.377 . . . . 0.0 116.543 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -125.38 179.74 4.97 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 120.046 1.923 . . . . 0.0 113.029 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.4 m -124.0 157.1 64.72 Favored Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 124.635 1.174 . . . . 0.0 109.496 169.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.42 150.63 88.02 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.05 1.833 . . . . 0.0 110.78 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.5 m -65.48 88.14 0.09 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.831 1.252 . . . . 0.0 112.326 -166.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.95 -17.04 3.22 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.1 1.809 . . . . 0.0 113.491 -173.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 mmt -94.59 170.75 9.24 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.724 1.609 . . . . 0.0 109.712 158.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -142.39 161.9 36.85 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.988 1.715 . . . . 0.0 110.906 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.5 t -103.91 115.87 31.24 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.939 1.695 . . . . 0.0 112.097 -166.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.407 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 7.7 t -77.87 167.88 20.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 122.302 1.049 . . . . 0.0 113.011 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.409 ' CD ' ' H ' ' A' ' 17' ' ' GLN . 11.1 mp0 -65.29 -16.72 63.86 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.313 2.245 . . . . 0.0 112.108 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -74.72 -5.98 46.28 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.704 2.002 . . . . 0.0 112.98 170.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.72 23.01 65.4 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.941 -0.922 . . . . 0.0 113.532 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -131.06 153.8 48.91 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.541 1.536 . . . . 0.0 112.716 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 74.5 m -84.17 160.99 20.73 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.597 1.159 . . . . 0.0 113.785 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.28 -158.8 31.88 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.919 2.199 . . . . 0.0 107.88 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -138.32 158.57 44.03 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.788 1.235 . . . . 0.0 110.8 -177.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.88 -178.14 40.55 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 123.962 0.791 . . . . 0.0 113.912 172.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.78 -13.51 6.17 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 125.07 3.847 . . . . 0.0 118.032 -167.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -96.94 -8.77 29.86 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.808 1.185 . . . . 0.0 111.956 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.407 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 92.1 m-85 -120.5 -41.79 2.58 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 128.335 2.654 . . . . 0.0 110.397 -174.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.6 m . . . . . 0 CA--C 1.547 0.84 0 C-N-CA 126.708 2.003 . . . . 0.0 112.555 179.962 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.2 m -46.78 142.16 3.51 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.796 1.638 . . . . 0.0 112.23 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.6 t -18.73 -76.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 129.555 3.142 . . . . 0.0 113.139 -163.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -124.08 25.61 7.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.173 2.189 . . . . 0.0 109.924 140.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.97 -6.39 2.04 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.482 1.515 . . . . 0.0 114.779 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -112.08 -177.92 3.29 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 127.683 2.393 . . . . 0.0 111.58 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -160.93 172.55 5.69 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 126.249 1.82 . . . . 0.0 109.59 169.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.49 178.97 6.93 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.158 2.572 . . . . 0.0 113.851 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.5 t 9.99 87.82 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 130.46 3.504 . . . . 0.0 116.06 169.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.48 34.25 74.82 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.3 0.953 . . . . 0.0 114.789 171.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.08 167.0 4.22 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 169.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.7 m -132.76 94.64 3.43 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.07 156.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -51.2 107.35 0.18 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.859 0.863 . . . . 0.0 110.734 160.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.2 p -64.79 164.55 12.08 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.709 1.204 . . . . 0.0 112.873 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.76 -21.22 60.46 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.0 0.92 . . . . 0.0 112.44 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -74.25 -10.54 59.7 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.806 1.642 . . . . 0.0 112.607 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.61 12.84 63.98 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.477 1.037 . . . . 0.0 113.802 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -124.86 142.49 51.41 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.841 1.32 . . . . 0.0 111.676 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.8 m -81.02 162.34 23.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.473 1.109 . . . . 0.0 113.289 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.86 -161.02 34.84 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 127.685 2.564 . . . . 0.0 106.857 -175.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.56 167.53 23.48 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.564 1.546 . . . . 0.0 109.309 173.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.47 -176.07 39.69 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 123.851 0.738 . . . . 0.0 114.52 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.69 9.2 0.79 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 124.83 3.686 . . . . 0.0 115.817 -165.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 tpmp? -125.64 6.8 7.52 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.287 0.949 . . . . 0.0 113.017 170.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -124.62 -54.41 1.66 Allowed 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 126.487 1.915 . . . . 0.0 109.729 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.6 m . . . . . 0 CA--C 1.536 0.408 0 C-N-CA 124.101 0.96 . . . . 0.0 109.527 164.811 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 . . . . . 0 CA--C 1.545 0.787 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.5 m -43.52 138.33 2.52 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.439 1.896 . . . . 0.0 111.732 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.8 t -28.36 -71.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 128.832 2.853 . . . . 0.0 113.101 -154.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -122.57 19.58 10.37 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.254 1.821 . . . . 0.0 110.402 140.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.18 -20.97 0.29 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.42 1.009 . . . . 0.0 114.857 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -106.42 177.68 4.78 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 124.962 1.305 . . . . 0.0 112.335 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.7 m -142.25 179.81 1.13 Allowed Pre-proline 0 CA--C 1.559 1.321 0 C-N-CA 125.957 1.703 . . . . 0.0 110.353 -174.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.97 -173.06 1.52 Allowed 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 123.676 2.917 . . . . 0.0 115.42 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.1 m -41.68 108.08 0.09 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.549 2.74 . . . . 0.0 114.688 -174.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.72 29.64 75.03 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.088 0.851 . . . . 0.0 113.864 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.99 172.63 0.94 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 171.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.86 115.75 9.24 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 113.15 -1.841 . . . . 0.0 109.665 148.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.7 t -62.95 113.11 2.89 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.658 -1.276 . . . . 0.0 110.537 172.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.3 p -61.36 162.02 8.42 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.327 1.051 . . . . 0.0 112.778 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -71.2 -15.95 62.49 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 53.4 m0 -75.0 -9.32 58.42 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.017 1.727 . . . . 0.0 112.603 167.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.78 16.4 51.85 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.459 -1.19 . . . . 0.0 114.447 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -124.42 148.62 47.48 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.693 1.746 . . . . 0.0 112.772 -175.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 67.1 m -73.11 154.41 40.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.551 1.54 . . . . 0.0 113.259 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.26 -168.15 37.14 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.806 1.67 . . . . 0.0 109.07 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -142.01 149.6 40.22 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.754 2.022 . . . . 0.0 109.537 -175.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.76 -171.52 30.37 Favored Glycine 0 CA--C 1.542 1.78 0 N-CA-C 114.829 0.692 . . . . 0.0 114.829 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.64 -14.28 7.17 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 125.126 3.884 . . . . 0.0 118.231 -170.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -99.38 7.03 45.88 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.02 1.328 . . . . 0.0 111.693 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -141.94 -64.31 0.43 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.875 2.07 . . . . 0.0 109.317 -167.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.3 m . . . . . 0 CA--C 1.538 0.498 0 C-N-CA 127.341 2.256 . . . . 0.0 111.963 173.584 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 121.585 0.707 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.7 m -52.92 128.86 28.5 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 118.275 -0.869 . . . . 0.0 108.917 163.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.5 t -13.39 -79.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 129.39 3.076 . . . . 0.0 113.216 -157.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -123.8 27.67 7.19 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 127.252 2.221 . . . . 0.0 109.564 139.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.32 -2.74 0.1 OUTLIER Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.222 1.391 . . . . 0.0 116.189 176.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.6 mmt-85 -129.38 -177.46 4.26 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.157 1.783 . . . . 0.0 112.991 -172.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.2 m -143.67 158.79 56.06 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 125.073 1.349 . . . . 0.0 111.051 173.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.27 170.42 20.05 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.51 2.806 . . . . 0.0 112.947 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.6 m -44.97 99.85 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.836 2.455 . . . . 0.0 114.412 -173.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.31 -8.89 62.77 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.864 1.221 . . . . 0.0 114.899 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 45.5 mtt -90.81 164.73 13.97 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.872 1.269 . . . . 0.0 110.426 165.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.8 m -145.4 158.17 43.89 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.232 1.013 . . . . 0.0 111.805 -174.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.7 t -85.28 115.77 23.23 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.192 0.997 . . . . 0.0 111.274 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.4 p -70.94 165.41 23.42 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.342 1.068 . . . . 0.0 113.142 175.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.495 ' CD ' ' H ' ' A' ' 17' ' ' GLN . 6.1 mp0 -60.33 -17.23 41.62 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.513 1.925 . . . . 0.0 113.049 175.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -80.13 -7.97 59.18 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.276 1.431 . . . . 0.0 113.277 172.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.62 13.09 83.85 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 118.701 0.682 . . . . 0.0 113.124 -168.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -105.84 141.77 36.69 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.917 1.687 . . . . 0.0 111.486 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.0 t -82.68 157.33 23.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.236 0.615 . . . . 0.0 112.089 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.63 -172.51 42.5 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.788 0.709 . . . . 0.0 112.917 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -134.17 132.52 39.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.311 1.845 . . . . 0.0 106.754 -174.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.0 179.31 15.86 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.314 0.959 . . . . 0.0 112.295 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.75 0.83 5.07 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.934 2.422 . . . . 0.0 115.846 -171.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -95.8 -8.53 34.05 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.532 1.133 . . . . 0.0 111.614 172.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -124.03 -53.16 1.75 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.758 2.423 . . . . 0.0 110.436 -169.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 32.7 m . . . . . 0 CA--C 1.536 0.422 0 C-N-CA 127.084 2.154 . . . . 0.0 114.23 -164.687 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.624 0 CA-C-O 120.983 0.421 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 41.7 m -53.55 146.23 13.34 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.4 1.88 . . . . 0.0 112.012 -175.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.5 t -44.93 -62.43 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.576 1.951 . . . . 0.0 111.334 -160.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -135.8 29.31 3.19 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.84 1.656 . . . . 0.0 110.259 129.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.27 -35.97 0.24 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.917 0.77 . . . . 0.0 114.555 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -88.41 177.09 6.92 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.703 1.252 . . . . 0.0 111.162 172.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.0 m -127.69 172.92 6.03 Favored Pre-proline 0 C--O 1.24 0.595 0 C-N-CA 125.035 1.334 . . . . 0.0 110.856 176.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.57 150.24 8.93 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.988 2.459 . . . . 0.0 112.196 171.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.5 m -67.89 79.94 0.21 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.325 1.45 . . . . 0.0 112.624 -166.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 144.14 -17.64 2.12 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.627 2.06 . . . . 0.0 113.94 -175.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.6 mtt -84.56 178.77 7.58 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.552 1.676 . . . . 0.0 112.728 174.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.7 m -129.03 146.85 50.9 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.767 2.427 . . . . 0.0 110.278 173.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.8 t -88.69 111.64 22.19 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.761 1.625 . . . . 0.0 111.039 173.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 t -67.38 155.98 37.62 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.824 0.85 . . . . 0.0 111.217 172.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -9.81 48.28 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.794 -1.191 . . . . 0.0 114.138 176.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.422 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 54.0 m0 -70.08 -5.17 24.92 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.833 1.253 . . . . 0.0 113.001 164.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.29 14.36 68.98 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.043 1.306 . . . . 0.0 113.759 176.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -120.81 154.22 36.04 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.869 1.668 . . . . 0.0 113.053 -175.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 94.3 m -93.34 147.41 22.96 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.012 1.325 . . . . 0.0 113.848 -174.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.25 -161.61 32.59 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.215 0.912 . . . . 0.0 112.071 176.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.7 tptt -134.24 167.54 20.5 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.835 1.654 . . . . 0.0 111.763 172.399 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.91 172.78 36.01 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.994 1.283 . . . . 0.0 112.569 -174.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.77 4.19 3.27 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.842 3.028 . . . . 0.0 114.967 -170.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.422 ' HE3' ' CE2' ' A' ' 18' ' ' TRP . 1.7 tmtm? -109.14 3.71 22.18 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.066 1.303 . . . . 0.0 111.906 171.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -122.91 -41.22 2.36 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 126.333 1.853 . . . . 0.0 110.466 178.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 m . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 124.691 1.196 . . . . 0.0 113.592 173.764 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 CA--C 1.539 0.521 0 CA-C-O 122.028 0.918 . . . . 0.0 111.974 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.6 m -69.0 164.89 21.32 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.886 1.274 . . . . 0.0 111.45 176.291 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.0 t -47.14 -68.32 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 125.762 1.625 . . . . 0.0 110.072 -176.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -139.64 19.15 2.52 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.145 2.178 . . . . 0.0 111.599 142.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.01 -14.18 0.07 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 115.656 1.023 . . . . 0.0 115.656 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -121.54 177.55 5.18 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.344 1.458 . . . . 0.0 112.12 170.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.93 -178.02 0.74 Allowed Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 126.593 1.957 . . . . 0.0 109.799 174.218 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -83.05 -174.85 2.16 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.769 2.979 . . . . 0.0 112.745 173.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.5 m 21.85 79.59 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 129.96 3.304 . . . . 0.0 116.39 161.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.2 18.68 71.43 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 115.638 1.015 . . . . 0.0 115.638 168.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.59 167.23 1.53 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 174.064 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.0 m -134.73 96.19 3.5 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 113.015 -1.902 . . . . 0.0 108.024 154.114 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -50.78 110.96 0.47 Allowed 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.559 -0.713 . . . . 0.0 111.655 168.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.9 t -67.09 137.29 56.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.16 1.384 . . . . 0.0 109.357 174.621 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -6.48 4.96 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -166.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -69.45 -9.91 55.72 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.465 1.106 . . . . 0.0 112.998 165.347 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.38 18.17 24.6 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.902 1.715 . . . . 0.0 113.932 -177.059 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -122.95 145.06 48.81 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.686 1.243 . . . . 0.0 114.04 -166.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.1 t -100.98 152.93 19.98 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.554 1.142 . . . . 0.0 113.347 -162.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.79 -162.78 30.58 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 127.286 2.374 . . . . 0.0 110.054 -171.017 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.22 170.69 20.65 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.811 1.644 . . . . 0.0 110.394 169.339 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.26 -176.91 25.89 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.939 1.257 . . . . 0.0 112.651 -177.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.95 -10.75 30.02 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.009 2.473 . . . . 0.0 114.915 -173.003 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.37 -13.94 59.82 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.494 1.043 . . . . 0.0 111.221 170.029 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -128.98 -49.89 1.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.336 1.454 . . . . 0.0 110.932 -154.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.6 m . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 124.619 1.167 . . . . 0.0 112.83 169.993 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 4.3 pm0 . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 121.425 0.631 . . . . 0.0 112.495 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 m -61.73 138.51 58.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.921 0.488 . . . . 0.0 109.762 173.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -45.38 -66.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.643 1.977 . . . . 0.0 110.941 -162.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -133.58 25.09 4.07 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.991 1.716 . . . . 0.0 110.957 137.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.08 -34.43 0.26 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.019 0.819 . . . . 0.0 113.852 176.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -88.95 173.19 8.62 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 118.665 1.233 . . . . 0.0 112.364 174.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.4 m -148.35 179.74 1.12 Allowed Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 127.902 2.481 . . . . 0.0 108.444 -179.062 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.15 -175.25 1.18 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 123.685 2.923 . . . . 0.0 115.996 -178.128 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.8 m -44.11 108.04 0.1 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 128.598 2.759 . . . . 0.0 114.418 -173.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.08 29.75 75.59 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.87 0.748 . . . . 0.0 113.747 179.114 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.79 170.84 0.55 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 170.314 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.8 104.39 5.49 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 113.511 -1.677 . . . . 0.0 109.004 153.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -56.7 112.05 1.19 Allowed 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.288 -0.883 . . . . 0.0 110.719 173.006 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.403 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 81.0 p -73.56 168.07 20.05 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -173.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.523 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 1.4 mp0 -57.68 -20.04 31.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.544 1.938 . . . . 0.0 112.866 170.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.52 -4.32 55.63 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.257 1.423 . . . . 0.0 112.484 174.204 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.7 20.56 79.72 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.226 -0.763 . . . . 0.0 112.9 -170.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -120.24 144.89 47.52 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.028 1.731 . . . . 0.0 112.447 -175.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.9 m -73.34 155.48 39.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.428 1.491 . . . . 0.0 112.92 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.64 -169.38 33.43 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 126.132 1.825 . . . . 0.0 109.082 -177.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -145.29 159.58 42.82 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.417 2.287 . . . . 0.0 108.907 -175.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.44 -169.46 33.01 Favored Glycine 0 CA--C 1.539 1.588 0 N-CA-C 114.414 0.526 . . . . 0.0 114.414 173.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.66 -1.04 6.85 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 124.08 3.187 . . . . 0.0 116.733 -162.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.11 1.8 24.45 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.34 0.973 . . . . 0.0 112.71 170.427 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.403 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 86.3 m-85 -129.26 -57.08 1.16 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.47 1.908 . . . . 0.0 109.699 -167.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.614 0 C-N-CA 124.406 1.083 . . . . 0.0 113.555 169.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.9 pm0 . . . . . 0 N--CA 1.469 0.495 0 CA-C-O 121.101 0.477 . . . . 0.0 111.35 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.2 m -64.85 147.33 53.47 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.043 -0.411 . . . . 0.0 109.943 174.394 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.2 t -48.81 -67.1 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.725 1.21 . . . . 0.0 110.212 -174.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -137.19 23.72 3.0 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.123 2.169 . . . . 0.0 111.023 139.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.28 -28.8 0.34 Allowed Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.226 1.393 . . . . 0.0 113.33 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.46 151.29 42.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 117.928 0.864 . . . . 0.0 111.921 169.381 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.2 m -149.85 171.0 6.83 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 128.504 2.722 . . . . 0.0 109.792 -176.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.78 -176.25 2.9 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.986 3.124 . . . . 0.0 115.501 -173.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.8 t -45.32 119.7 2.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.97 1.708 . . . . 0.0 113.626 -173.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.37 29.59 75.0 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.352 0.977 . . . . 0.0 114.26 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.01 168.56 0.12 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 173.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -132.26 144.92 50.95 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 112.947 -1.933 . . . . 0.0 110.137 122.505 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 32.5 t -85.33 117.7 24.42 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.898 1.279 . . . . 0.0 109.356 168.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 t -65.9 153.2 42.66 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.328 0.651 . . . . 0.0 111.967 177.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -16.79 14.82 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.211 1.004 . . . . 0.0 112.518 167.42 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 27.8 m95 -76.24 -8.26 56.67 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.417 1.887 . . . . 0.0 113.119 172.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.92 14.15 61.31 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.467 1.032 . . . . 0.0 114.686 178.446 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -123.71 147.58 47.33 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.258 1.423 . . . . 0.0 112.804 -176.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 65.4 m -81.87 152.1 27.0 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.816 1.646 . . . . 0.0 112.349 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.9 -154.53 21.98 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 178.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 159.2 44.04 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.535 1.534 . . . . 0.0 109.613 176.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.54 -178.15 52.58 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 123.722 0.677 . . . . 0.0 113.489 178.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.73 2.02 2.8 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.469 3.446 . . . . 0.0 116.218 -166.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.73 -6.15 46.8 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 123.11 1.433 . . . . 0.0 111.031 172.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -132.01 -49.25 0.94 Allowed 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 127.919 2.488 . . . . 0.0 109.919 -169.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 67.3 m . . . . . 0 CA--C 1.548 0.886 0 C-N-CA 126.646 1.978 . . . . 0.0 112.013 167.991 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.443 ' H2 ' ' CD ' ' A' ' 3' ' ' GLU . 12.0 p . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 118.463 -0.779 . . . . 0.0 112.507 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.35 4.2 82.18 Favored Glycine 0 CA--C 1.534 1.273 0 N-CA-C 116.268 1.267 . . . . 0.0 116.268 -170.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.443 ' CD ' ' H2 ' ' A' ' 1' ' ' VAL . 3.2 pm0 -55.05 150.31 10.66 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.605 1.203 . . . . 0.0 112.62 174.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 97.9 m -38.96 127.56 1.61 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 128.486 2.715 . . . . 0.0 112.129 -173.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.5 t 1.34 -85.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 130.191 3.396 . . . . 0.0 112.192 -159.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -130.98 30.04 4.63 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.345 2.258 . . . . 0.0 109.771 142.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.97 -15.86 0.04 OUTLIER Glycine 0 CA--C 1.536 1.375 0 N-CA-C 116.656 1.422 . . . . 0.0 116.656 168.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -133.18 174.49 10.32 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 119.937 1.869 . . . . 0.0 113.662 -173.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.0 m -97.46 166.76 13.06 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.322 1.049 . . . . 0.0 111.638 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -50.68 149.58 13.68 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.94 2.427 . . . . 0.0 111.4 157.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.6 m -68.25 80.06 0.24 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.209 1.403 . . . . 0.0 111.583 -174.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 150.22 -14.81 0.98 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.723 1.63 . . . . 0.0 114.428 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.7 mtt -106.27 174.91 5.68 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.905 1.853 . . . . 0.0 111.754 175.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.5 m -126.27 130.4 50.81 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.389 1.876 . . . . 0.0 111.374 -172.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.9 t -84.0 114.82 21.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.467 0.707 . . . . 0.0 110.57 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.2 p -66.4 163.95 17.24 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -5.4 21.72 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 169.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.79 -8.87 58.61 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.152 0.887 . . . . 0.0 112.321 163.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.07 4.44 90.25 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.626 1.108 . . . . 0.0 113.701 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -109.82 148.95 30.56 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.098 1.359 . . . . 0.0 110.784 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.1 t -91.59 150.41 21.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.749 1.22 . . . . 0.0 113.153 -169.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.57 -156.69 24.59 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.01 0.814 . . . . 0.0 113.548 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -139.6 161.32 37.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.468 1.907 . . . . 0.0 112.153 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.2 -179.96 51.77 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.802 1.191 . . . . 0.0 112.798 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.7 -1.6 8.71 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.125 2.55 . . . . 0.0 115.802 -166.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.59 -6.04 58.48 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.194 0.998 . . . . 0.0 110.798 171.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -138.15 -53.47 0.63 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.104 1.762 . . . . 0.0 111.479 -165.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 63.9 m -90.7 -9.3 47.28 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.625 1.57 . . . . 0.0 113.746 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.09 -3.38 22.05 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 124.394 0.997 . . . . 0.0 114.692 -170.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.106 0 C-N-CA 128.451 2.7 . . . . 0.0 109.561 174.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.412 ' H1 ' ' CD ' ' A' ' 3' ' ' GLU . 12.4 p . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.02 2.88 55.97 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.325 0.964 . . . . 0.0 114.288 -172.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.412 ' CD ' ' H1 ' ' A' ' 1' ' ' VAL . 45.3 mp0 -58.66 147.99 30.76 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.454 1.502 . . . . 0.0 111.352 174.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.3 m -62.63 135.72 57.52 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.947 0.88 . . . . 0.0 111.483 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.46 69.88 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.782 1.633 . . . . 0.0 110.381 -164.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 47.97 25.31 0.75 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.864 -155.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 128.84 -13.95 6.05 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.582 1.086 . . . . 0.0 115.544 162.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.79 171.77 7.34 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.198 1.799 . . . . 0.0 110.79 175.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 67.8 m -145.25 153.96 53.16 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.567 0.747 . . . . 0.0 112.157 -169.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.42 172.93 15.34 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.94 3.094 . . . . 0.0 112.229 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.6 m 42.4 41.69 2.34 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.603 1.961 . . . . 0.0 115.495 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.61 26.84 17.08 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.807 1.67 . . . . 0.0 114.438 -174.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.1 mtt -70.0 170.79 10.62 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.782 1.291 . . . . 0.0 110.76 172.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -122.77 140.52 52.81 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.027 1.731 . . . . 0.0 110.448 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t -71.56 116.94 12.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.488 1.115 . . . . 0.0 110.868 173.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.8 p -70.52 161.77 30.01 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.518 1.127 . . . . 0.0 113.133 172.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -14.67 9.49 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.415 1.486 . . . . 0.0 114.212 166.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -78.5 -11.76 59.97 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.238 1.015 . . . . 0.0 113.047 170.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.6 16.68 67.84 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-N 118.674 0.67 . . . . 0.0 113.732 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -119.32 143.63 47.28 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.576 1.551 . . . . 0.0 111.977 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.5 m -77.4 151.94 34.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.598 1.159 . . . . 0.0 112.663 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.6 -170.41 43.49 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.656 1.122 . . . . 0.0 111.24 174.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -119.4 145.65 46.04 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.698 1.199 . . . . 0.0 111.061 -173.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.98 -173.88 24.84 Favored Glycine 0 CA--C 1.542 1.74 0 N-CA-C 115.932 1.133 . . . . 0.0 115.932 166.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -71.88 12.53 0.57 Allowed 'Trans proline' 0 CA--C 1.541 0.847 1 C-N-CA 125.881 4.387 . . . . 0.0 116.282 -161.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.59 -11.87 6.71 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 167.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -88.26 -58.06 2.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.501 1.52 . . . . 0.0 109.272 168.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.9 m -78.41 -45.47 22.26 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.572 1.949 . . . . 0.0 110.872 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.17 110.85 3.64 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 167.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? . . . . . 0 C--O 1.249 1.067 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -158.716 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.25 23.62 8.04 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.848 1.213 . . . . 0.0 114.599 -175.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.9 mp0 -60.88 145.31 50.64 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.222 1.409 . . . . 0.0 112.079 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.1 m -62.88 131.28 48.22 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.161 0.981 . . . . 0.0 110.458 168.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.473 ' C ' ' H ' ' A' ' 7' ' ' GLY . 21.9 t -74.09 77.36 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 128.746 2.819 . . . . 0.0 109.893 -169.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 52.94 1.32 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.99 1.716 . . . . 0.0 114.532 -158.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 5' ' ' VAL . . . 151.47 -20.71 0.93 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-O 118.264 -1.298 . . . . 0.0 114.285 174.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -90.48 170.38 10.26 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 119.453 1.626 . . . . 0.0 111.875 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.7 m -141.73 -179.73 1.04 Allowed Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 126.245 1.818 . . . . 0.0 107.935 174.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.79 152.1 18.11 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.96 2.44 . . . . 0.0 113.997 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.7 m -68.38 93.25 0.47 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.724 0.81 . . . . 0.0 111.302 -172.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.19 -8.95 4.12 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 126.021 1.772 . . . . 0.0 114.287 -169.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.55 176.04 0.1 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 129.468 3.107 . . . . 0.0 118.413 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.7 m -135.85 111.95 9.66 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.728 2.011 . . . . 0.0 108.476 143.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.0 t -60.92 116.92 4.84 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.15 -0.969 . . . . 0.0 110.239 169.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.1 p -68.08 159.18 31.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.828 0.851 . . . . 0.0 113.183 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -54.2 -27.26 33.04 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.52 1.128 . . . . 0.0 112.581 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 34.1 m0 -76.47 -2.53 32.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.593 1.557 . . . . 0.0 112.253 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.89 23.08 67.52 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.295 -0.725 . . . . 0.0 112.686 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.41 148.4 44.45 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.6 1.56 . . . . 0.0 112.695 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.4 m -86.51 153.29 21.96 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.07 1.748 . . . . 0.0 114.247 -178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.05 -161.92 31.87 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 127.044 2.259 . . . . 0.0 110.556 -177.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.11 157.95 43.79 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.846 2.458 . . . . 0.0 108.37 174.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.24 -174.68 18.43 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.809 1.195 . . . . 0.0 113.154 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.46 -14.8 40.73 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.95 2.434 . . . . 0.0 114.29 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.3 tptp -78.87 -4.22 48.58 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.172 1.389 . . . . 0.0 111.832 174.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -137.32 -54.92 0.7 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.537 1.535 . . . . 0.0 110.684 -158.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.2 m -81.83 -4.99 57.81 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.156 1.382 . . . . 0.0 113.191 169.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.2 -82.62 0.46 Allowed Glycine 0 C--N 1.343 0.935 0 C-N-CA 124.955 1.264 . . . . 0.0 112.972 -172.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.601 -172.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.421 ' H3 ' ' CD ' ' A' ' 3' ' ' GLU . 17.1 m . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.84 7.4 61.37 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 119.225 -0.764 . . . . 0.0 114.299 -173.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.421 ' CD ' ' H3 ' ' A' ' 1' ' ' VAL . 44.5 mp0 -60.55 150.44 31.56 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.301 1.44 . . . . 0.0 111.45 172.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 m -66.0 146.66 54.43 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.605 -0.684 . . . . 0.0 111.262 170.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.1 t -50.73 -69.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.093 1.757 . . . . 0.0 109.73 -173.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -138.41 21.67 2.75 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 127.591 2.356 . . . . 0.0 111.201 142.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.62 -24.36 0.3 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.856 1.217 . . . . 0.0 113.809 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.3 169.86 14.25 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.476 1.11 . . . . 0.0 112.837 165.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.1 m -137.39 176.39 2.79 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 128.733 2.813 . . . . 0.0 108.845 173.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -52.88 168.82 0.43 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.653 2.902 . . . . 0.0 115.431 175.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.9 p -54.69 106.03 0.19 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.261 1.824 . . . . 0.0 111.632 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.57 9.18 64.95 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.402 -1.221 . . . . 0.0 114.578 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 54.0 mtt -110.92 166.93 10.64 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.364 1.466 . . . . 0.0 112.067 172.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.7 m -134.32 143.35 47.65 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.906 2.082 . . . . 0.0 111.006 -173.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.6 t -84.81 115.81 22.94 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.626 1.57 . . . . 0.0 111.793 177.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.1 t -70.72 159.49 34.38 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 172.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -48.35 -24.22 1.16 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.555 2.342 . . . . 0.0 113.538 168.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -83.55 -4.47 58.58 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.132 1.773 . . . . 0.0 113.172 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.42 13.05 68.75 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.102 0.858 . . . . 0.0 114.433 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -122.0 153.33 38.71 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.677 1.591 . . . . 0.0 112.336 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.4 m -88.39 158.13 18.49 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.557 1.543 . . . . 0.0 113.426 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.22 -165.1 38.01 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -137.37 163.82 30.1 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.859 0.863 . . . . 0.0 111.185 -175.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.34 -170.25 52.16 Favored Glycine 0 CA--C 1.539 1.547 0 N-CA-C 114.756 0.663 . . . . 0.0 114.756 172.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.35 13.4 0.55 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 124.708 3.605 . . . . 0.0 115.469 -166.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.27 9.95 7.99 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.363 1.065 . . . . 0.0 112.44 169.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -138.69 -50.78 0.55 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 125.749 1.62 . . . . 0.0 110.862 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.1 m -73.2 -43.76 60.81 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.759 0.824 . . . . 0.0 109.026 161.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.94 63.96 2.36 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 157.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.3 0.0 OUTLIER . . . . . 0 C--O 1.253 1.287 0 C-N-CA 128.489 2.715 . . . . 0.0 117.396 -164.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.95 -7.03 53.56 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 129.117 3.246 . . . . 0.0 114.935 -1.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.407 ' OE2' ' OH ' ' A' ' 20' ' ' TYR . 6.3 mp0 57.45 -176.66 0.06 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.506 1.522 . . . . 0.0 112.263 -170.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 41.2 m -65.23 102.27 0.64 Allowed 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.529 -1.357 . . . . 0.0 108.003 157.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -4.57 -88.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 130.641 3.577 . . . . 0.0 112.515 -156.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 67.9 mmt-85 -130.16 41.19 3.44 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.051 0.941 . . . . 0.0 109.526 143.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 157.67 -10.12 0.23 Allowed Glycine 0 CA--C 1.534 1.25 0 N-CA-C 116.254 1.262 . . . . 0.0 116.254 163.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -121.65 178.79 4.69 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 119.839 1.819 . . . . 0.0 112.883 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 39.8 m -127.59 166.78 21.05 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 124.651 1.18 . . . . 0.0 110.586 173.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.67 149.85 13.19 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.432 2.755 . . . . 0.0 112.537 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.7 m -69.49 76.27 0.4 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.542 1.537 . . . . 0.0 111.682 -171.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.38 -17.07 1.14 Allowed Glycine 0 CA--C 1.537 1.432 0 C-N-CA 126.249 1.881 . . . . 0.0 114.231 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.1 mtt -86.43 -168.59 2.29 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.674 1.737 . . . . 0.0 112.261 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.76 160.9 41.08 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.651 2.381 . . . . 0.0 110.159 162.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.1 t -98.24 120.78 39.24 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.402 1.881 . . . . 0.0 112.044 -173.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.1 t -76.43 159.19 30.67 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -7.92 7.07 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 160.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -71.59 -10.34 59.62 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.38 1.072 . . . . 0.0 112.436 164.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.63 13.8 82.0 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.492 1.044 . . . . 0.0 113.723 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.407 ' OH ' ' OE2' ' A' ' 3' ' ' GLU . 17.9 m-85 -130.27 164.12 25.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.444 1.898 . . . . 0.0 111.495 -178.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 78.0 m -94.32 158.24 15.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.823 1.249 . . . . 0.0 113.83 -172.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.57 -156.18 26.92 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.175 1.369 . . . . 0.0 111.102 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.7 tptt -138.34 164.47 29.21 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.839 1.656 . . . . 0.0 111.662 171.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.06 -176.18 31.59 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 124.119 0.866 . . . . 0.0 114.263 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.31 18.57 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.861 1 C-N-CA 125.745 4.296 . . . . 0.0 115.087 -168.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.49 6.46 6.92 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.889 1.276 . . . . 0.0 112.447 170.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -134.28 -48.88 0.78 Allowed 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 128.049 2.54 . . . . 0.0 109.911 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.1 m -95.25 5.54 51.46 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.696 1.598 . . . . 0.0 111.565 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.11 156.71 26.88 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.524 2.011 . . . . 0.0 110.353 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 C-N-CA 125.238 1.415 . . . . 0.0 112.251 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 118.146 -0.931 . . . . 0.0 113.046 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.25 -0.57 0.29 Allowed Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.429 1.014 . . . . 0.0 115.627 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -60.13 165.25 3.52 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 127.682 2.393 . . . . 0.0 113.66 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.5 m -47.18 140.9 4.83 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.032 1.733 . . . . 0.0 112.094 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.8 t -30.44 -70.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 128.377 2.671 . . . . 0.0 112.908 -152.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -123.01 21.12 9.87 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.194 1.798 . . . . 0.0 110.415 138.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.07 -21.34 0.5 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.975 1.274 . . . . 0.0 114.985 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -98.78 -178.29 3.92 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.188 1.395 . . . . 0.0 111.971 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.9 m -130.95 170.43 11.24 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.737 1.215 . . . . 0.0 112.026 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.98 177.0 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 125.231 3.954 . . . . 0.0 115.386 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.7 p -53.86 90.83 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.107 2.163 . . . . 0.0 113.764 -174.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.77 -1.52 75.12 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.255 1.407 . . . . 0.0 114.661 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.29 170.27 16.87 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.369 1.585 . . . . 0.0 110.795 175.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.1 m -134.4 137.3 43.96 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.532 1.533 . . . . 0.0 110.805 -168.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 32.2 t -86.83 115.39 24.22 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.14 1.376 . . . . 0.0 110.865 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.4 t -74.44 164.88 26.08 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.628 0.728 . . . . 0.0 112.745 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -45.44 -23.13 0.18 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.948 2.499 . . . . 0.0 114.373 158.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -66.6 -16.67 64.35 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.621 1.568 . . . . 0.0 112.54 173.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.18 10.11 86.47 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.629 1.109 . . . . 0.0 113.14 -167.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -121.4 153.57 37.65 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.88 1.672 . . . . 0.0 111.269 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.1 m -84.01 155.5 22.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.116 0.967 . . . . 0.0 113.58 -177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.52 -155.44 15.77 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.142 1.829 . . . . 0.0 110.244 174.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -145.02 161.68 38.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.706 1.602 . . . . 0.0 109.965 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.79 -172.38 35.53 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.486 0.954 . . . . 0.0 115.486 172.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.19 -0.7 0.68 Allowed 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 126.11 4.54 . . . . 0.0 117.96 -172.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.412 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -125.74 9.74 7.68 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.39 0.995 . . . . 0.0 112.636 175.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -136.91 -47.07 0.59 Allowed 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 125.218 1.407 . . . . 0.0 112.409 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.38 -33.77 28.61 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.153 0.433 . . . . 0.0 110.432 159.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.15 64.2 1.65 Allowed Glycine 0 CA--C 1.532 1.15 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 151.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 C-N-CA 127.227 2.211 . . . . 0.0 115.544 -162.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.86 -7.1 58.92 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.34 1.448 . . . . 0.0 115.109 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.24 160.01 5.49 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.748 1.274 . . . . 0.0 111.854 173.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.9 m -57.45 138.67 54.78 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 157.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.2 t -31.88 -68.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 128.261 2.624 . . . . 0.0 112.461 -158.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -123.32 19.11 9.8 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.491 1.916 . . . . 0.0 110.423 134.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.23 -26.78 0.32 Allowed Glycine 0 CA--C 1.54 1.597 0 C-N-CA 125.309 1.433 . . . . 0.0 114.806 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -85.23 -179.01 6.91 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.748 1.619 . . . . 0.0 111.633 172.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.7 m -134.49 142.66 43.59 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.158 0.983 . . . . 0.0 111.258 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -80.4 174.89 10.78 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.764 2.976 . . . . 0.0 111.584 172.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.1 m 37.74 46.99 0.78 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 127.672 2.389 . . . . 0.0 115.599 167.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.03 11.3 54.61 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-O 118.346 -1.252 . . . . 0.0 115.843 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.3 mmt -72.68 172.28 10.98 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.264 2.032 . . . . 0.0 112.206 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m -122.12 137.67 54.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.935 2.094 . . . . 0.0 111.006 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -86.87 117.77 25.82 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.945 0.898 . . . . 0.0 111.309 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.0 p -75.26 159.81 31.09 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.309 1.044 . . . . 0.0 113.29 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -59.2 -13.58 7.99 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.031 1.732 . . . . 0.0 113.961 167.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -75.56 -9.33 58.48 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.838 1.255 . . . . 0.0 112.45 171.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.93 9.82 86.66 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.064 0.84 . . . . 0.0 113.106 -169.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -107.49 145.83 32.58 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.655 1.582 . . . . 0.0 111.872 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.9 t -96.42 143.83 27.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.238 1.015 . . . . 0.0 111.691 -175.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.68 -160.42 29.63 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.891 -0.506 . . . . 0.0 112.918 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -132.82 163.1 29.82 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.45 1.5 . . . . 0.0 111.999 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.65 177.68 31.05 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.64 1.114 . . . . 0.0 113.947 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.01 8.87 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 124.551 3.5 . . . . 0.0 115.246 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 tpmp? -123.78 10.21 8.94 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.309 0.959 . . . . 0.0 112.144 169.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -125.37 -55.26 1.55 Allowed 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 126.608 1.963 . . . . 0.0 110.04 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 64.1 m -75.01 -36.41 61.96 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.049 0.939 . . . . 0.0 110.847 167.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.29 71.74 1.48 Allowed Glycine 0 CA--C 1.529 0.913 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 155.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? . . . . . 0 C--O 1.248 0.994 0 C-N-CA 128.312 2.645 . . . . 0.0 113.957 -168.229 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 86.7 t . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.4 -8.33 48.04 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.619 1.581 . . . . 0.0 114.785 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.41 157.39 6.7 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.592 1.196 . . . . 0.0 111.685 173.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.6 m -56.16 133.67 52.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 161.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.1 t -19.95 -76.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 129.2 3.0 . . . . 0.0 113.173 -160.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -122.41 25.14 9.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.804 2.042 . . . . 0.0 109.88 139.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.03 -6.92 0.45 Allowed Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.216 1.389 . . . . 0.0 115.45 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -114.13 -178.08 3.29 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.229 2.212 . . . . 0.0 112.38 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.5 m -144.75 159.93 48.97 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.661 1.584 . . . . 0.0 110.342 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.04 166.96 28.06 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.135 2.557 . . . . 0.0 113.123 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.5 m -56.63 92.71 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.12 2.168 . . . . 0.0 113.117 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.76 -8.5 6.46 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.415 1.483 . . . . 0.0 113.954 -176.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -122.03 165.54 15.87 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.56 1.944 . . . . 0.0 111.26 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.6 m -142.27 157.44 44.83 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.834 1.654 . . . . 0.0 111.047 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.3 t -83.53 118.92 24.11 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.621 0.768 . . . . 0.0 111.175 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 90.2 p -72.09 165.52 24.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.493 1.139 . . . . 0.0 113.225 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.477 ' CD ' ' H ' ' A' ' 17' ' ' GLN . 5.7 mp0 -60.04 -17.13 36.8 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.355 1.862 . . . . 0.0 113.046 173.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -81.82 -7.61 59.62 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.322 1.449 . . . . 0.0 113.292 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.37 12.27 84.38 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 118.959 0.8 . . . . 0.0 113.336 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -105.07 146.03 29.67 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.791 1.637 . . . . 0.0 111.518 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.8 t -85.41 157.82 20.39 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.503 0.721 . . . . 0.0 112.095 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.36 -171.45 38.23 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.662 1.125 . . . . 0.0 111.921 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.89 175.77 9.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.176 0.988 . . . . 0.0 112.04 174.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.25 177.55 45.94 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.676 1.131 . . . . 0.0 111.755 -165.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.98 5.47 3.48 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.624 2.216 . . . . 0.0 116.097 -164.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -90.69 -8.22 50.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.265 0.939 . . . . 0.0 111.304 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -130.92 -51.27 1.04 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.754 2.422 . . . . 0.0 111.283 -168.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.95 -1.58 0.96 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -148.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.07 -62.1 0.76 Allowed Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.515 -0.741 . . . . 0.0 111.51 -160.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? . . . . . 0 C--O 1.249 1.041 0 C-N-CA 126.207 1.803 . . . . 0.0 110.665 179.097 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 38.7 t . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 118.615 -0.707 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.69 29.97 2.09 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.92 1.248 . . . . 0.0 113.758 -176.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.453 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.4 pm0 -70.69 152.19 44.1 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.896 0.878 . . . . 0.0 111.783 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.9 m -61.34 148.1 42.55 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.911 0.484 . . . . 0.0 111.442 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t -49.09 -66.61 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.906 1.682 . . . . 0.0 109.907 -173.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -138.3 19.24 2.76 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.023 2.129 . . . . 0.0 111.721 140.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.91 -19.36 0.2 Allowed Glycine 0 CA--C 1.532 1.12 0 N-CA-C 115.162 0.825 . . . . 0.0 115.162 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -99.87 173.79 6.51 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.209 1.404 . . . . 0.0 110.777 165.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.9 m -139.48 154.12 71.24 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.086 1.354 . . . . 0.0 110.939 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.45 170.45 15.95 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.553 2.835 . . . . 0.0 112.914 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.1 p 54.47 30.65 13.26 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 173.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.29 30.48 58.24 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.606 1.098 . . . . 0.0 113.399 -171.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.8 mmt -72.19 168.17 18.79 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.611 1.206 . . . . 0.0 109.782 163.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.0 m -124.13 130.85 53.24 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.081 1.752 . . . . 0.0 110.13 -173.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.9 t -73.1 102.32 3.53 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.978 0.911 . . . . 0.0 112.287 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.1 p -61.91 171.48 1.67 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 175.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -67.82 -11.27 58.2 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.246 1.418 . . . . 0.0 113.744 166.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -79.26 -4.45 50.75 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.183 0.901 . . . . 0.0 112.535 168.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.54 18.99 77.51 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.828 0.74 . . . . 0.0 112.741 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.71 146.58 46.3 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.936 1.694 . . . . 0.0 112.007 -176.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.1 m -84.09 157.46 21.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.844 1.658 . . . . 0.0 112.341 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.05 -172.55 39.09 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 128.05 2.738 . . . . 0.0 107.278 -174.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -132.39 163.68 28.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.047 1.424 . . . . 0.0 110.885 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.37 -165.98 36.07 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 114.882 0.713 . . . . 0.0 114.882 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.88 8.46 1.32 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 125.04 3.827 . . . . 0.0 115.722 -165.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.45 5.9 9.59 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.555 1.07 . . . . 0.0 113.41 168.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -133.45 -52.4 0.88 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.521 1.528 . . . . 0.0 111.733 -173.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 m -81.69 -36.3 28.86 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.675 0.39 . . . . 0.0 110.031 162.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.1 72.09 1.14 Allowed Glycine 0 CA--C 1.532 1.109 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 153.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.8 mtp-105 . . . . . 0 C--O 1.249 1.039 0 C-N-CA 127.405 2.282 . . . . 0.0 116.085 -159.962 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 91.1 t . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.0 9.32 67.9 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.306 -1.275 . . . . 0.0 115.244 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.39 157.45 6.59 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.294 1.547 . . . . 0.0 112.438 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.5 m -66.58 99.69 0.61 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 163.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t 2.73 -90.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 131.257 3.823 . . . . 0.0 111.547 -162.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 75.7 mmt-85 -131.06 41.97 3.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.774 1.23 . . . . 0.0 109.283 141.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.02 -16.36 0.08 OUTLIER Glycine 0 CA--C 1.538 1.486 0 N-CA-C 117.169 1.628 . . . . 0.0 117.169 165.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -130.77 175.77 8.76 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 120.583 2.191 . . . . 0.0 113.248 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.8 m -119.95 166.6 14.53 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 123.894 0.878 . . . . 0.0 111.018 173.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -51.57 149.85 17.46 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.27 2.647 . . . . 0.0 112.816 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.0 m -69.83 76.22 0.46 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.546 1.538 . . . . 0.0 111.206 -175.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 151.13 -19.84 0.95 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 126.113 1.816 . . . . 0.0 113.93 -171.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.5 mmt -86.5 -167.29 1.82 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.307 1.843 . . . . 0.0 111.575 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 p -147.43 162.17 39.55 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.494 1.918 . . . . 0.0 110.749 161.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.7 t -102.04 114.11 27.93 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.169 1.788 . . . . 0.0 111.997 -171.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.4 t -65.77 147.55 53.2 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.153 0.581 . . . . 0.0 111.747 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.5 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -60.74 -8.44 2.98 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.951 1.7 . . . . 0.0 114.666 175.134 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -90.7 -2.43 57.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.098 1.359 . . . . 0.0 113.792 168.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.4 18.14 31.77 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.287 -1.285 . . . . 0.0 115.542 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -127.77 152.86 47.23 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.283 1.541 . . . . 0.0 112.707 -175.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.8 m -91.11 155.97 18.24 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.57 -161.22 35.01 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.187 1.375 . . . . 0.0 111.251 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -134.77 161.72 34.39 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.76 1.624 . . . . 0.0 112.082 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.46 176.02 35.74 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.962 1.268 . . . . 0.0 112.701 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.44 -2.82 10.6 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.467 2.778 . . . . 0.0 115.257 -169.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -81.27 -16.95 51.05 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.449 1.099 . . . . 0.0 110.672 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -123.81 -42.79 2.16 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 129.014 2.926 . . . . 0.0 111.43 -167.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.2 m -99.91 -9.2 23.08 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.339 1.455 . . . . 0.0 113.268 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.35 -174.38 41.63 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-N 118.68 0.673 . . . . 0.0 113.363 -170.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.786 2.035 . . . . 0.0 108.875 173.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.58 2.46 72.82 Favored Glycine 0 CA--C 1.536 1.374 0 N-CA-C 116.005 1.162 . . . . 0.0 116.005 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.53 163.81 6.52 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.303 1.552 . . . . 0.0 112.617 175.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.0 m -54.25 129.28 34.62 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.994 0.918 . . . . 0.0 109.48 162.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.2 t -22.47 -74.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 128.833 2.853 . . . . 0.0 113.163 -158.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -122.87 23.44 9.38 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.765 2.026 . . . . 0.0 110.077 138.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.33 -5.05 0.2 Allowed Glycine 0 CA--C 1.536 1.356 0 N-CA-C 116.171 1.229 . . . . 0.0 116.171 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -115.01 167.87 10.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.694 1.747 . . . . 0.0 112.056 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 72.9 m -152.73 173.01 4.92 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 125.912 1.685 . . . . 0.0 110.066 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -58.39 -178.0 0.11 Allowed 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 125.797 4.331 . . . . 0.0 118.894 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.6 m -43.8 105.18 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 129.016 2.926 . . . . 0.0 114.299 -178.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.74 33.26 86.31 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 123.885 0.755 . . . . 0.0 113.356 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.01 167.89 0.14 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.721 1.608 . . . . 0.0 114.985 170.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -134.69 88.29 2.42 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.002 156.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.2 t -50.55 112.51 0.71 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.186 0.995 . . . . 0.0 110.359 173.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 30' ' ' ARG . 13.7 t -61.22 152.38 29.01 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.987 0.915 . . . . 0.0 111.119 -176.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -64.1 -18.27 64.25 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -90.66 3.67 53.54 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.672 1.989 . . . . 0.0 111.929 175.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.36 6.89 47.09 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-O 118.109 -1.384 . . . . 0.0 115.831 162.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -114.62 152.77 31.31 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.638 1.719 . . . . 0.0 113.765 -169.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.6 m -79.37 152.28 30.49 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.67 -175.76 31.9 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 127.218 2.342 . . . . 0.0 109.514 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -141.65 158.15 44.18 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.927 2.091 . . . . 0.0 109.351 -175.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.44 -176.56 24.35 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 123.82 0.724 . . . . 0.0 114.67 171.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.45 -1.61 8.51 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.415 3.41 . . . . 0.0 115.854 -166.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -115.99 7.01 14.24 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.83 1.252 . . . . 0.0 111.847 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -120.39 -52.16 2.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 126.721 2.009 . . . . 0.0 109.905 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.2 m -62.36 -50.96 69.5 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 164.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.46 60.99 0.86 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.762 1.649 . . . . 0.0 112.823 162.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.427 ' O ' ' OG ' ' A' ' 16' ' ' SER . 3.7 mmp_? . . . . . 0 C--O 1.255 1.351 1 C-N-CA 133.171 4.589 . . . . 0.0 118.407 159.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.453 ' H2 ' ' CD ' ' A' ' 3' ' ' GLU . 48.9 t . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.85 7.96 12.52 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.075 1.321 . . . . 0.0 114.669 -174.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.479 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.7 pm0 -64.48 148.55 50.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.142 1.377 . . . . 0.0 111.836 172.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.0 m -64.81 139.53 58.77 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.214 0.606 . . . . 0.0 110.74 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.0 t -52.77 -66.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.262 1.825 . . . . 0.0 111.287 -165.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.3 mmt-85 -129.68 16.97 5.83 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.476 1.91 . . . . 0.0 110.269 151.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.98 -23.25 2.28 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.933 1.73 . . . . 0.0 113.007 -176.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.17 157.95 33.79 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.035 0.918 . . . . 0.0 112.225 168.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.5 m -149.24 -179.12 0.91 Allowed Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 130.0 3.32 . . . . 0.0 107.461 174.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -55.81 177.97 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.637 3.558 . . . . 0.0 117.774 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.2 m -53.77 121.77 8.57 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.851 1.66 . . . . 0.0 111.607 174.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.46 4.67 80.81 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.624 -1.098 . . . . 0.0 115.349 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.81 165.89 0.17 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 176.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.9 m -136.69 99.29 4.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.481 154.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.0 t -51.41 113.08 0.86 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.3 1.04 . . . . 0.0 110.66 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.3 t -67.6 160.51 27.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.294 1.438 . . . . 0.0 113.435 -169.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -57.86 -20.49 36.79 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.273 1.029 . . . . 0.0 112.712 161.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.43 ' CD2' ' HE2' ' A' ' 26' ' ' LYS . 6.1 m-90 -79.18 -2.39 40.69 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.441 1.496 . . . . 0.0 112.987 170.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.36 18.69 79.01 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.405 1.002 . . . . 0.0 113.877 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -121.44 155.45 34.84 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.849 1.66 . . . . 0.0 113.022 -172.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.98 152.42 28.0 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.288 1.835 . . . . 0.0 112.304 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.91 -170.79 30.68 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.645 1.117 . . . . 0.0 111.104 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -146.8 165.67 28.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 129.879 3.272 . . . . 0.0 109.698 -172.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.56 -170.29 38.43 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.505 1.05 . . . . 0.0 112.943 -171.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.56 3.04 7.18 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.617 2.878 . . . . 0.0 115.648 -171.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.43 ' HE2' ' CD2' ' A' ' 18' ' ' TRP . 1.6 ttpm? -98.19 11.69 36.98 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 119.534 1.061 . . . . 0.0 111.823 172.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -147.24 -53.02 0.21 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.898 2.479 . . . . 0.0 110.179 -164.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.76 -46.53 0.49 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 131.38 -52.67 0.82 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 -152.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 49.1 tpt85 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 115.701 -2.095 . . . . 0.0 112.25 171.4 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.427 ' H2 ' ' CD ' ' A' ' 3' ' ' GLU . 51.3 t . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 115.89 6.63 16.37 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.135 1.35 . . . . 0.0 114.576 -174.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.453 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.7 pm0 -64.19 148.94 48.91 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.895 1.278 . . . . 0.0 111.797 172.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.3 m -64.0 154.84 32.95 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.689 0.796 . . . . 0.0 111.005 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.9 t -45.7 -67.21 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.987 1.715 . . . . 0.0 110.191 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -138.49 23.18 2.72 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.246 2.218 . . . . 0.0 110.907 139.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.78 -11.14 0.2 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.1 0.857 . . . . 0.0 114.957 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -105.89 165.69 11.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.561 1.944 . . . . 0.0 111.312 170.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.3 m -155.56 178.52 1.63 Allowed Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 127.079 2.152 . . . . 0.0 109.24 -170.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -57.54 178.71 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.941 3.761 . . . . 0.0 118.137 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.9 m -42.87 109.13 0.12 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 128.214 2.606 . . . . 0.0 114.0 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.19 29.12 74.51 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.235 -0.759 . . . . 0.0 114.041 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.72 168.7 0.4 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 170.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -132.73 106.27 7.66 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 113.377 -1.738 . . . . 0.0 108.712 147.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.1 t -54.68 117.48 3.41 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.336 -0.852 . . . . 0.0 110.569 170.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 t -64.95 164.1 13.29 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.05 0.94 . . . . 0.0 113.091 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -60.51 -18.92 55.04 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.672 1.989 . . . . 0.0 111.5 168.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 30.5 m0 -90.97 0.75 57.46 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.739 2.016 . . . . 0.0 113.391 172.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.98 25.21 69.73 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.858 -0.968 . . . . 0.0 114.24 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -120.01 152.69 37.12 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.909 1.684 . . . . 0.0 112.527 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.3 m -81.86 151.05 27.5 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.148 1.379 . . . . 0.0 113.072 -177.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.48 -165.23 32.86 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.539 2.018 . . . . 0.0 108.471 -174.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.75 160.79 42.85 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.588 1.955 . . . . 0.0 108.907 177.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.35 -169.81 26.59 Favored Glycine 0 CA--C 1.543 1.796 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 171.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -54.64 -10.13 2.23 Favored 'Trans proline' 0 CA--C 1.538 0.713 1 C-N-CA 126.101 4.534 . . . . 0.0 119.143 -170.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.438 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -119.14 12.34 12.63 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.87 1.214 . . . . 0.0 112.636 176.138 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -129.96 -70.48 0.64 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 127.346 2.258 . . . . 0.0 108.085 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.94 -20.65 57.78 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.111 0.964 . . . . 0.0 113.331 170.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.3 -0.1 81.36 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 118.491 0.587 . . . . 0.0 113.273 -165.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? . . . . . 0 C--O 1.251 1.16 0 C-N-CA 129.521 3.128 . . . . 0.0 107.033 177.551 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.12 2.94 24.81 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.681 1.134 . . . . 0.0 113.868 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.6 mp0 -60.2 150.79 28.92 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.188 1.795 . . . . 0.0 112.213 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.9 m -69.51 156.76 38.37 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.794 -0.566 . . . . 0.0 110.774 163.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.4 t -49.18 -70.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.272 1.829 . . . . 0.0 109.613 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -141.92 17.28 2.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 127.717 2.407 . . . . 0.0 111.916 145.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 171.38 -17.84 0.06 OUTLIER Glycine 0 CA--C 1.532 1.106 0 N-CA-C 115.455 0.942 . . . . 0.0 115.455 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -121.76 179.43 4.49 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.136 1.374 . . . . 0.0 111.821 168.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.51 -173.51 0.36 Allowed Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 127.384 2.274 . . . . 0.0 109.105 173.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.02 151.97 15.17 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.063 2.508 . . . . 0.0 113.792 174.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.9 m -72.12 30.07 0.05 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 -159.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -130.45 -4.78 4.32 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 127.391 2.424 . . . . 0.0 115.029 165.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -179.67 0.15 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.055 2.542 . . . . 0.0 117.452 -176.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.07 96.08 2.83 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.493 1.117 . . . . 0.0 110.206 146.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.7 t -49.82 115.02 1.21 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.234 1.014 . . . . 0.0 111.899 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.6 t -70.04 152.56 44.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.81 1.244 . . . . 0.0 111.081 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -6.12 7.61 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 171.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -6.51 50.12 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.542 1.137 . . . . 0.0 113.159 163.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.96 23.94 60.76 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.996 0.816 . . . . 0.0 113.493 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -126.8 159.02 35.05 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.393 1.877 . . . . 0.0 112.467 -174.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.0 m -115.05 165.83 12.47 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.05 1.34 . . . . 0.0 113.218 -175.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.48 -170.65 24.33 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 -162.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -139.48 161.99 36.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.527 2.331 . . . . 0.0 109.872 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.27 -174.63 28.74 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 123.936 0.779 . . . . 0.0 113.35 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -57.96 -16.11 25.03 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 124.011 3.141 . . . . 0.0 117.551 -169.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.79 -7.14 59.53 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.544 1.066 . . . . 0.0 111.359 178.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -134.08 -58.76 0.85 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.991 2.116 . . . . 0.0 110.198 -160.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.0 m -98.42 -7.04 29.38 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.781 2.032 . . . . 0.0 113.008 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.14 -9.09 10.12 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 124.668 1.128 . . . . 0.0 114.418 -170.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.14 0 C-N-CA 128.574 2.749 . . . . 0.0 107.617 172.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 117.714 -1.136 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.18 4.77 23.68 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 119.527 1.058 . . . . 0.0 115.3 -173.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.7 pm0 -57.61 150.76 18.5 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.833 1.253 . . . . 0.0 113.045 178.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.4 m -34.17 119.76 0.42 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 128.939 2.896 . . . . 0.0 112.406 -168.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.2 t 0.92 -85.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 130.18 3.392 . . . . 0.0 112.426 -160.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -130.94 32.59 4.3 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.608 2.363 . . . . 0.0 109.171 140.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 164.37 -11.96 0.08 OUTLIER Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.864 1.697 . . . . 0.0 115.76 172.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -121.94 174.46 6.88 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.333 1.853 . . . . 0.0 113.456 -172.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.1 m -150.58 175.74 2.67 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 126.912 2.085 . . . . 0.0 109.188 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -57.39 178.41 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 125.129 3.886 . . . . 0.0 118.577 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -50.52 120.14 4.39 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.647 1.579 . . . . 0.0 112.364 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.78 32.33 74.18 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 118.761 -1.022 . . . . 0.0 113.808 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.37 166.86 2.1 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 169.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.8 m -133.81 94.26 3.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.648 1.979 . . . . 0.0 107.421 152.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -50.42 113.3 0.85 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.868 0.867 . . . . 0.0 109.381 170.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.5 t -64.95 159.45 22.89 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.023 0.916 . . . . 0.0 112.53 -169.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.447 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -48.82 -26.1 2.22 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.903 2.481 . . . . 0.0 113.552 169.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -100.23 3.33 43.53 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.728 2.011 . . . . 0.0 112.664 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.31 8.61 58.6 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.955 -1.47 . . . . 0.0 115.661 169.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -118.59 158.67 24.99 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.617 2.209 . . . . 0.0 113.328 -172.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.5 m -89.47 156.07 18.9 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -167.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.56 -166.43 27.75 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 128.07 2.747 . . . . 0.0 109.596 -175.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.39 170.26 21.79 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.996 1.318 . . . . 0.0 110.895 163.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 126.69 172.19 13.25 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.612 1.577 . . . . 0.0 112.63 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.24 -23.03 16.85 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 124.575 3.517 . . . . 0.0 117.545 -169.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HZ3' ' C ' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -116.8 -4.54 11.6 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.487 1.115 . . . . 0.0 113.607 -177.396 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -76.36 -55.9 5.13 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.634 1.174 . . . . 0.0 109.23 155.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.4 m -71.49 -44.12 65.31 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.499 1.52 . . . . 0.0 112.962 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.46 145.46 26.53 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 118.748 0.703 . . . . 0.0 112.257 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.404 ' C ' ' HZ3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 C-N-CA 124.491 1.117 . . . . 0.0 113.053 -175.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.76 12.44 78.28 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 119.369 -0.684 . . . . 0.0 114.748 -172.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -62.37 168.81 3.27 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.355 1.462 . . . . 0.0 113.502 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 62.7 m -45.72 140.93 3.17 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.749 1.62 . . . . 0.0 112.091 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t -33.23 -67.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 127.931 2.492 . . . . 0.0 112.877 -155.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -124.16 19.66 9.07 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.402 1.881 . . . . 0.0 110.517 138.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.4 -19.2 0.81 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.732 1.158 . . . . 0.0 115.053 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.5 ptp85 -96.78 177.3 5.69 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.45 1.5 . . . . 0.0 111.559 172.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -137.57 169.37 13.25 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.798 1.239 . . . . 0.0 112.459 -172.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.23 167.99 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.613 3.542 . . . . 0.0 114.842 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 m -38.68 96.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.388 2.675 . . . . 0.0 114.628 -174.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.71 3.39 90.53 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 118.268 -1.296 . . . . 0.0 115.8 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.2 mmt -78.27 173.46 12.26 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 120.19 1.995 . . . . 0.0 112.716 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.9 m -119.3 136.28 54.32 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.609 2.364 . . . . 0.0 109.722 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.6 t -75.9 113.91 13.93 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.945 0.498 . . . . 0.0 109.738 166.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.2 t -62.35 151.28 37.2 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.996 0.903 . . . . 0.0 110.359 167.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.411 ' CD ' ' H ' ' A' ' 17' ' ' GLN . 17.8 mp0 -72.7 -4.93 34.24 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.557 1.543 . . . . 0.0 111.33 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -75.47 -11.19 59.98 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.486 1.914 . . . . 0.0 113.597 162.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.53 9.91 48.94 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.457 1.504 . . . . 0.0 115.195 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -131.07 147.18 52.59 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.928 1.864 . . . . 0.0 113.193 -171.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 82.6 m -82.99 149.51 26.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -169.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.02 -160.3 33.18 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.074 1.321 . . . . 0.0 111.827 176.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.6 tptt -135.94 162.1 33.78 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.395 1.478 . . . . 0.0 112.165 176.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.05 178.73 36.03 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.761 1.172 . . . . 0.0 113.862 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.34 19.29 0.53 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 125.271 3.981 . . . . 0.0 114.697 -170.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.479 ' HZ2' ' C ' ' A' ' 30' ' ' ARG . 12.3 mmtm -121.42 4.44 10.21 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.325 1.85 . . . . 0.0 111.616 169.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -130.14 -63.34 0.91 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.815 2.446 . . . . 0.0 108.876 -177.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.1 m -71.25 -5.86 35.3 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.11 1.364 . . . . 0.0 113.56 174.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.37 166.52 34.25 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 127.676 2.56 . . . . 0.0 109.067 168.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.479 ' C ' ' HZ2' ' A' ' 26' ' ' LYS . 2.8 tpm_? . . . . . 0 C--O 1.243 0.763 0 CA-C-N 117.408 0.604 . . . . 0.0 112.017 -176.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.8 t . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 117.061 -1.447 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.41 -45.29 6.22 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 120.462 1.483 . . . . 0.0 112.522 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 44.63 -173.68 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 128.082 2.553 . . . . 0.0 114.129 -169.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 62.2 m -58.21 116.82 3.81 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.607 -1.308 . . . . 0.0 108.185 148.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -4.67 -81.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 131.056 3.742 . . . . 0.0 113.67 -160.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -129.27 22.38 5.63 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.114 2.165 . . . . 0.0 109.807 147.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.6 -14.38 0.07 OUTLIER Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.543 1.377 . . . . 0.0 116.543 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -125.38 179.74 4.97 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 120.046 1.923 . . . . 0.0 113.029 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.4 m -124.0 157.1 64.72 Favored Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 124.635 1.174 . . . . 0.0 109.496 169.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.42 150.63 88.02 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.05 1.833 . . . . 0.0 110.78 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.5 m -65.48 88.14 0.09 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.831 1.252 . . . . 0.0 112.326 -166.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.95 -17.04 3.22 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.1 1.809 . . . . 0.0 113.491 -173.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 mmt -94.59 170.75 9.24 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.724 1.609 . . . . 0.0 109.712 158.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -142.39 161.9 36.85 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.988 1.715 . . . . 0.0 110.906 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.5 t -103.91 115.87 31.24 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.939 1.695 . . . . 0.0 112.097 -166.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.407 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 7.7 t -77.87 167.88 20.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 122.302 1.049 . . . . 0.0 113.011 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.409 ' CD ' ' H ' ' A' ' 17' ' ' GLN . 11.1 mp0 -65.29 -16.72 63.86 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.313 2.245 . . . . 0.0 112.108 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -74.72 -5.98 46.28 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.704 2.002 . . . . 0.0 112.98 170.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.72 23.01 65.4 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.941 -0.922 . . . . 0.0 113.532 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -131.06 153.8 48.91 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.541 1.536 . . . . 0.0 112.716 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 74.5 m -84.17 160.99 20.73 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.597 1.159 . . . . 0.0 113.785 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.28 -158.8 31.88 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.919 2.199 . . . . 0.0 107.88 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -138.32 158.57 44.03 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.788 1.235 . . . . 0.0 110.8 -177.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.88 -178.14 40.55 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 123.962 0.791 . . . . 0.0 113.912 172.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.78 -13.51 6.17 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 125.07 3.847 . . . . 0.0 118.032 -167.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -96.94 -8.77 29.86 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.808 1.185 . . . . 0.0 111.956 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.407 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 92.1 m-85 -120.5 -41.79 2.58 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 128.335 2.654 . . . . 0.0 110.397 -174.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.6 m -101.24 1.62 39.07 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.708 2.003 . . . . 0.0 112.555 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.83 -88.92 0.23 Allowed Glycine 0 CA--C 1.531 1.093 0 CA-C-N 119.153 0.888 . . . . 0.0 114.895 -171.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? . . . . . 0 C--O 1.247 0.937 0 C-N-CA 124.744 1.217 . . . . 0.0 112.192 -162.475 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.4 8.76 87.08 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-O 119.189 -0.784 . . . . 0.0 114.849 -174.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -61.33 166.39 3.92 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.176 1.391 . . . . 0.0 113.344 174.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.2 m -46.78 142.16 3.51 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.796 1.638 . . . . 0.0 112.23 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.6 t -18.73 -76.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 129.555 3.142 . . . . 0.0 113.139 -163.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -124.08 25.61 7.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.173 2.189 . . . . 0.0 109.924 140.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.97 -6.39 2.04 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.482 1.515 . . . . 0.0 114.779 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -112.08 -177.92 3.29 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 127.683 2.393 . . . . 0.0 111.58 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -160.93 172.55 5.69 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 126.249 1.82 . . . . 0.0 109.59 169.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.49 178.97 6.93 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.158 2.572 . . . . 0.0 113.851 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.5 t 9.99 87.82 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 130.46 3.504 . . . . 0.0 116.06 169.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.48 34.25 74.82 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.3 0.953 . . . . 0.0 114.789 171.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.08 167.0 4.22 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 169.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.7 m -132.76 94.64 3.43 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.07 156.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -51.2 107.35 0.18 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.859 0.863 . . . . 0.0 110.734 160.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.2 p -64.79 164.55 12.08 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.709 1.204 . . . . 0.0 112.873 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.76 -21.22 60.46 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.0 0.92 . . . . 0.0 112.44 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -74.25 -10.54 59.7 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.806 1.642 . . . . 0.0 112.607 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.61 12.84 63.98 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.477 1.037 . . . . 0.0 113.802 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -124.86 142.49 51.41 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.841 1.32 . . . . 0.0 111.676 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.8 m -81.02 162.34 23.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.473 1.109 . . . . 0.0 113.289 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.86 -161.02 34.84 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 127.685 2.564 . . . . 0.0 106.857 -175.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.56 167.53 23.48 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.564 1.546 . . . . 0.0 109.309 173.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.47 -176.07 39.69 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 123.851 0.738 . . . . 0.0 114.52 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.69 9.2 0.79 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 124.83 3.686 . . . . 0.0 115.817 -165.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 tpmp? -125.64 6.8 7.52 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.287 0.949 . . . . 0.0 113.017 170.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -124.62 -54.41 1.66 Allowed 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 126.487 1.915 . . . . 0.0 109.729 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.6 m -68.89 -41.28 78.5 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.101 0.96 . . . . 0.0 109.527 164.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.35 64.9 2.43 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.96 0.791 . . . . 0.0 111.382 162.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.312 0.0 OUTLIER . . . . . 0 C--O 1.245 0.863 1 C-N-CA 132.155 4.182 . . . . 0.0 118.241 172.427 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.44 13.76 82.6 Favored Glycine 0 CA--C 1.537 1.433 0 CA-C-O 119.494 -0.615 . . . . 0.0 114.472 -170.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -60.38 168.84 1.9 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.944 1.698 . . . . 0.0 113.838 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.5 m -43.52 138.33 2.52 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.439 1.896 . . . . 0.0 111.732 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.8 t -28.36 -71.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 128.832 2.853 . . . . 0.0 113.101 -154.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -122.57 19.58 10.37 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.254 1.821 . . . . 0.0 110.402 140.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.18 -20.97 0.29 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.42 1.009 . . . . 0.0 114.857 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -106.42 177.68 4.78 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 124.962 1.305 . . . . 0.0 112.335 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.7 m -142.25 179.81 1.13 Allowed Pre-proline 0 CA--C 1.559 1.321 0 C-N-CA 125.957 1.703 . . . . 0.0 110.353 -174.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.97 -173.06 1.52 Allowed 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 123.676 2.917 . . . . 0.0 115.42 -177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.1 m -41.68 108.08 0.09 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.549 2.74 . . . . 0.0 114.688 -174.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.72 29.64 75.03 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.088 0.851 . . . . 0.0 113.864 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.99 172.63 0.94 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 171.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.86 115.75 9.24 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 113.15 -1.841 . . . . 0.0 109.665 148.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.7 t -62.95 113.11 2.89 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.658 -1.276 . . . . 0.0 110.537 172.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.3 p -61.36 162.02 8.42 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.327 1.051 . . . . 0.0 112.778 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -71.2 -15.95 62.49 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 53.4 m0 -75.0 -9.32 58.42 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.017 1.727 . . . . 0.0 112.603 167.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.78 16.4 51.85 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.459 -1.19 . . . . 0.0 114.447 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -124.42 148.62 47.48 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.693 1.746 . . . . 0.0 112.772 -175.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 67.1 m -73.11 154.41 40.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.551 1.54 . . . . 0.0 113.259 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.26 -168.15 37.14 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.806 1.67 . . . . 0.0 109.07 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -142.01 149.6 40.22 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.754 2.022 . . . . 0.0 109.537 -175.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.76 -171.52 30.37 Favored Glycine 0 CA--C 1.542 1.78 0 N-CA-C 114.829 0.692 . . . . 0.0 114.829 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.64 -14.28 7.17 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 125.126 3.884 . . . . 0.0 118.231 -170.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -99.38 7.03 45.88 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.02 1.328 . . . . 0.0 111.693 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -141.94 -64.31 0.43 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.875 2.07 . . . . 0.0 109.317 -167.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.3 m -79.78 -16.24 55.93 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.341 2.256 . . . . 0.0 111.963 173.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.35 -112.15 0.19 Allowed Glycine 0 CA--C 1.53 1.013 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 147.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.165 1.386 . . . . 0.0 111.224 176.419 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 7.8 p . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 117.808 -1.092 . . . . 0.0 112.398 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -92.51 8.24 77.16 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-N 119.639 1.109 . . . . 0.0 115.292 -171.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -51.62 154.08 2.08 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.585 0.707 . . . . 0.0 111.015 171.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.7 m -52.92 128.86 28.5 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 118.275 -0.869 . . . . 0.0 108.917 163.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.5 t -13.39 -79.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 129.39 3.076 . . . . 0.0 113.216 -157.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -123.8 27.67 7.19 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 127.252 2.221 . . . . 0.0 109.564 139.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.32 -2.74 0.1 OUTLIER Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.222 1.391 . . . . 0.0 116.189 176.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.6 mmt-85 -129.38 -177.46 4.26 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.157 1.783 . . . . 0.0 112.991 -172.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.2 m -143.67 158.79 56.06 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 125.073 1.349 . . . . 0.0 111.051 173.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.27 170.42 20.05 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.51 2.806 . . . . 0.0 112.947 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.6 m -44.97 99.85 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.836 2.455 . . . . 0.0 114.412 -173.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.31 -8.89 62.77 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.864 1.221 . . . . 0.0 114.899 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 45.5 mtt -90.81 164.73 13.97 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.872 1.269 . . . . 0.0 110.426 165.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.8 m -145.4 158.17 43.89 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.232 1.013 . . . . 0.0 111.805 -174.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.7 t -85.28 115.77 23.23 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.192 0.997 . . . . 0.0 111.274 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.4 p -70.94 165.41 23.42 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.342 1.068 . . . . 0.0 113.142 175.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.495 ' CD ' ' H ' ' A' ' 17' ' ' GLN . 6.1 mp0 -60.33 -17.23 41.62 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.513 1.925 . . . . 0.0 113.049 175.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -80.13 -7.97 59.18 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.276 1.431 . . . . 0.0 113.277 172.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.62 13.09 83.85 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 118.701 0.682 . . . . 0.0 113.124 -168.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -105.84 141.77 36.69 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.917 1.687 . . . . 0.0 111.486 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.0 t -82.68 157.33 23.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.236 0.615 . . . . 0.0 112.089 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.63 -172.51 42.5 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.788 0.709 . . . . 0.0 112.917 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -134.17 132.52 39.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.311 1.845 . . . . 0.0 106.754 -174.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.0 179.31 15.86 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.314 0.959 . . . . 0.0 112.295 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.75 0.83 5.07 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.934 2.422 . . . . 0.0 115.846 -171.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -95.8 -8.53 34.05 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.532 1.133 . . . . 0.0 111.614 172.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -124.03 -53.16 1.75 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.758 2.423 . . . . 0.0 110.436 -169.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 32.7 m -120.43 -16.03 8.45 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.084 2.154 . . . . 0.0 114.23 -164.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.25 -17.43 13.02 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-O 118.699 -1.056 . . . . 0.0 113.92 -159.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.145 0 C-N-CA 125.867 1.667 . . . . 0.0 112.791 -178.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.424 ' H3 ' ' CD ' ' A' ' 3' ' ' GLU . 7.3 p . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.686 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -89.04 -42.38 5.64 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 165.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.424 ' CD ' ' H3 ' ' A' ' 1' ' ' VAL . 0.0 OUTLIER -60.47 141.87 55.89 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.025 0.93 . . . . 0.0 110.504 154.224 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 41.7 m -53.55 146.23 13.34 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.4 1.88 . . . . 0.0 112.012 -175.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.5 t -44.93 -62.43 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.576 1.951 . . . . 0.0 111.334 -160.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -135.8 29.31 3.19 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.84 1.656 . . . . 0.0 110.259 129.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.27 -35.97 0.24 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.917 0.77 . . . . 0.0 114.555 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -88.41 177.09 6.92 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.703 1.252 . . . . 0.0 111.162 172.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.0 m -127.69 172.92 6.03 Favored Pre-proline 0 C--O 1.24 0.595 0 C-N-CA 125.035 1.334 . . . . 0.0 110.856 176.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.57 150.24 8.93 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.988 2.459 . . . . 0.0 112.196 171.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.5 m -67.89 79.94 0.21 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.325 1.45 . . . . 0.0 112.624 -166.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 144.14 -17.64 2.12 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.627 2.06 . . . . 0.0 113.94 -175.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.6 mtt -84.56 178.77 7.58 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.552 1.676 . . . . 0.0 112.728 174.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.7 m -129.03 146.85 50.9 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.767 2.427 . . . . 0.0 110.278 173.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.8 t -88.69 111.64 22.19 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.761 1.625 . . . . 0.0 111.039 173.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 t -67.38 155.98 37.62 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.824 0.85 . . . . 0.0 111.217 172.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -9.81 48.28 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.794 -1.191 . . . . 0.0 114.138 176.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.422 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 54.0 m0 -70.08 -5.17 24.92 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.833 1.253 . . . . 0.0 113.001 164.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.29 14.36 68.98 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.043 1.306 . . . . 0.0 113.759 176.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -120.81 154.22 36.04 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.869 1.668 . . . . 0.0 113.053 -175.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 94.3 m -93.34 147.41 22.96 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.012 1.325 . . . . 0.0 113.848 -174.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.25 -161.61 32.59 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.215 0.912 . . . . 0.0 112.071 176.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.7 tptt -134.24 167.54 20.5 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.835 1.654 . . . . 0.0 111.763 172.399 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.91 172.78 36.01 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.994 1.283 . . . . 0.0 112.569 -174.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.77 4.19 3.27 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.842 3.028 . . . . 0.0 114.967 -170.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.422 ' HE3' ' CE2' ' A' ' 18' ' ' TRP . 1.7 tmtm? -109.14 3.71 22.18 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.066 1.303 . . . . 0.0 111.906 171.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -122.91 -41.22 2.36 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 126.333 1.853 . . . . 0.0 110.466 178.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 m -93.61 3.6 55.25 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.691 1.196 . . . . 0.0 113.592 173.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.05 -85.59 0.05 OUTLIER Glycine 0 CA--C 1.536 1.348 0 CA-C-N 119.744 1.157 . . . . 0.0 115.889 177.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.187 0 C-N-CA 126.601 1.96 . . . . 0.0 113.255 -171.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.53 9.45 64.71 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.214 0.912 . . . . 0.0 114.484 -173.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -71.41 153.32 42.37 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.684 1.242 . . . . 0.0 111.974 174.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.6 m -69.0 164.89 21.32 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.886 1.274 . . . . 0.0 111.45 176.291 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.0 t -47.14 -68.32 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 125.762 1.625 . . . . 0.0 110.072 -176.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -139.64 19.15 2.52 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.145 2.178 . . . . 0.0 111.599 142.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.01 -14.18 0.07 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 115.656 1.023 . . . . 0.0 115.656 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -121.54 177.55 5.18 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.344 1.458 . . . . 0.0 112.12 170.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.93 -178.02 0.74 Allowed Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 126.593 1.957 . . . . 0.0 109.799 174.218 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -83.05 -174.85 2.16 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.769 2.979 . . . . 0.0 112.745 173.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.5 m 21.85 79.59 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 129.96 3.304 . . . . 0.0 116.39 161.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.2 18.68 71.43 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 115.638 1.015 . . . . 0.0 115.638 168.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.59 167.23 1.53 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 174.064 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.0 m -134.73 96.19 3.5 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 113.015 -1.902 . . . . 0.0 108.024 154.114 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -50.78 110.96 0.47 Allowed 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.559 -0.713 . . . . 0.0 111.655 168.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 30' ' ' ARG . 43.9 t -67.09 137.29 56.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.16 1.384 . . . . 0.0 109.357 174.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -6.48 4.96 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -166.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -69.45 -9.91 55.72 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.465 1.106 . . . . 0.0 112.998 165.347 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.38 18.17 24.6 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.902 1.715 . . . . 0.0 113.932 -177.059 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -122.95 145.06 48.81 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.686 1.243 . . . . 0.0 114.04 -166.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.1 t -100.98 152.93 19.98 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.554 1.142 . . . . 0.0 113.347 -162.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.79 -162.78 30.58 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 127.286 2.374 . . . . 0.0 110.054 -171.017 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.22 170.69 20.65 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.811 1.644 . . . . 0.0 110.394 169.339 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.26 -176.91 25.89 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.939 1.257 . . . . 0.0 112.651 -177.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.95 -10.75 30.02 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.009 2.473 . . . . 0.0 114.915 -173.003 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.37 -13.94 59.82 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.494 1.043 . . . . 0.0 111.221 170.029 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -128.98 -49.89 1.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.336 1.454 . . . . 0.0 110.932 -154.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.6 m -73.44 -7.76 53.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.619 1.167 . . . . 0.0 112.83 169.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.39 11.24 1.0 Allowed Glycine 0 CA--C 1.534 1.243 0 CA-C-O 117.546 -1.696 . . . . 0.0 116.681 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.437 ' O ' ' OG ' ' A' ' 16' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.236 0 CA-C-N 120.629 2.214 . . . . 0.0 114.046 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.95 4.1 3.2 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 119.614 1.097 . . . . 0.0 115.462 -175.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 4.3 pm0 -57.79 148.46 24.98 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.171 1.788 . . . . 0.0 112.495 172.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 m -61.73 138.51 58.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.921 0.488 . . . . 0.0 109.762 173.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -45.38 -66.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.643 1.977 . . . . 0.0 110.941 -162.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -133.58 25.09 4.07 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.991 1.716 . . . . 0.0 110.957 137.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.08 -34.43 0.26 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.019 0.819 . . . . 0.0 113.852 176.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -88.95 173.19 8.62 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 118.665 1.233 . . . . 0.0 112.364 174.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.4 m -148.35 179.74 1.12 Allowed Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 127.902 2.481 . . . . 0.0 108.444 -179.062 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.15 -175.25 1.18 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 123.685 2.923 . . . . 0.0 115.996 -178.128 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.8 m -44.11 108.04 0.1 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 128.598 2.759 . . . . 0.0 114.418 -173.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.08 29.75 75.59 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.87 0.748 . . . . 0.0 113.747 179.114 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.79 170.84 0.55 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 170.314 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.8 104.39 5.49 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 113.511 -1.677 . . . . 0.0 109.004 153.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -56.7 112.05 1.19 Allowed 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.288 -0.883 . . . . 0.0 110.719 173.006 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.403 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 81.0 p -73.56 168.07 20.05 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -173.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.523 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 1.4 mp0 -57.68 -20.04 31.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.544 1.938 . . . . 0.0 112.866 170.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.52 -4.32 55.63 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.257 1.423 . . . . 0.0 112.484 174.204 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.7 20.56 79.72 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.226 -0.763 . . . . 0.0 112.9 -170.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -120.24 144.89 47.52 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.028 1.731 . . . . 0.0 112.447 -175.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.9 m -73.34 155.48 39.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.428 1.491 . . . . 0.0 112.92 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.64 -169.38 33.43 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 126.132 1.825 . . . . 0.0 109.082 -177.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -145.29 159.58 42.82 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.417 2.287 . . . . 0.0 108.907 -175.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.44 -169.46 33.01 Favored Glycine 0 CA--C 1.539 1.588 0 N-CA-C 114.414 0.526 . . . . 0.0 114.414 173.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.66 -1.04 6.85 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 124.08 3.187 . . . . 0.0 116.733 -162.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.11 1.8 24.45 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.34 0.973 . . . . 0.0 112.71 170.427 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.403 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 86.3 m-85 -129.26 -57.08 1.16 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.47 1.908 . . . . 0.0 109.699 -167.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -93.42 -12.92 28.69 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.406 1.083 . . . . 0.0 113.555 169.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.68 -7.3 58.89 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-N 118.795 0.725 . . . . 0.0 113.774 -168.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.136 0 C-N-CA 128.666 2.787 . . . . 0.0 108.262 164.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.453 ' H2 ' ' CD ' ' A' ' 3' ' ' GLU . 65.5 t . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.24 12.46 58.66 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.25 0.929 . . . . 0.0 114.257 -177.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.453 ' CD ' ' H2 ' ' A' ' 1' ' ' VAL . 1.9 pm0 -65.9 145.15 56.27 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.663 1.231 . . . . 0.0 111.35 175.067 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.2 m -64.85 147.33 53.47 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.043 -0.411 . . . . 0.0 109.943 174.394 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.2 t -48.81 -67.1 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.725 1.21 . . . . 0.0 110.212 -174.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -137.19 23.72 3.0 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.123 2.169 . . . . 0.0 111.023 139.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.28 -28.8 0.34 Allowed Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.226 1.393 . . . . 0.0 113.33 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.46 151.29 42.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 117.928 0.864 . . . . 0.0 111.921 169.381 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.2 m -149.85 171.0 6.83 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 128.504 2.722 . . . . 0.0 109.792 -176.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.78 -176.25 2.9 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.986 3.124 . . . . 0.0 115.501 -173.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.8 t -45.32 119.7 2.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.97 1.708 . . . . 0.0 113.626 -173.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.37 29.59 75.0 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.352 0.977 . . . . 0.0 114.26 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.01 168.56 0.12 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 173.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -132.26 144.92 50.95 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 112.947 -1.933 . . . . 0.0 110.137 122.505 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 32.5 t -85.33 117.7 24.42 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.898 1.279 . . . . 0.0 109.356 168.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 t -65.9 153.2 42.66 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.328 0.651 . . . . 0.0 111.967 177.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -16.79 14.82 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.211 1.004 . . . . 0.0 112.518 167.42 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 27.8 m95 -76.24 -8.26 56.67 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.417 1.887 . . . . 0.0 113.119 172.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.92 14.15 61.31 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.467 1.032 . . . . 0.0 114.686 178.446 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -123.71 147.58 47.33 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.258 1.423 . . . . 0.0 112.804 -176.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 65.4 m -81.87 152.1 27.0 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.816 1.646 . . . . 0.0 112.349 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.9 -154.53 21.98 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 178.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 159.2 44.04 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.535 1.534 . . . . 0.0 109.613 176.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.54 -178.15 52.58 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 123.722 0.677 . . . . 0.0 113.489 178.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.73 2.02 2.8 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.469 3.446 . . . . 0.0 116.218 -166.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.73 -6.15 46.8 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 123.11 1.433 . . . . 0.0 111.031 172.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -132.01 -49.25 0.94 Allowed 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 127.919 2.488 . . . . 0.0 109.919 -169.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 67.3 m -81.53 8.79 8.73 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.646 1.978 . . . . 0.0 112.013 167.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.51 -92.09 0.09 OUTLIER Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.262 0.934 . . . . 0.0 114.233 -176.028 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 -157.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 97.9 m -38.96 127.56 1.61 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 128.486 2.715 . . . . 0.0 112.129 -173.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.5 t 1.34 -85.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 130.191 3.396 . . . . 0.0 112.192 -159.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -130.98 30.04 4.63 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.345 2.258 . . . . 0.0 109.771 142.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.97 -15.86 0.04 OUTLIER Glycine 0 CA--C 1.536 1.375 0 N-CA-C 116.656 1.422 . . . . 0.0 116.656 168.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -133.18 174.49 10.32 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 119.937 1.869 . . . . 0.0 113.662 -173.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.0 m -97.46 166.76 13.06 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.322 1.049 . . . . 0.0 111.638 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -50.68 149.58 13.68 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.94 2.427 . . . . 0.0 111.4 157.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.6 m -68.25 80.06 0.24 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.209 1.403 . . . . 0.0 111.583 -174.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 150.22 -14.81 0.98 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.723 1.63 . . . . 0.0 114.428 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.7 mtt -106.27 174.91 5.68 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.905 1.853 . . . . 0.0 111.754 175.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.5 m -126.27 130.4 50.81 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.389 1.876 . . . . 0.0 111.374 -172.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.9 t -84.0 114.82 21.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.467 0.707 . . . . 0.0 110.57 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.2 p -66.4 163.95 17.24 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -5.4 21.72 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 169.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.79 -8.87 58.61 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.152 0.887 . . . . 0.0 112.321 163.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.07 4.44 90.25 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.626 1.108 . . . . 0.0 113.701 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -109.82 148.95 30.56 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.098 1.359 . . . . 0.0 110.784 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.1 t -91.59 150.41 21.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.749 1.22 . . . . 0.0 113.153 -169.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.57 -156.69 24.59 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.01 0.814 . . . . 0.0 113.548 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -139.6 161.32 37.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.468 1.907 . . . . 0.0 112.153 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.2 -179.96 51.77 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.802 1.191 . . . . 0.0 112.798 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.7 -1.6 8.71 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.125 2.55 . . . . 0.0 115.802 -166.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.59 -6.04 58.48 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.194 0.998 . . . . 0.0 110.798 171.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -138.15 -53.47 0.63 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.104 1.762 . . . . 0.0 111.479 -165.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 63.9 m . . . . . 0 CA--C 1.541 0.608 0 C-N-CA 125.625 1.57 . . . . 0.0 113.746 176.914 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 120.842 0.353 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.3 m -62.63 135.72 57.52 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.947 0.88 . . . . 0.0 111.483 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.46 69.88 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.782 1.633 . . . . 0.0 110.381 -164.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 47.97 25.31 0.75 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.864 -155.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 128.84 -13.95 6.05 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.582 1.086 . . . . 0.0 115.544 162.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.79 171.77 7.34 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.198 1.799 . . . . 0.0 110.79 175.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 67.8 m -145.25 153.96 53.16 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.567 0.747 . . . . 0.0 112.157 -169.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.42 172.93 15.34 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.94 3.094 . . . . 0.0 112.229 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.6 m 42.4 41.69 2.34 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.603 1.961 . . . . 0.0 115.495 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.61 26.84 17.08 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.807 1.67 . . . . 0.0 114.438 -174.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.1 mtt -70.0 170.79 10.62 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.782 1.291 . . . . 0.0 110.76 172.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -122.77 140.52 52.81 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.027 1.731 . . . . 0.0 110.448 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t -71.56 116.94 12.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.488 1.115 . . . . 0.0 110.868 173.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.432 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 78.8 p -70.52 161.77 30.01 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.518 1.127 . . . . 0.0 113.133 172.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -58.83 -14.67 9.49 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.415 1.486 . . . . 0.0 114.212 166.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -78.5 -11.76 59.97 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.238 1.015 . . . . 0.0 113.047 170.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.6 16.68 67.84 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-N 118.674 0.67 . . . . 0.0 113.732 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -119.32 143.63 47.28 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.576 1.551 . . . . 0.0 111.977 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.5 m -77.4 151.94 34.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.598 1.159 . . . . 0.0 112.663 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.6 -170.41 43.49 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.656 1.122 . . . . 0.0 111.24 174.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -119.4 145.65 46.04 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.698 1.199 . . . . 0.0 111.061 -173.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.98 -173.88 24.84 Favored Glycine 0 CA--C 1.542 1.74 0 N-CA-C 115.932 1.133 . . . . 0.0 115.932 166.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -71.88 12.53 0.57 Allowed 'Trans proline' 0 CA--C 1.541 0.847 1 C-N-CA 125.881 4.387 . . . . 0.0 116.282 -161.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.59 -11.87 6.71 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 167.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 75.8 m-85 -88.26 -58.06 2.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.501 1.52 . . . . 0.0 109.272 168.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.9 m . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 126.572 1.949 . . . . 0.0 110.872 177.019 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.9 mp0 . . . . . 0 CA--C 1.539 0.552 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.1 m -62.88 131.28 48.22 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.161 0.981 . . . . 0.0 110.458 168.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.09 77.36 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 128.746 2.819 . . . . 0.0 109.893 -169.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 52.94 1.32 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.99 1.716 . . . . 0.0 114.532 -158.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.47 -20.71 0.93 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-O 118.264 -1.298 . . . . 0.0 114.285 174.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -90.48 170.38 10.26 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 119.453 1.626 . . . . 0.0 111.875 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.7 m -141.73 -179.73 1.04 Allowed Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 126.245 1.818 . . . . 0.0 107.935 174.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.79 152.1 18.11 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.96 2.44 . . . . 0.0 113.997 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.7 m -68.38 93.25 0.47 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.724 0.81 . . . . 0.0 111.302 -172.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.19 -8.95 4.12 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 126.021 1.772 . . . . 0.0 114.287 -169.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.55 176.04 0.1 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 129.468 3.107 . . . . 0.0 118.413 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.7 m -135.85 111.95 9.66 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.728 2.011 . . . . 0.0 108.476 143.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.0 t -60.92 116.92 4.84 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.15 -0.969 . . . . 0.0 110.239 169.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.1 p -68.08 159.18 31.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.828 0.851 . . . . 0.0 113.183 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -54.2 -27.26 33.04 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.52 1.128 . . . . 0.0 112.581 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.452 ' CZ2' ' HE2' ' A' ' 26' ' ' LYS . 34.1 m0 -76.47 -2.53 32.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.593 1.557 . . . . 0.0 112.253 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.89 23.08 67.52 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.295 -0.725 . . . . 0.0 112.686 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.41 148.4 44.45 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.6 1.56 . . . . 0.0 112.695 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.4 m -86.51 153.29 21.96 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.07 1.748 . . . . 0.0 114.247 -178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.05 -161.92 31.87 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 127.044 2.259 . . . . 0.0 110.556 -177.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.11 157.95 43.79 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.846 2.458 . . . . 0.0 108.37 174.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.24 -174.68 18.43 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.809 1.195 . . . . 0.0 113.154 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.46 -14.8 40.73 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.95 2.434 . . . . 0.0 114.29 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.452 ' HE2' ' CZ2' ' A' ' 18' ' ' TRP . 7.3 tptp -78.87 -4.22 48.58 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.172 1.389 . . . . 0.0 111.832 174.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -137.32 -54.92 0.7 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.537 1.535 . . . . 0.0 110.684 -158.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.2 m . . . . . 0 CA--C 1.544 0.737 0 C-N-CA 125.156 1.382 . . . . 0.0 113.191 169.683 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 . . . . . 0 CA--C 1.541 0.607 0 CA-C-O 120.965 0.412 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 m -66.0 146.66 54.43 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.605 -0.684 . . . . 0.0 111.262 170.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.1 t -50.73 -69.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.093 1.757 . . . . 0.0 109.73 -173.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -138.41 21.67 2.75 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 127.591 2.356 . . . . 0.0 111.201 142.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.62 -24.36 0.3 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.856 1.217 . . . . 0.0 113.809 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.3 169.86 14.25 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.476 1.11 . . . . 0.0 112.837 165.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.1 m -137.39 176.39 2.79 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 128.733 2.813 . . . . 0.0 108.845 173.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -52.88 168.82 0.43 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.653 2.902 . . . . 0.0 115.431 175.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.9 p -54.69 106.03 0.19 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.261 1.824 . . . . 0.0 111.632 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.57 9.18 64.95 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.402 -1.221 . . . . 0.0 114.578 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 54.0 mtt -110.92 166.93 10.64 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.364 1.466 . . . . 0.0 112.067 172.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.7 m -134.32 143.35 47.65 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.906 2.082 . . . . 0.0 111.006 -173.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.6 t -84.81 115.81 22.94 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.626 1.57 . . . . 0.0 111.793 177.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.1 t -70.72 159.49 34.38 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 172.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -48.35 -24.22 1.16 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.555 2.342 . . . . 0.0 113.538 168.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -83.55 -4.47 58.58 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.132 1.773 . . . . 0.0 113.172 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.42 13.05 68.75 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.102 0.858 . . . . 0.0 114.433 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -122.0 153.33 38.71 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.677 1.591 . . . . 0.0 112.336 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.4 m -88.39 158.13 18.49 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.557 1.543 . . . . 0.0 113.426 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.22 -165.1 38.01 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -137.37 163.82 30.1 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.859 0.863 . . . . 0.0 111.185 -175.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.34 -170.25 52.16 Favored Glycine 0 CA--C 1.539 1.547 0 N-CA-C 114.756 0.663 . . . . 0.0 114.756 172.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.35 13.4 0.55 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 124.708 3.605 . . . . 0.0 115.469 -166.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.47 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -125.27 9.95 7.99 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.363 1.065 . . . . 0.0 112.44 169.662 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -138.69 -50.78 0.55 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 125.749 1.62 . . . . 0.0 110.862 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.1 m . . . . . 0 CA--C 1.539 0.526 0 C-N-CA 123.759 0.824 . . . . 0.0 109.026 161.359 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 . . . . . 0 CA--C 1.548 0.871 0 CA-C-O 122.082 0.944 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 41.2 m -65.23 102.27 0.64 Allowed 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.529 -1.357 . . . . 0.0 108.003 157.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -4.57 -88.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 130.641 3.577 . . . . 0.0 112.515 -156.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 67.9 mmt-85 -130.16 41.19 3.44 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.051 0.941 . . . . 0.0 109.526 143.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 157.67 -10.12 0.23 Allowed Glycine 0 CA--C 1.534 1.25 0 N-CA-C 116.254 1.262 . . . . 0.0 116.254 163.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -121.65 178.79 4.69 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 119.839 1.819 . . . . 0.0 112.883 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 39.8 m -127.59 166.78 21.05 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 124.651 1.18 . . . . 0.0 110.586 173.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.67 149.85 13.19 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.432 2.755 . . . . 0.0 112.537 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.7 m -69.49 76.27 0.4 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.542 1.537 . . . . 0.0 111.682 -171.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.38 -17.07 1.14 Allowed Glycine 0 CA--C 1.537 1.432 0 C-N-CA 126.249 1.881 . . . . 0.0 114.231 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.1 mtt -86.43 -168.59 2.29 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.674 1.737 . . . . 0.0 112.261 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.76 160.9 41.08 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.651 2.381 . . . . 0.0 110.159 162.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.1 t -98.24 120.78 39.24 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.402 1.881 . . . . 0.0 112.044 -173.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.466 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 13.1 t -76.43 159.19 30.67 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -7.92 7.07 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 160.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -71.59 -10.34 59.62 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.38 1.072 . . . . 0.0 112.436 164.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.63 13.8 82.0 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.492 1.044 . . . . 0.0 113.723 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -130.27 164.12 25.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.444 1.898 . . . . 0.0 111.495 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 78.0 m -94.32 158.24 15.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.823 1.249 . . . . 0.0 113.83 -172.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.57 -156.18 26.92 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.175 1.369 . . . . 0.0 111.102 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.7 tptt -138.34 164.47 29.21 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.839 1.656 . . . . 0.0 111.662 171.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.06 -176.18 31.59 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 124.119 0.866 . . . . 0.0 114.263 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.31 18.57 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.861 1 C-N-CA 125.745 4.296 . . . . 0.0 115.087 -168.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.49 6.46 6.92 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.889 1.276 . . . . 0.0 112.447 170.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.466 ' CD2' ' HB2' ' A' ' 16' ' ' SER . 96.3 m-85 -134.28 -48.88 0.78 Allowed 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 128.049 2.54 . . . . 0.0 109.911 -176.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.1 m . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 125.696 1.598 . . . . 0.0 111.565 173.373 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 . . . . . 0 CA--C 1.545 0.75 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.5 m -47.18 140.9 4.83 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.032 1.733 . . . . 0.0 112.094 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.8 t -30.44 -70.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 128.377 2.671 . . . . 0.0 112.908 -152.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -123.01 21.12 9.87 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.194 1.798 . . . . 0.0 110.415 138.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.07 -21.34 0.5 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.975 1.274 . . . . 0.0 114.985 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -98.78 -178.29 3.92 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.188 1.395 . . . . 0.0 111.971 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.9 m -130.95 170.43 11.24 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.737 1.215 . . . . 0.0 112.026 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.98 177.0 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 125.231 3.954 . . . . 0.0 115.386 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.7 p -53.86 90.83 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.107 2.163 . . . . 0.0 113.764 -174.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.77 -1.52 75.12 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.255 1.407 . . . . 0.0 114.661 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.29 170.27 16.87 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.369 1.585 . . . . 0.0 110.795 175.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.1 m -134.4 137.3 43.96 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.532 1.533 . . . . 0.0 110.805 -168.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 32.2 t -86.83 115.39 24.22 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.14 1.376 . . . . 0.0 110.865 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.4 t -74.44 164.88 26.08 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.628 0.728 . . . . 0.0 112.745 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -45.44 -23.13 0.18 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.948 2.499 . . . . 0.0 114.373 158.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -66.6 -16.67 64.35 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.621 1.568 . . . . 0.0 112.54 173.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.18 10.11 86.47 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.629 1.109 . . . . 0.0 113.14 -167.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -121.4 153.57 37.65 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.88 1.672 . . . . 0.0 111.269 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.1 m -84.01 155.5 22.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.116 0.967 . . . . 0.0 113.58 -177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.52 -155.44 15.77 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.142 1.829 . . . . 0.0 110.244 174.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -145.02 161.68 38.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.706 1.602 . . . . 0.0 109.965 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.79 -172.38 35.53 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.486 0.954 . . . . 0.0 115.486 172.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.19 -0.7 0.68 Allowed 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 126.11 4.54 . . . . 0.0 117.96 -172.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.486 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -125.74 9.74 7.68 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.39 0.995 . . . . 0.0 112.636 175.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -136.91 -47.07 0.59 Allowed 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 125.218 1.407 . . . . 0.0 112.409 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.441 0 CA-C-N 118.153 0.433 . . . . 0.0 110.432 159.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 CA--C 1.54 0.569 0 CA-C-O 121.801 0.81 . . . . 0.0 111.854 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.9 m -57.45 138.67 54.78 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 157.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.2 t -31.88 -68.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 128.261 2.624 . . . . 0.0 112.461 -158.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -123.32 19.11 9.8 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.491 1.916 . . . . 0.0 110.423 134.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.23 -26.78 0.32 Allowed Glycine 0 CA--C 1.54 1.597 0 C-N-CA 125.309 1.433 . . . . 0.0 114.806 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -85.23 -179.01 6.91 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.748 1.619 . . . . 0.0 111.633 172.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.7 m -134.49 142.66 43.59 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.158 0.983 . . . . 0.0 111.258 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -80.4 174.89 10.78 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.764 2.976 . . . . 0.0 111.584 172.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.1 m 37.74 46.99 0.78 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 127.672 2.389 . . . . 0.0 115.599 167.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.03 11.3 54.61 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-O 118.346 -1.252 . . . . 0.0 115.843 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.3 mmt -72.68 172.28 10.98 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.264 2.032 . . . . 0.0 112.206 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m -122.12 137.67 54.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.935 2.094 . . . . 0.0 111.006 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -86.87 117.77 25.82 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.945 0.898 . . . . 0.0 111.309 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.0 p -75.26 159.81 31.09 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.309 1.044 . . . . 0.0 113.29 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -59.2 -13.58 7.99 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.031 1.732 . . . . 0.0 113.961 167.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.474 ' CZ2' ' HE3' ' A' ' 26' ' ' LYS . 6.0 m95 -75.56 -9.33 58.48 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.838 1.255 . . . . 0.0 112.45 171.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.93 9.82 86.66 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.064 0.84 . . . . 0.0 113.106 -169.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -107.49 145.83 32.58 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.655 1.582 . . . . 0.0 111.872 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.9 t -96.42 143.83 27.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.238 1.015 . . . . 0.0 111.691 -175.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.68 -160.42 29.63 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.891 -0.506 . . . . 0.0 112.918 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -132.82 163.1 29.82 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.45 1.5 . . . . 0.0 111.999 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.65 177.68 31.05 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.64 1.114 . . . . 0.0 113.947 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.01 8.87 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 124.551 3.5 . . . . 0.0 115.246 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.474 ' HE3' ' CZ2' ' A' ' 18' ' ' TRP . 2.9 tpmp? -123.78 10.21 8.94 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.309 0.959 . . . . 0.0 112.144 169.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -125.37 -55.26 1.55 Allowed 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 126.608 1.963 . . . . 0.0 110.04 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 64.1 m . . . . . 0 CA--C 1.536 0.412 0 C-N-CA 124.049 0.939 . . . . 0.0 110.847 167.216 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 CA--C 1.539 0.529 0 CA-C-O 121.707 0.765 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.6 m -56.16 133.67 52.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 161.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.1 t -19.95 -76.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 129.2 3.0 . . . . 0.0 113.173 -160.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -122.41 25.14 9.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.804 2.042 . . . . 0.0 109.88 139.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.03 -6.92 0.45 Allowed Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.216 1.389 . . . . 0.0 115.45 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -114.13 -178.08 3.29 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.229 2.212 . . . . 0.0 112.38 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.5 m -144.75 159.93 48.97 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.661 1.584 . . . . 0.0 110.342 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.04 166.96 28.06 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.135 2.557 . . . . 0.0 113.123 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.5 m -56.63 92.71 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.12 2.168 . . . . 0.0 113.117 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.76 -8.5 6.46 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.415 1.483 . . . . 0.0 113.954 -176.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -122.03 165.54 15.87 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.56 1.944 . . . . 0.0 111.26 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.6 m -142.27 157.44 44.83 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.834 1.654 . . . . 0.0 111.047 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.3 t -83.53 118.92 24.11 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.621 0.768 . . . . 0.0 111.175 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 90.2 p -72.09 165.52 24.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.493 1.139 . . . . 0.0 113.225 175.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.546 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 5.7 mp0 -60.04 -17.13 36.8 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.355 1.862 . . . . 0.0 113.046 173.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -81.82 -7.61 59.62 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.322 1.449 . . . . 0.0 113.292 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.37 12.27 84.38 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 118.959 0.8 . . . . 0.0 113.336 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -105.07 146.03 29.67 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.791 1.637 . . . . 0.0 111.518 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.8 t -85.41 157.82 20.39 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.503 0.721 . . . . 0.0 112.095 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.36 -171.45 38.23 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.662 1.125 . . . . 0.0 111.921 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.89 175.77 9.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.176 0.988 . . . . 0.0 112.04 174.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.25 177.55 45.94 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.676 1.131 . . . . 0.0 111.755 -165.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.98 5.47 3.48 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.624 2.216 . . . . 0.0 116.097 -164.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -90.69 -8.22 50.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.265 0.939 . . . . 0.0 111.304 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.445 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 96.6 m-85 -130.92 -51.27 1.04 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.754 2.422 . . . . 0.0 111.283 -168.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -148.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 N--CA 1.468 0.472 0 CA-C-O 121.538 0.685 . . . . 0.0 111.783 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.9 m -61.34 148.1 42.55 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.911 0.484 . . . . 0.0 111.442 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t -49.09 -66.61 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.906 1.682 . . . . 0.0 109.907 -173.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -138.3 19.24 2.76 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.023 2.129 . . . . 0.0 111.721 140.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.91 -19.36 0.2 Allowed Glycine 0 CA--C 1.532 1.12 0 N-CA-C 115.162 0.825 . . . . 0.0 115.162 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -99.87 173.79 6.51 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.209 1.404 . . . . 0.0 110.777 165.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.9 m -139.48 154.12 71.24 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.086 1.354 . . . . 0.0 110.939 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.45 170.45 15.95 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.553 2.835 . . . . 0.0 112.914 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.1 p 54.47 30.65 13.26 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 173.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.29 30.48 58.24 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.606 1.098 . . . . 0.0 113.399 -171.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.8 mmt -72.19 168.17 18.79 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.611 1.206 . . . . 0.0 109.782 163.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.0 m -124.13 130.85 53.24 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.081 1.752 . . . . 0.0 110.13 -173.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.9 t -73.1 102.32 3.53 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.978 0.911 . . . . 0.0 112.287 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.1 p -61.91 171.48 1.67 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 175.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -67.82 -11.27 58.2 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.246 1.418 . . . . 0.0 113.744 166.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -79.26 -4.45 50.75 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.183 0.901 . . . . 0.0 112.535 168.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.54 18.99 77.51 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.828 0.74 . . . . 0.0 112.741 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.71 146.58 46.3 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.936 1.694 . . . . 0.0 112.007 -176.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.1 m -84.09 157.46 21.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.844 1.658 . . . . 0.0 112.341 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.05 -172.55 39.09 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 128.05 2.738 . . . . 0.0 107.278 -174.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -132.39 163.68 28.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.047 1.424 . . . . 0.0 110.885 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.37 -165.98 36.07 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 114.882 0.713 . . . . 0.0 114.882 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.88 8.46 1.32 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 125.04 3.827 . . . . 0.0 115.722 -165.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.45 5.9 9.59 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.555 1.07 . . . . 0.0 113.41 168.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -133.45 -52.4 0.88 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.521 1.528 . . . . 0.0 111.733 -173.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 CA--C 1.537 0.462 0 C-N-CA 122.675 0.39 . . . . 0.0 110.031 162.47 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 CA--C 1.541 0.618 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.5 m -66.58 99.69 0.61 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 163.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t 2.73 -90.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 131.257 3.823 . . . . 0.0 111.547 -162.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 75.7 mmt-85 -131.06 41.97 3.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.774 1.23 . . . . 0.0 109.283 141.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.02 -16.36 0.08 OUTLIER Glycine 0 CA--C 1.538 1.486 0 N-CA-C 117.169 1.628 . . . . 0.0 117.169 165.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -130.77 175.77 8.76 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 120.583 2.191 . . . . 0.0 113.248 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.8 m -119.95 166.6 14.53 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 123.894 0.878 . . . . 0.0 111.018 173.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -51.57 149.85 17.46 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.27 2.647 . . . . 0.0 112.816 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.0 m -69.83 76.22 0.46 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.546 1.538 . . . . 0.0 111.206 -175.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 151.13 -19.84 0.95 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 126.113 1.816 . . . . 0.0 113.93 -171.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.5 mmt -86.5 -167.29 1.82 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.307 1.843 . . . . 0.0 111.575 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 p -147.43 162.17 39.55 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.494 1.918 . . . . 0.0 110.749 161.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.7 t -102.04 114.11 27.93 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.169 1.788 . . . . 0.0 111.997 -171.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.441 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 5.4 t -65.77 147.55 53.2 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.153 0.581 . . . . 0.0 111.747 175.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.529 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -60.74 -8.44 2.98 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.951 1.7 . . . . 0.0 114.666 175.134 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -90.7 -2.43 57.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.098 1.359 . . . . 0.0 113.792 168.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.4 18.14 31.77 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.287 -1.285 . . . . 0.0 115.542 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -127.77 152.86 47.23 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.283 1.541 . . . . 0.0 112.707 -175.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.8 m -91.11 155.97 18.24 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.57 -161.22 35.01 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.187 1.375 . . . . 0.0 111.251 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -134.77 161.72 34.39 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.76 1.624 . . . . 0.0 112.082 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.46 176.02 35.74 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.962 1.268 . . . . 0.0 112.701 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.44 -2.82 10.6 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.467 2.778 . . . . 0.0 115.257 -169.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -81.27 -16.95 51.05 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.449 1.099 . . . . 0.0 110.672 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 98.3 m-85 -123.81 -42.79 2.16 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 129.014 2.926 . . . . 0.0 111.43 -167.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.2 m . . . . . 0 CA--C 1.541 0.625 0 C-N-CA 125.339 1.455 . . . . 0.0 113.268 -179.35 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 121.645 0.736 . . . . 0.0 112.617 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.0 m -54.25 129.28 34.62 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.994 0.918 . . . . 0.0 109.48 162.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.2 t -22.47 -74.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 128.833 2.853 . . . . 0.0 113.163 -158.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -122.87 23.44 9.38 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.765 2.026 . . . . 0.0 110.077 138.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.33 -5.05 0.2 Allowed Glycine 0 CA--C 1.536 1.356 0 N-CA-C 116.171 1.229 . . . . 0.0 116.171 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -115.01 167.87 10.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.694 1.747 . . . . 0.0 112.056 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 72.9 m -152.73 173.01 4.92 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 125.912 1.685 . . . . 0.0 110.066 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -58.39 -178.0 0.11 Allowed 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 125.797 4.331 . . . . 0.0 118.894 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.6 m -43.8 105.18 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 129.016 2.926 . . . . 0.0 114.299 -178.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.74 33.26 86.31 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 123.885 0.755 . . . . 0.0 113.356 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.01 167.89 0.14 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.721 1.608 . . . . 0.0 114.985 170.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -134.69 88.29 2.42 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.002 156.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.2 t -50.55 112.51 0.71 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.186 0.995 . . . . 0.0 110.359 173.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.7 t -61.22 152.38 29.01 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.987 0.915 . . . . 0.0 111.119 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -64.1 -18.27 64.25 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -90.66 3.67 53.54 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.672 1.989 . . . . 0.0 111.929 175.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.36 6.89 47.09 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-O 118.109 -1.384 . . . . 0.0 115.831 162.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -114.62 152.77 31.31 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.638 1.719 . . . . 0.0 113.765 -169.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.6 m -79.37 152.28 30.49 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.67 -175.76 31.9 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 127.218 2.342 . . . . 0.0 109.514 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -141.65 158.15 44.18 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.927 2.091 . . . . 0.0 109.351 -175.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.44 -176.56 24.35 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 123.82 0.724 . . . . 0.0 114.67 171.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.45 -1.61 8.51 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.415 3.41 . . . . 0.0 115.854 -166.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -115.99 7.01 14.24 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.83 1.252 . . . . 0.0 111.847 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -120.39 -52.16 2.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 126.721 2.009 . . . . 0.0 109.905 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.2 m . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 164.739 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 121.217 0.532 . . . . 0.0 111.836 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.0 m -64.81 139.53 58.77 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.214 0.606 . . . . 0.0 110.74 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.0 t -52.77 -66.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.262 1.825 . . . . 0.0 111.287 -165.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.3 mmt-85 -129.68 16.97 5.83 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.476 1.91 . . . . 0.0 110.269 151.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.98 -23.25 2.28 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.933 1.73 . . . . 0.0 113.007 -176.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.17 157.95 33.79 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.035 0.918 . . . . 0.0 112.225 168.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.5 m -149.24 -179.12 0.91 Allowed Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 130.0 3.32 . . . . 0.0 107.461 174.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -55.81 177.97 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.637 3.558 . . . . 0.0 117.774 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.2 m -53.77 121.77 8.57 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.851 1.66 . . . . 0.0 111.607 174.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.46 4.67 80.81 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.624 -1.098 . . . . 0.0 115.349 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.81 165.89 0.17 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 176.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.9 m -136.69 99.29 4.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.481 154.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.0 t -51.41 113.08 0.86 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.3 1.04 . . . . 0.0 110.66 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.448 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 26.3 t -67.6 160.51 27.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.294 1.438 . . . . 0.0 113.435 -169.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -57.86 -20.49 36.79 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.273 1.029 . . . . 0.0 112.712 161.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.522 ' CD2' ' HE2' ' A' ' 26' ' ' LYS . 6.1 m-90 -79.18 -2.39 40.69 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.441 1.496 . . . . 0.0 112.987 170.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.36 18.69 79.01 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.405 1.002 . . . . 0.0 113.877 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -121.44 155.45 34.84 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.849 1.66 . . . . 0.0 113.022 -172.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.98 152.42 28.0 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.288 1.835 . . . . 0.0 112.304 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.91 -170.79 30.68 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.645 1.117 . . . . 0.0 111.104 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -146.8 165.67 28.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 129.879 3.272 . . . . 0.0 109.698 -172.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.56 -170.29 38.43 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.505 1.05 . . . . 0.0 112.943 -171.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.56 3.04 7.18 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.617 2.878 . . . . 0.0 115.648 -171.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.522 ' HE2' ' CD2' ' A' ' 18' ' ' TRP . 1.6 ttpm? -98.19 11.69 36.98 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 119.534 1.061 . . . . 0.0 111.823 172.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.448 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 92.1 m-85 -147.24 -53.02 0.21 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.898 2.479 . . . . 0.0 110.179 -164.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 121.587 0.708 . . . . 0.0 111.797 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.3 m -64.0 154.84 32.95 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.689 0.796 . . . . 0.0 111.005 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.9 t -45.7 -67.21 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.987 1.715 . . . . 0.0 110.191 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -138.49 23.18 2.72 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.246 2.218 . . . . 0.0 110.907 139.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.78 -11.14 0.2 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.1 0.857 . . . . 0.0 114.957 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -105.89 165.69 11.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.561 1.944 . . . . 0.0 111.312 170.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.3 m -155.56 178.52 1.63 Allowed Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 127.079 2.152 . . . . 0.0 109.24 -170.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -57.54 178.71 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.941 3.761 . . . . 0.0 118.137 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.9 m -42.87 109.13 0.12 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 128.214 2.606 . . . . 0.0 114.0 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.19 29.12 74.51 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.235 -0.759 . . . . 0.0 114.041 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.72 168.7 0.4 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 170.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -132.73 106.27 7.66 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 113.377 -1.738 . . . . 0.0 108.712 147.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.1 t -54.68 117.48 3.41 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.336 -0.852 . . . . 0.0 110.569 170.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.427 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 10.8 t -64.95 164.1 13.29 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.05 0.94 . . . . 0.0 113.091 -175.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.554 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 18.1 mp0 -60.51 -18.92 55.04 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.672 1.989 . . . . 0.0 111.5 168.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 30.5 m0 -90.97 0.75 57.46 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.739 2.016 . . . . 0.0 113.391 172.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.98 25.21 69.73 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.858 -0.968 . . . . 0.0 114.24 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -120.01 152.69 37.12 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.909 1.684 . . . . 0.0 112.527 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.3 m -81.86 151.05 27.5 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.148 1.379 . . . . 0.0 113.072 -177.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.48 -165.23 32.86 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.539 2.018 . . . . 0.0 108.471 -174.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.75 160.79 42.85 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.588 1.955 . . . . 0.0 108.907 177.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.35 -169.81 26.59 Favored Glycine 0 CA--C 1.543 1.796 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 171.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -54.64 -10.13 2.23 Favored 'Trans proline' 0 CA--C 1.538 0.713 1 C-N-CA 126.101 4.534 . . . . 0.0 119.143 -170.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.501 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -119.14 12.34 12.63 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.87 1.214 . . . . 0.0 112.636 176.138 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 57.1 m-85 -129.96 -70.48 0.64 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 127.346 2.258 . . . . 0.0 108.085 -176.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.539 0.548 0 C-N-CA 124.111 0.964 . . . . 0.0 113.331 170.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.6 mp0 . . . . . 0 CA--C 1.542 0.656 0 CA-C-O 121.102 0.477 . . . . 0.0 112.213 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.9 m -69.51 156.76 38.37 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.794 -0.566 . . . . 0.0 110.774 163.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.4 t -49.18 -70.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.272 1.829 . . . . 0.0 109.613 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -141.92 17.28 2.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 127.717 2.407 . . . . 0.0 111.916 145.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 171.38 -17.84 0.06 OUTLIER Glycine 0 CA--C 1.532 1.106 0 N-CA-C 115.455 0.942 . . . . 0.0 115.455 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -121.76 179.43 4.49 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.136 1.374 . . . . 0.0 111.821 168.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.51 -173.51 0.36 Allowed Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 127.384 2.274 . . . . 0.0 109.105 173.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.02 151.97 15.17 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.063 2.508 . . . . 0.0 113.792 174.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.9 m -72.12 30.07 0.05 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 -159.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -130.45 -4.78 4.32 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 127.391 2.424 . . . . 0.0 115.029 165.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -179.67 0.15 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.055 2.542 . . . . 0.0 117.452 -176.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.07 96.08 2.83 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.493 1.117 . . . . 0.0 110.206 146.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.7 t -49.82 115.02 1.21 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.234 1.014 . . . . 0.0 111.899 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.6 t -70.04 152.56 44.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.81 1.244 . . . . 0.0 111.081 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -6.12 7.61 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 171.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -6.51 50.12 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.542 1.137 . . . . 0.0 113.159 163.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.96 23.94 60.76 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.996 0.816 . . . . 0.0 113.493 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -126.8 159.02 35.05 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.393 1.877 . . . . 0.0 112.467 -174.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.0 m -115.05 165.83 12.47 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.05 1.34 . . . . 0.0 113.218 -175.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.48 -170.65 24.33 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 -162.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -139.48 161.99 36.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.527 2.331 . . . . 0.0 109.872 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.27 -174.63 28.74 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 123.936 0.779 . . . . 0.0 113.35 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -57.96 -16.11 25.03 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 124.011 3.141 . . . . 0.0 117.551 -169.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.79 -7.14 59.53 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.544 1.066 . . . . 0.0 111.359 178.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -134.08 -58.76 0.85 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.991 2.116 . . . . 0.0 110.198 -160.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.0 m . . . . . 0 CA--C 1.539 0.546 0 C-N-CA 126.781 2.032 . . . . 0.0 113.008 -177.506 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.4 m -34.17 119.76 0.42 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 128.939 2.896 . . . . 0.0 112.406 -168.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.2 t 0.92 -85.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 130.18 3.392 . . . . 0.0 112.426 -160.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -130.94 32.59 4.3 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.608 2.363 . . . . 0.0 109.171 140.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 164.37 -11.96 0.08 OUTLIER Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.864 1.697 . . . . 0.0 115.76 172.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -121.94 174.46 6.88 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.333 1.853 . . . . 0.0 113.456 -172.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.1 m -150.58 175.74 2.67 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 126.912 2.085 . . . . 0.0 109.188 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -57.39 178.41 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 125.129 3.886 . . . . 0.0 118.577 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -50.52 120.14 4.39 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.647 1.579 . . . . 0.0 112.364 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.78 32.33 74.18 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 118.761 -1.022 . . . . 0.0 113.808 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.37 166.86 2.1 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 169.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.8 m -133.81 94.26 3.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.648 1.979 . . . . 0.0 107.421 152.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -50.42 113.3 0.85 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.868 0.867 . . . . 0.0 109.381 170.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.5 t -64.95 159.45 22.89 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.023 0.916 . . . . 0.0 112.53 -169.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.44 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -48.82 -26.1 2.22 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.903 2.481 . . . . 0.0 113.552 169.873 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -100.23 3.33 43.53 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.728 2.011 . . . . 0.0 112.664 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.31 8.61 58.6 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.955 -1.47 . . . . 0.0 115.661 169.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -118.59 158.67 24.99 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.617 2.209 . . . . 0.0 113.328 -172.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.5 m -89.47 156.07 18.9 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -167.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.56 -166.43 27.75 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 128.07 2.747 . . . . 0.0 109.596 -175.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.39 170.26 21.79 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.996 1.318 . . . . 0.0 110.895 163.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 126.69 172.19 13.25 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.612 1.577 . . . . 0.0 112.63 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.24 -23.03 16.85 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 124.575 3.517 . . . . 0.0 117.545 -169.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.8 -4.54 11.6 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.487 1.115 . . . . 0.0 113.607 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -76.36 -55.9 5.13 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.634 1.174 . . . . 0.0 109.23 155.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.4 m . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 125.499 1.52 . . . . 0.0 112.962 -179.205 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 . . . . . 0 CA--C 1.545 0.769 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 62.7 m -45.72 140.93 3.17 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.749 1.62 . . . . 0.0 112.091 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t -33.23 -67.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 127.931 2.492 . . . . 0.0 112.877 -155.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -124.16 19.66 9.07 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.402 1.881 . . . . 0.0 110.517 138.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.4 -19.2 0.81 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.732 1.158 . . . . 0.0 115.053 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.5 ptp85 -96.78 177.3 5.69 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.45 1.5 . . . . 0.0 111.559 172.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -137.57 169.37 13.25 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.798 1.239 . . . . 0.0 112.459 -172.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.23 167.99 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.613 3.542 . . . . 0.0 114.842 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 m -38.68 96.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.388 2.675 . . . . 0.0 114.628 -174.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.71 3.39 90.53 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 118.268 -1.296 . . . . 0.0 115.8 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.2 mmt -78.27 173.46 12.26 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 120.19 1.995 . . . . 0.0 112.716 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.9 m -119.3 136.28 54.32 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.609 2.364 . . . . 0.0 109.722 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.6 t -75.9 113.91 13.93 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.945 0.498 . . . . 0.0 109.738 166.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.455 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 9.2 t -62.35 151.28 37.2 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.996 0.903 . . . . 0.0 110.359 167.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.404 ' CD ' ' H ' ' A' ' 17' ' ' GLN . 17.8 mp0 -72.7 -4.93 34.24 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.557 1.543 . . . . 0.0 111.33 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -75.47 -11.19 59.98 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.486 1.914 . . . . 0.0 113.597 162.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.53 9.91 48.94 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.457 1.504 . . . . 0.0 115.195 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -131.07 147.18 52.59 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.928 1.864 . . . . 0.0 113.193 -171.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 82.6 m -82.99 149.51 26.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -169.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.02 -160.3 33.18 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.074 1.321 . . . . 0.0 111.827 176.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.6 tptt -135.94 162.1 33.78 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.395 1.478 . . . . 0.0 112.165 176.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.05 178.73 36.03 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.761 1.172 . . . . 0.0 113.862 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.34 19.29 0.53 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 125.271 3.981 . . . . 0.0 114.697 -170.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm -121.42 4.44 10.21 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.325 1.85 . . . . 0.0 111.616 169.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.455 ' CD2' ' HB2' ' A' ' 16' ' ' SER . 82.5 m-85 -130.14 -63.34 0.91 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.815 2.446 . . . . 0.0 108.876 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.1 m . . . . . 0 CA--C 1.545 0.76 0 C-N-CA 125.11 1.364 . . . . 0.0 113.56 174.245 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 CA--C 1.551 0.994 0 CA-C-O 123.018 1.39 . . . . 0.0 114.129 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 62.2 m -58.21 116.82 3.81 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.607 -1.308 . . . . 0.0 108.185 148.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -4.67 -81.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 131.056 3.742 . . . . 0.0 113.67 -160.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -129.27 22.38 5.63 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.114 2.165 . . . . 0.0 109.807 147.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.6 -14.38 0.07 OUTLIER Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.543 1.377 . . . . 0.0 116.543 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -125.38 179.74 4.97 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 120.046 1.923 . . . . 0.0 113.029 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.4 m -124.0 157.1 64.72 Favored Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 124.635 1.174 . . . . 0.0 109.496 169.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.42 150.63 88.02 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.05 1.833 . . . . 0.0 110.78 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.5 m -65.48 88.14 0.09 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.831 1.252 . . . . 0.0 112.326 -166.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.95 -17.04 3.22 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.1 1.809 . . . . 0.0 113.491 -173.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 mmt -94.59 170.75 9.24 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.724 1.609 . . . . 0.0 109.712 158.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -142.39 161.9 36.85 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.988 1.715 . . . . 0.0 110.906 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.5 t -103.91 115.87 31.24 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.939 1.695 . . . . 0.0 112.097 -166.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.494 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 7.7 t -77.87 167.88 20.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 122.302 1.049 . . . . 0.0 113.011 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.524 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 11.1 mp0 -65.29 -16.72 63.86 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.313 2.245 . . . . 0.0 112.108 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -74.72 -5.98 46.28 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.704 2.002 . . . . 0.0 112.98 170.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.72 23.01 65.4 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.941 -0.922 . . . . 0.0 113.532 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -131.06 153.8 48.91 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.541 1.536 . . . . 0.0 112.716 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 74.5 m -84.17 160.99 20.73 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.597 1.159 . . . . 0.0 113.785 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.28 -158.8 31.88 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.919 2.199 . . . . 0.0 107.88 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -138.32 158.57 44.03 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.788 1.235 . . . . 0.0 110.8 -177.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.88 -178.14 40.55 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 123.962 0.791 . . . . 0.0 113.912 172.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.78 -13.51 6.17 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 125.07 3.847 . . . . 0.0 118.032 -167.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -96.94 -8.77 29.86 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.808 1.185 . . . . 0.0 111.956 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.494 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 92.1 m-85 -120.5 -41.79 2.58 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 128.335 2.654 . . . . 0.0 110.397 -174.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.6 m . . . . . 0 CA--C 1.547 0.84 0 C-N-CA 126.708 2.003 . . . . 0.0 112.555 179.962 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.2 m -46.78 142.16 3.51 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.796 1.638 . . . . 0.0 112.23 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.6 t -18.73 -76.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 129.555 3.142 . . . . 0.0 113.139 -163.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -124.08 25.61 7.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.173 2.189 . . . . 0.0 109.924 140.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.97 -6.39 2.04 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.482 1.515 . . . . 0.0 114.779 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -112.08 -177.92 3.29 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 127.683 2.393 . . . . 0.0 111.58 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -160.93 172.55 5.69 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 126.249 1.82 . . . . 0.0 109.59 169.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.49 178.97 6.93 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.158 2.572 . . . . 0.0 113.851 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.5 t 9.99 87.82 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 130.46 3.504 . . . . 0.0 116.06 169.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.48 34.25 74.82 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.3 0.953 . . . . 0.0 114.789 171.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.08 167.0 4.22 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 169.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.7 m -132.76 94.64 3.43 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.07 156.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -51.2 107.35 0.18 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.859 0.863 . . . . 0.0 110.734 160.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.2 p -64.79 164.55 12.08 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.709 1.204 . . . . 0.0 112.873 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.76 -21.22 60.46 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.0 0.92 . . . . 0.0 112.44 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -74.25 -10.54 59.7 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.806 1.642 . . . . 0.0 112.607 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.61 12.84 63.98 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.477 1.037 . . . . 0.0 113.802 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -124.86 142.49 51.41 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.841 1.32 . . . . 0.0 111.676 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.8 m -81.02 162.34 23.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.473 1.109 . . . . 0.0 113.289 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.86 -161.02 34.84 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 127.685 2.564 . . . . 0.0 106.857 -175.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.56 167.53 23.48 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.564 1.546 . . . . 0.0 109.309 173.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.47 -176.07 39.69 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 123.851 0.738 . . . . 0.0 114.52 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.69 9.2 0.79 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 124.83 3.686 . . . . 0.0 115.817 -165.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 tpmp? -125.64 6.8 7.52 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.287 0.949 . . . . 0.0 113.017 170.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -124.62 -54.41 1.66 Allowed 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 126.487 1.915 . . . . 0.0 109.729 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.6 m . . . . . 0 CA--C 1.536 0.408 0 C-N-CA 124.101 0.96 . . . . 0.0 109.527 164.811 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 . . . . . 0 CA--C 1.545 0.787 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.5 m -43.52 138.33 2.52 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.439 1.896 . . . . 0.0 111.732 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.8 t -28.36 -71.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 128.832 2.853 . . . . 0.0 113.101 -154.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -122.57 19.58 10.37 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.254 1.821 . . . . 0.0 110.402 140.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.18 -20.97 0.29 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.42 1.009 . . . . 0.0 114.857 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -106.42 177.68 4.78 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 124.962 1.305 . . . . 0.0 112.335 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.482 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 53.7 m -142.25 179.81 1.13 Allowed Pre-proline 0 CA--C 1.559 1.321 0 C-N-CA 125.957 1.703 . . . . 0.0 110.353 -174.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 74.4 Cg_endo -75.97 -173.06 1.52 Allowed 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 123.676 2.917 . . . . 0.0 115.42 -177.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.1 m -41.68 108.08 0.09 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.549 2.74 . . . . 0.0 114.688 -174.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.72 29.64 75.03 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.088 0.851 . . . . 0.0 113.864 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.99 172.63 0.94 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 171.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.86 115.75 9.24 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 113.15 -1.841 . . . . 0.0 109.665 148.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.7 t -62.95 113.11 2.89 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.658 -1.276 . . . . 0.0 110.537 172.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.416 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 77.3 p -61.36 162.02 8.42 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.327 1.051 . . . . 0.0 112.778 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -71.2 -15.95 62.49 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 53.4 m0 -75.0 -9.32 58.42 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.017 1.727 . . . . 0.0 112.603 167.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.78 16.4 51.85 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.459 -1.19 . . . . 0.0 114.447 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -124.42 148.62 47.48 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.693 1.746 . . . . 0.0 112.772 -175.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 67.1 m -73.11 154.41 40.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.551 1.54 . . . . 0.0 113.259 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.26 -168.15 37.14 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.806 1.67 . . . . 0.0 109.07 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -142.01 149.6 40.22 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.754 2.022 . . . . 0.0 109.537 -175.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.76 -171.52 30.37 Favored Glycine 0 CA--C 1.542 1.78 0 N-CA-C 114.829 0.692 . . . . 0.0 114.829 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.64 -14.28 7.17 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 125.126 3.884 . . . . 0.0 118.231 -170.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -99.38 7.03 45.88 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.02 1.328 . . . . 0.0 111.693 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 90.1 m-85 -141.94 -64.31 0.43 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.875 2.07 . . . . 0.0 109.317 -167.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.3 m . . . . . 0 CA--C 1.538 0.498 0 C-N-CA 127.341 2.256 . . . . 0.0 111.963 173.584 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 121.585 0.707 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.7 m -52.92 128.86 28.5 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 118.275 -0.869 . . . . 0.0 108.917 163.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.5 t -13.39 -79.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 129.39 3.076 . . . . 0.0 113.216 -157.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -123.8 27.67 7.19 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 127.252 2.221 . . . . 0.0 109.564 139.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.32 -2.74 0.1 OUTLIER Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.222 1.391 . . . . 0.0 116.189 176.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.6 mmt-85 -129.38 -177.46 4.26 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.157 1.783 . . . . 0.0 112.991 -172.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.2 m -143.67 158.79 56.06 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 125.073 1.349 . . . . 0.0 111.051 173.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.27 170.42 20.05 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.51 2.806 . . . . 0.0 112.947 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.6 m -44.97 99.85 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.836 2.455 . . . . 0.0 114.412 -173.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.31 -8.89 62.77 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.864 1.221 . . . . 0.0 114.899 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 45.5 mtt -90.81 164.73 13.97 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.872 1.269 . . . . 0.0 110.426 165.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.8 m -145.4 158.17 43.89 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.232 1.013 . . . . 0.0 111.805 -174.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.7 t -85.28 115.77 23.23 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.192 0.997 . . . . 0.0 111.274 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.43 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 96.4 p -70.94 165.41 23.42 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.342 1.068 . . . . 0.0 113.142 175.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.561 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 6.1 mp0 -60.33 -17.23 41.62 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.513 1.925 . . . . 0.0 113.049 175.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -80.13 -7.97 59.18 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.276 1.431 . . . . 0.0 113.277 172.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.62 13.09 83.85 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 118.701 0.682 . . . . 0.0 113.124 -168.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -105.84 141.77 36.69 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.917 1.687 . . . . 0.0 111.486 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.0 t -82.68 157.33 23.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.236 0.615 . . . . 0.0 112.089 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.63 -172.51 42.5 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.788 0.709 . . . . 0.0 112.917 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -134.17 132.52 39.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.311 1.845 . . . . 0.0 106.754 -174.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.0 179.31 15.86 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.314 0.959 . . . . 0.0 112.295 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.75 0.83 5.07 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.934 2.422 . . . . 0.0 115.846 -171.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -95.8 -8.53 34.05 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.532 1.133 . . . . 0.0 111.614 172.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 98.9 m-85 -124.03 -53.16 1.75 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.758 2.423 . . . . 0.0 110.436 -169.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 32.7 m . . . . . 0 CA--C 1.536 0.422 0 C-N-CA 127.084 2.154 . . . . 0.0 114.23 -164.687 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.624 0 CA-C-O 120.983 0.421 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 41.7 m -53.55 146.23 13.34 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.4 1.88 . . . . 0.0 112.012 -175.341 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.5 t -44.93 -62.43 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.576 1.951 . . . . 0.0 111.334 -160.009 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.549 ' HE ' ' HA ' ' A' ' 6' ' ' ARG . 1.7 mmp_? -135.8 29.31 3.19 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.84 1.656 . . . . 0.0 110.259 129.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.27 -35.97 0.24 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.917 0.77 . . . . 0.0 114.555 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -88.41 177.09 6.92 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.703 1.252 . . . . 0.0 111.162 172.612 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.0 m -127.69 172.92 6.03 Favored Pre-proline 0 C--O 1.24 0.595 0 C-N-CA 125.035 1.334 . . . . 0.0 110.856 176.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.57 150.24 8.93 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.988 2.459 . . . . 0.0 112.196 171.793 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.5 m -67.89 79.94 0.21 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.325 1.45 . . . . 0.0 112.624 -166.625 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 144.14 -17.64 2.12 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.627 2.06 . . . . 0.0 113.94 -175.675 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.6 mtt -84.56 178.77 7.58 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.552 1.676 . . . . 0.0 112.728 174.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.7 m -129.03 146.85 50.9 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.767 2.427 . . . . 0.0 110.278 173.768 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.8 t -88.69 111.64 22.19 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.761 1.625 . . . . 0.0 111.039 173.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 t -67.38 155.98 37.62 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.824 0.85 . . . . 0.0 111.217 172.687 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -9.81 48.28 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.794 -1.191 . . . . 0.0 114.138 176.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.509 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 54.0 m0 -70.08 -5.17 24.92 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.833 1.253 . . . . 0.0 113.001 164.32 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.29 14.36 68.98 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.043 1.306 . . . . 0.0 113.759 176.508 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -120.81 154.22 36.04 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.869 1.668 . . . . 0.0 113.053 -175.04 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 94.3 m -93.34 147.41 22.96 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.012 1.325 . . . . 0.0 113.848 -174.158 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.25 -161.61 32.59 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.215 0.912 . . . . 0.0 112.071 176.538 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.7 tptt -134.24 167.54 20.5 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.835 1.654 . . . . 0.0 111.763 172.399 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.91 172.78 36.01 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.994 1.283 . . . . 0.0 112.569 -174.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.77 4.19 3.27 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.842 3.028 . . . . 0.0 114.967 -170.721 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.509 ' HE3' ' CE2' ' A' ' 18' ' ' TRP . 1.7 tmtm? -109.14 3.71 22.18 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.066 1.303 . . . . 0.0 111.906 171.793 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -122.91 -41.22 2.36 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 126.333 1.853 . . . . 0.0 110.466 178.578 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 m . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 124.691 1.196 . . . . 0.0 113.592 173.764 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 CA--C 1.539 0.521 0 CA-C-O 122.028 0.918 . . . . 0.0 111.974 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.6 m -69.0 164.89 21.32 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.886 1.274 . . . . 0.0 111.45 176.291 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.0 t -47.14 -68.32 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 125.762 1.625 . . . . 0.0 110.072 -176.192 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -139.64 19.15 2.52 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.145 2.178 . . . . 0.0 111.599 142.01 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.01 -14.18 0.07 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 115.656 1.023 . . . . 0.0 115.656 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -121.54 177.55 5.18 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.344 1.458 . . . . 0.0 112.12 170.694 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.93 -178.02 0.74 Allowed Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 126.593 1.957 . . . . 0.0 109.799 174.218 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -83.05 -174.85 2.16 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.769 2.979 . . . . 0.0 112.745 173.831 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.5 m 21.85 79.59 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 129.96 3.304 . . . . 0.0 116.39 161.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.2 18.68 71.43 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 115.638 1.015 . . . . 0.0 115.638 168.537 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.59 167.23 1.53 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 174.064 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.0 m -134.73 96.19 3.5 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 113.015 -1.902 . . . . 0.0 108.024 154.114 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -50.78 110.96 0.47 Allowed 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.559 -0.713 . . . . 0.0 111.655 168.113 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.416 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 43.9 t -67.09 137.29 56.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.16 1.384 . . . . 0.0 109.357 174.621 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -6.48 4.96 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -166.596 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -69.45 -9.91 55.72 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.465 1.106 . . . . 0.0 112.998 165.347 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.38 18.17 24.6 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.902 1.715 . . . . 0.0 113.932 -177.059 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -122.95 145.06 48.81 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.686 1.243 . . . . 0.0 114.04 -166.76 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.1 t -100.98 152.93 19.98 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.554 1.142 . . . . 0.0 113.347 -162.24 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.79 -162.78 30.58 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 127.286 2.374 . . . . 0.0 110.054 -171.017 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.22 170.69 20.65 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.811 1.644 . . . . 0.0 110.394 169.339 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.26 -176.91 25.89 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.939 1.257 . . . . 0.0 112.651 -177.407 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.95 -10.75 30.02 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.009 2.473 . . . . 0.0 114.915 -173.003 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.37 -13.94 59.82 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.494 1.043 . . . . 0.0 111.221 170.029 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.416 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 11.8 m-85 -128.98 -49.89 1.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.336 1.454 . . . . 0.0 110.932 -154.526 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.6 m . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 124.619 1.167 . . . . 0.0 112.83 169.993 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 121.425 0.631 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 m -61.73 138.51 58.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.921 0.488 . . . . 0.0 109.762 173.097 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -45.38 -66.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.643 1.977 . . . . 0.0 110.941 -162.532 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -133.58 25.09 4.07 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.991 1.716 . . . . 0.0 110.957 137.583 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.08 -34.43 0.26 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.019 0.819 . . . . 0.0 113.852 176.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -88.95 173.19 8.62 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 118.665 1.233 . . . . 0.0 112.364 174.781 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 19.4 m -148.35 179.74 1.12 Allowed Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 127.902 2.481 . . . . 0.0 108.444 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 49.7 Cg_endo -70.15 -175.25 1.18 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 123.685 2.923 . . . . 0.0 115.996 -178.128 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.8 m -44.11 108.04 0.1 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 128.598 2.759 . . . . 0.0 114.418 -173.644 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.08 29.75 75.59 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.87 0.748 . . . . 0.0 113.747 179.114 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.79 170.84 0.55 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 170.314 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.8 104.39 5.49 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 113.511 -1.677 . . . . 0.0 109.004 153.53 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -56.7 112.05 1.19 Allowed 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.288 -0.883 . . . . 0.0 110.719 173.006 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.483 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 81.0 p -73.56 168.07 20.05 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -173.362 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.541 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 1.4 mp0 -57.68 -20.04 31.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.544 1.938 . . . . 0.0 112.866 170.731 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.52 -4.32 55.63 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.257 1.423 . . . . 0.0 112.484 174.204 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.7 20.56 79.72 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.226 -0.763 . . . . 0.0 112.9 -170.85 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -120.24 144.89 47.52 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.028 1.731 . . . . 0.0 112.447 -175.018 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.9 m -73.34 155.48 39.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.428 1.491 . . . . 0.0 112.92 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.64 -169.38 33.43 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 126.132 1.825 . . . . 0.0 109.082 -177.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -145.29 159.58 42.82 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.417 2.287 . . . . 0.0 108.907 -175.893 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.44 -169.46 33.01 Favored Glycine 0 CA--C 1.539 1.588 0 N-CA-C 114.414 0.526 . . . . 0.0 114.414 173.312 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.66 -1.04 6.85 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 124.08 3.187 . . . . 0.0 116.733 -162.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.11 1.8 24.45 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.34 0.973 . . . . 0.0 112.71 170.427 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.483 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 86.3 m-85 -129.26 -57.08 1.16 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.47 1.908 . . . . 0.0 109.699 -167.494 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.614 0 C-N-CA 124.406 1.083 . . . . 0.0 113.555 169.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 . . . . . 0 N--CA 1.469 0.495 0 CA-C-O 121.101 0.477 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.2 m -64.85 147.33 53.47 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.043 -0.411 . . . . 0.0 109.943 174.394 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.2 t -48.81 -67.1 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.725 1.21 . . . . 0.0 110.212 -174.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -137.19 23.72 3.0 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.123 2.169 . . . . 0.0 111.023 139.369 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.28 -28.8 0.34 Allowed Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.226 1.393 . . . . 0.0 113.33 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.46 151.29 42.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 117.928 0.864 . . . . 0.0 111.921 169.381 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.2 m -149.85 171.0 6.83 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 128.504 2.722 . . . . 0.0 109.792 -176.66 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.78 -176.25 2.9 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.986 3.124 . . . . 0.0 115.501 -173.118 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.8 t -45.32 119.7 2.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.97 1.708 . . . . 0.0 113.626 -173.674 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.37 29.59 75.0 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.352 0.977 . . . . 0.0 114.26 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.01 168.56 0.12 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 173.592 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -132.26 144.92 50.95 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 112.947 -1.933 . . . . 0.0 110.137 122.505 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 32.5 t -85.33 117.7 24.42 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.898 1.279 . . . . 0.0 109.356 168.668 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 t -65.9 153.2 42.66 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.328 0.651 . . . . 0.0 111.967 177.487 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -16.79 14.82 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.211 1.004 . . . . 0.0 112.518 167.42 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 27.8 m95 -76.24 -8.26 56.67 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.417 1.887 . . . . 0.0 113.119 172.286 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.92 14.15 61.31 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.467 1.032 . . . . 0.0 114.686 178.446 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -123.71 147.58 47.33 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.258 1.423 . . . . 0.0 112.804 -176.655 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 65.4 m -81.87 152.1 27.0 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.816 1.646 . . . . 0.0 112.349 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.9 -154.53 21.98 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 178.892 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 159.2 44.04 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.535 1.534 . . . . 0.0 109.613 176.864 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.54 -178.15 52.58 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 123.722 0.677 . . . . 0.0 113.489 178.324 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.73 2.02 2.8 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.469 3.446 . . . . 0.0 116.218 -166.216 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.73 -6.15 46.8 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 123.11 1.433 . . . . 0.0 111.031 172.692 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -132.01 -49.25 0.94 Allowed 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 127.919 2.488 . . . . 0.0 109.919 -169.491 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 67.3 m . . . . . 0 CA--C 1.548 0.886 0 C-N-CA 126.646 1.978 . . . . 0.0 112.013 167.991 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 118.463 -0.779 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.35 4.2 82.18 Favored Glycine 0 CA--C 1.534 1.273 0 N-CA-C 116.268 1.267 . . . . 0.0 116.268 -170.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 3.2 pm0 -55.05 150.31 10.66 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.605 1.203 . . . . 0.0 112.62 174.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 97.9 m -38.96 127.56 1.61 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 128.486 2.715 . . . . 0.0 112.129 -173.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.5 t 1.34 -85.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 130.191 3.396 . . . . 0.0 112.192 -159.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -130.98 30.04 4.63 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.345 2.258 . . . . 0.0 109.771 142.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.97 -15.86 0.04 OUTLIER Glycine 0 CA--C 1.536 1.375 0 N-CA-C 116.656 1.422 . . . . 0.0 116.656 168.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -133.18 174.49 10.32 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 119.937 1.869 . . . . 0.0 113.662 -173.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.0 m -97.46 166.76 13.06 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.322 1.049 . . . . 0.0 111.638 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -50.68 149.58 13.68 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.94 2.427 . . . . 0.0 111.4 157.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.6 m -68.25 80.06 0.24 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.209 1.403 . . . . 0.0 111.583 -174.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 150.22 -14.81 0.98 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.723 1.63 . . . . 0.0 114.428 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.7 mtt -106.27 174.91 5.68 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.905 1.853 . . . . 0.0 111.754 175.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.5 m -126.27 130.4 50.81 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.389 1.876 . . . . 0.0 111.374 -172.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.9 t -84.0 114.82 21.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.467 0.707 . . . . 0.0 110.57 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.2 p -66.4 163.95 17.24 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -5.4 21.72 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 169.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.79 -8.87 58.61 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.152 0.887 . . . . 0.0 112.321 163.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.07 4.44 90.25 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.626 1.108 . . . . 0.0 113.701 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -109.82 148.95 30.56 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.098 1.359 . . . . 0.0 110.784 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.1 t -91.59 150.41 21.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.749 1.22 . . . . 0.0 113.153 -169.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.57 -156.69 24.59 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.01 0.814 . . . . 0.0 113.548 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -139.6 161.32 37.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.468 1.907 . . . . 0.0 112.153 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.2 -179.96 51.77 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.802 1.191 . . . . 0.0 112.798 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.7 -1.6 8.71 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.125 2.55 . . . . 0.0 115.802 -166.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.59 -6.04 58.48 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.194 0.998 . . . . 0.0 110.798 171.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -138.15 -53.47 0.63 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.104 1.762 . . . . 0.0 111.479 -165.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 63.9 m -90.7 -9.3 47.28 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.625 1.57 . . . . 0.0 113.746 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.09 -3.38 22.05 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 124.394 0.997 . . . . 0.0 114.692 -170.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.106 0 C-N-CA 128.451 2.7 . . . . 0.0 109.561 174.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.02 2.88 55.97 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.325 0.964 . . . . 0.0 114.288 -172.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -58.66 147.99 30.76 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.454 1.502 . . . . 0.0 111.352 174.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.3 m -62.63 135.72 57.52 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.947 0.88 . . . . 0.0 111.483 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.46 69.88 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.782 1.633 . . . . 0.0 110.381 -164.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 47.97 25.31 0.75 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.864 -155.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 128.84 -13.95 6.05 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.582 1.086 . . . . 0.0 115.544 162.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.79 171.77 7.34 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.198 1.799 . . . . 0.0 110.79 175.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 67.8 m -145.25 153.96 53.16 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.567 0.747 . . . . 0.0 112.157 -169.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.42 172.93 15.34 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.94 3.094 . . . . 0.0 112.229 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.6 m 42.4 41.69 2.34 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.603 1.961 . . . . 0.0 115.495 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.61 26.84 17.08 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.807 1.67 . . . . 0.0 114.438 -174.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.1 mtt -70.0 170.79 10.62 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.782 1.291 . . . . 0.0 110.76 172.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -122.77 140.52 52.81 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.027 1.731 . . . . 0.0 110.448 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t -71.56 116.94 12.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.488 1.115 . . . . 0.0 110.868 173.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.432 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 78.8 p -70.52 161.77 30.01 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.518 1.127 . . . . 0.0 113.133 172.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -58.83 -14.67 9.49 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.415 1.486 . . . . 0.0 114.212 166.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -78.5 -11.76 59.97 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.238 1.015 . . . . 0.0 113.047 170.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.6 16.68 67.84 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-N 118.674 0.67 . . . . 0.0 113.732 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -119.32 143.63 47.28 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.576 1.551 . . . . 0.0 111.977 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.5 m -77.4 151.94 34.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.598 1.159 . . . . 0.0 112.663 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.6 -170.41 43.49 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.656 1.122 . . . . 0.0 111.24 174.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -119.4 145.65 46.04 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.698 1.199 . . . . 0.0 111.061 -173.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.98 -173.88 24.84 Favored Glycine 0 CA--C 1.542 1.74 0 N-CA-C 115.932 1.133 . . . . 0.0 115.932 166.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -71.88 12.53 0.57 Allowed 'Trans proline' 0 CA--C 1.541 0.847 1 C-N-CA 125.881 4.387 . . . . 0.0 116.282 -161.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.59 -11.87 6.71 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 167.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 75.8 m-85 -88.26 -58.06 2.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.501 1.52 . . . . 0.0 109.272 168.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.9 m -78.41 -45.47 22.26 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.572 1.949 . . . . 0.0 110.872 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.17 110.85 3.64 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 167.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? . . . . . 0 C--O 1.249 1.067 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -158.716 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.25 23.62 8.04 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.848 1.213 . . . . 0.0 114.599 -175.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.9 mp0 -60.88 145.31 50.64 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.222 1.409 . . . . 0.0 112.079 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.1 m -62.88 131.28 48.22 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.161 0.981 . . . . 0.0 110.458 168.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.09 77.36 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 128.746 2.819 . . . . 0.0 109.893 -169.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 52.94 1.32 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.99 1.716 . . . . 0.0 114.532 -158.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.47 -20.71 0.93 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-O 118.264 -1.298 . . . . 0.0 114.285 174.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -90.48 170.38 10.26 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 119.453 1.626 . . . . 0.0 111.875 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.7 m -141.73 -179.73 1.04 Allowed Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 126.245 1.818 . . . . 0.0 107.935 174.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.79 152.1 18.11 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.96 2.44 . . . . 0.0 113.997 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.7 m -68.38 93.25 0.47 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.724 0.81 . . . . 0.0 111.302 -172.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.19 -8.95 4.12 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 126.021 1.772 . . . . 0.0 114.287 -169.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.55 176.04 0.1 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 129.468 3.107 . . . . 0.0 118.413 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.7 m -135.85 111.95 9.66 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.728 2.011 . . . . 0.0 108.476 143.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.0 t -60.92 116.92 4.84 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.15 -0.969 . . . . 0.0 110.239 169.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.1 p -68.08 159.18 31.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.828 0.851 . . . . 0.0 113.183 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -54.2 -27.26 33.04 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.52 1.128 . . . . 0.0 112.581 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.452 ' CZ2' ' HE2' ' A' ' 26' ' ' LYS . 34.1 m0 -76.47 -2.53 32.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.593 1.557 . . . . 0.0 112.253 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.89 23.08 67.52 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.295 -0.725 . . . . 0.0 112.686 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.41 148.4 44.45 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.6 1.56 . . . . 0.0 112.695 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.4 m -86.51 153.29 21.96 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.07 1.748 . . . . 0.0 114.247 -178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.05 -161.92 31.87 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 127.044 2.259 . . . . 0.0 110.556 -177.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.11 157.95 43.79 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.846 2.458 . . . . 0.0 108.37 174.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.24 -174.68 18.43 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.809 1.195 . . . . 0.0 113.154 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.46 -14.8 40.73 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.95 2.434 . . . . 0.0 114.29 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.452 ' HE2' ' CZ2' ' A' ' 18' ' ' TRP . 7.3 tptp -78.87 -4.22 48.58 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.172 1.389 . . . . 0.0 111.832 174.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -137.32 -54.92 0.7 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.537 1.535 . . . . 0.0 110.684 -158.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.2 m -81.83 -4.99 57.81 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.156 1.382 . . . . 0.0 113.191 169.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.2 -82.62 0.46 Allowed Glycine 0 C--N 1.343 0.935 0 C-N-CA 124.955 1.264 . . . . 0.0 112.972 -172.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.601 -172.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.84 7.4 61.37 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 119.225 -0.764 . . . . 0.0 114.299 -173.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -60.55 150.44 31.56 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.301 1.44 . . . . 0.0 111.45 172.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 m -66.0 146.66 54.43 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.605 -0.684 . . . . 0.0 111.262 170.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.1 t -50.73 -69.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.093 1.757 . . . . 0.0 109.73 -173.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -138.41 21.67 2.75 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 127.591 2.356 . . . . 0.0 111.201 142.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.62 -24.36 0.3 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.856 1.217 . . . . 0.0 113.809 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.3 169.86 14.25 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.476 1.11 . . . . 0.0 112.837 165.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.1 m -137.39 176.39 2.79 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 128.733 2.813 . . . . 0.0 108.845 173.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -52.88 168.82 0.43 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.653 2.902 . . . . 0.0 115.431 175.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.9 p -54.69 106.03 0.19 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.261 1.824 . . . . 0.0 111.632 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.57 9.18 64.95 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.402 -1.221 . . . . 0.0 114.578 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 54.0 mtt -110.92 166.93 10.64 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.364 1.466 . . . . 0.0 112.067 172.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.7 m -134.32 143.35 47.65 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.906 2.082 . . . . 0.0 111.006 -173.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.6 t -84.81 115.81 22.94 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.626 1.57 . . . . 0.0 111.793 177.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.1 t -70.72 159.49 34.38 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 172.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -48.35 -24.22 1.16 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.555 2.342 . . . . 0.0 113.538 168.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -83.55 -4.47 58.58 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.132 1.773 . . . . 0.0 113.172 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.42 13.05 68.75 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.102 0.858 . . . . 0.0 114.433 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -122.0 153.33 38.71 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.677 1.591 . . . . 0.0 112.336 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.4 m -88.39 158.13 18.49 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.557 1.543 . . . . 0.0 113.426 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.22 -165.1 38.01 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -137.37 163.82 30.1 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.859 0.863 . . . . 0.0 111.185 -175.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.34 -170.25 52.16 Favored Glycine 0 CA--C 1.539 1.547 0 N-CA-C 114.756 0.663 . . . . 0.0 114.756 172.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.35 13.4 0.55 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 124.708 3.605 . . . . 0.0 115.469 -166.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.47 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -125.27 9.95 7.99 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.363 1.065 . . . . 0.0 112.44 169.662 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -138.69 -50.78 0.55 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 125.749 1.62 . . . . 0.0 110.862 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.1 m -73.2 -43.76 60.81 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.759 0.824 . . . . 0.0 109.026 161.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.94 63.96 2.36 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 157.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.3 0.0 OUTLIER . . . . . 0 C--O 1.253 1.287 0 C-N-CA 128.489 2.715 . . . . 0.0 117.396 -164.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.95 -7.03 53.56 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 129.117 3.246 . . . . 0.0 114.935 -1.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 57.45 -176.66 0.06 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.506 1.522 . . . . 0.0 112.263 -170.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 41.2 m -65.23 102.27 0.64 Allowed 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.529 -1.357 . . . . 0.0 108.003 157.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -4.57 -88.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 130.641 3.577 . . . . 0.0 112.515 -156.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 67.9 mmt-85 -130.16 41.19 3.44 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.051 0.941 . . . . 0.0 109.526 143.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 157.67 -10.12 0.23 Allowed Glycine 0 CA--C 1.534 1.25 0 N-CA-C 116.254 1.262 . . . . 0.0 116.254 163.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -121.65 178.79 4.69 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 119.839 1.819 . . . . 0.0 112.883 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 39.8 m -127.59 166.78 21.05 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 124.651 1.18 . . . . 0.0 110.586 173.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.67 149.85 13.19 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.432 2.755 . . . . 0.0 112.537 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.7 m -69.49 76.27 0.4 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.542 1.537 . . . . 0.0 111.682 -171.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.38 -17.07 1.14 Allowed Glycine 0 CA--C 1.537 1.432 0 C-N-CA 126.249 1.881 . . . . 0.0 114.231 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.1 mtt -86.43 -168.59 2.29 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.674 1.737 . . . . 0.0 112.261 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.76 160.9 41.08 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.651 2.381 . . . . 0.0 110.159 162.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.1 t -98.24 120.78 39.24 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.402 1.881 . . . . 0.0 112.044 -173.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.466 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 13.1 t -76.43 159.19 30.67 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -7.92 7.07 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 160.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -71.59 -10.34 59.62 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.38 1.072 . . . . 0.0 112.436 164.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.63 13.8 82.0 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.492 1.044 . . . . 0.0 113.723 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -130.27 164.12 25.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.444 1.898 . . . . 0.0 111.495 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 78.0 m -94.32 158.24 15.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.823 1.249 . . . . 0.0 113.83 -172.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.57 -156.18 26.92 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.175 1.369 . . . . 0.0 111.102 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.7 tptt -138.34 164.47 29.21 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.839 1.656 . . . . 0.0 111.662 171.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.06 -176.18 31.59 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 124.119 0.866 . . . . 0.0 114.263 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.31 18.57 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.861 1 C-N-CA 125.745 4.296 . . . . 0.0 115.087 -168.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.49 6.46 6.92 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.889 1.276 . . . . 0.0 112.447 170.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.466 ' CD2' ' HB2' ' A' ' 16' ' ' SER . 96.3 m-85 -134.28 -48.88 0.78 Allowed 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 128.049 2.54 . . . . 0.0 109.911 -176.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.1 m -95.25 5.54 51.46 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.696 1.598 . . . . 0.0 111.565 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.11 156.71 26.88 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.524 2.011 . . . . 0.0 110.353 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 C-N-CA 125.238 1.415 . . . . 0.0 112.251 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 118.146 -0.931 . . . . 0.0 113.046 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.25 -0.57 0.29 Allowed Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.429 1.014 . . . . 0.0 115.627 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -60.13 165.25 3.52 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 127.682 2.393 . . . . 0.0 113.66 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.5 m -47.18 140.9 4.83 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.032 1.733 . . . . 0.0 112.094 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.8 t -30.44 -70.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 128.377 2.671 . . . . 0.0 112.908 -152.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -123.01 21.12 9.87 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.194 1.798 . . . . 0.0 110.415 138.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.07 -21.34 0.5 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.975 1.274 . . . . 0.0 114.985 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -98.78 -178.29 3.92 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.188 1.395 . . . . 0.0 111.971 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.9 m -130.95 170.43 11.24 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.737 1.215 . . . . 0.0 112.026 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.98 177.0 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 125.231 3.954 . . . . 0.0 115.386 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.7 p -53.86 90.83 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.107 2.163 . . . . 0.0 113.764 -174.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.77 -1.52 75.12 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.255 1.407 . . . . 0.0 114.661 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.29 170.27 16.87 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.369 1.585 . . . . 0.0 110.795 175.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.1 m -134.4 137.3 43.96 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.532 1.533 . . . . 0.0 110.805 -168.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 32.2 t -86.83 115.39 24.22 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.14 1.376 . . . . 0.0 110.865 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.4 t -74.44 164.88 26.08 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.628 0.728 . . . . 0.0 112.745 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -45.44 -23.13 0.18 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.948 2.499 . . . . 0.0 114.373 158.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -66.6 -16.67 64.35 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.621 1.568 . . . . 0.0 112.54 173.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.18 10.11 86.47 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.629 1.109 . . . . 0.0 113.14 -167.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -121.4 153.57 37.65 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.88 1.672 . . . . 0.0 111.269 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.1 m -84.01 155.5 22.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.116 0.967 . . . . 0.0 113.58 -177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.52 -155.44 15.77 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.142 1.829 . . . . 0.0 110.244 174.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -145.02 161.68 38.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.706 1.602 . . . . 0.0 109.965 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.79 -172.38 35.53 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.486 0.954 . . . . 0.0 115.486 172.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.19 -0.7 0.68 Allowed 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 126.11 4.54 . . . . 0.0 117.96 -172.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.486 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -125.74 9.74 7.68 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.39 0.995 . . . . 0.0 112.636 175.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -136.91 -47.07 0.59 Allowed 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 125.218 1.407 . . . . 0.0 112.409 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.38 -33.77 28.61 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.153 0.433 . . . . 0.0 110.432 159.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.15 64.2 1.65 Allowed Glycine 0 CA--C 1.532 1.15 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 151.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 C-N-CA 127.227 2.211 . . . . 0.0 115.544 -162.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.86 -7.1 58.92 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.34 1.448 . . . . 0.0 115.109 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.24 160.01 5.49 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.748 1.274 . . . . 0.0 111.854 173.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.9 m -57.45 138.67 54.78 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 157.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.2 t -31.88 -68.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 128.261 2.624 . . . . 0.0 112.461 -158.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -123.32 19.11 9.8 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.491 1.916 . . . . 0.0 110.423 134.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.23 -26.78 0.32 Allowed Glycine 0 CA--C 1.54 1.597 0 C-N-CA 125.309 1.433 . . . . 0.0 114.806 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -85.23 -179.01 6.91 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.748 1.619 . . . . 0.0 111.633 172.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.7 m -134.49 142.66 43.59 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.158 0.983 . . . . 0.0 111.258 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -80.4 174.89 10.78 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.764 2.976 . . . . 0.0 111.584 172.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.1 m 37.74 46.99 0.78 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 127.672 2.389 . . . . 0.0 115.599 167.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.03 11.3 54.61 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-O 118.346 -1.252 . . . . 0.0 115.843 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.3 mmt -72.68 172.28 10.98 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.264 2.032 . . . . 0.0 112.206 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m -122.12 137.67 54.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.935 2.094 . . . . 0.0 111.006 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -86.87 117.77 25.82 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.945 0.898 . . . . 0.0 111.309 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.0 p -75.26 159.81 31.09 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.309 1.044 . . . . 0.0 113.29 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -59.2 -13.58 7.99 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.031 1.732 . . . . 0.0 113.961 167.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.474 ' CZ2' ' HE3' ' A' ' 26' ' ' LYS . 6.0 m95 -75.56 -9.33 58.48 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.838 1.255 . . . . 0.0 112.45 171.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.93 9.82 86.66 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.064 0.84 . . . . 0.0 113.106 -169.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -107.49 145.83 32.58 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.655 1.582 . . . . 0.0 111.872 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.9 t -96.42 143.83 27.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.238 1.015 . . . . 0.0 111.691 -175.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.68 -160.42 29.63 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.891 -0.506 . . . . 0.0 112.918 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -132.82 163.1 29.82 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.45 1.5 . . . . 0.0 111.999 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.65 177.68 31.05 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.64 1.114 . . . . 0.0 113.947 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.01 8.87 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 124.551 3.5 . . . . 0.0 115.246 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.474 ' HE3' ' CZ2' ' A' ' 18' ' ' TRP . 2.9 tpmp? -123.78 10.21 8.94 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.309 0.959 . . . . 0.0 112.144 169.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -125.37 -55.26 1.55 Allowed 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 126.608 1.963 . . . . 0.0 110.04 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 64.1 m -75.01 -36.41 61.96 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.049 0.939 . . . . 0.0 110.847 167.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.29 71.74 1.48 Allowed Glycine 0 CA--C 1.529 0.913 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 155.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? . . . . . 0 C--O 1.248 0.994 0 C-N-CA 128.312 2.645 . . . . 0.0 113.957 -168.229 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 86.7 t . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.4 -8.33 48.04 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.619 1.581 . . . . 0.0 114.785 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.41 157.39 6.7 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.592 1.196 . . . . 0.0 111.685 173.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.6 m -56.16 133.67 52.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 161.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.1 t -19.95 -76.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 129.2 3.0 . . . . 0.0 113.173 -160.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -122.41 25.14 9.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.804 2.042 . . . . 0.0 109.88 139.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.03 -6.92 0.45 Allowed Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.216 1.389 . . . . 0.0 115.45 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -114.13 -178.08 3.29 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.229 2.212 . . . . 0.0 112.38 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.5 m -144.75 159.93 48.97 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.661 1.584 . . . . 0.0 110.342 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.04 166.96 28.06 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.135 2.557 . . . . 0.0 113.123 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.5 m -56.63 92.71 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.12 2.168 . . . . 0.0 113.117 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.76 -8.5 6.46 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.415 1.483 . . . . 0.0 113.954 -176.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -122.03 165.54 15.87 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.56 1.944 . . . . 0.0 111.26 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.6 m -142.27 157.44 44.83 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.834 1.654 . . . . 0.0 111.047 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.3 t -83.53 118.92 24.11 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.621 0.768 . . . . 0.0 111.175 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 90.2 p -72.09 165.52 24.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.493 1.139 . . . . 0.0 113.225 175.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.546 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 5.7 mp0 -60.04 -17.13 36.8 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.355 1.862 . . . . 0.0 113.046 173.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -81.82 -7.61 59.62 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.322 1.449 . . . . 0.0 113.292 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.37 12.27 84.38 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 118.959 0.8 . . . . 0.0 113.336 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -105.07 146.03 29.67 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.791 1.637 . . . . 0.0 111.518 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.8 t -85.41 157.82 20.39 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.503 0.721 . . . . 0.0 112.095 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.36 -171.45 38.23 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.662 1.125 . . . . 0.0 111.921 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.89 175.77 9.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.176 0.988 . . . . 0.0 112.04 174.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.25 177.55 45.94 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.676 1.131 . . . . 0.0 111.755 -165.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.98 5.47 3.48 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.624 2.216 . . . . 0.0 116.097 -164.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -90.69 -8.22 50.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.265 0.939 . . . . 0.0 111.304 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.445 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 96.6 m-85 -130.92 -51.27 1.04 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.754 2.422 . . . . 0.0 111.283 -168.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.95 -1.58 0.96 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -148.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.07 -62.1 0.76 Allowed Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.515 -0.741 . . . . 0.0 111.51 -160.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? . . . . . 0 C--O 1.249 1.041 0 C-N-CA 126.207 1.803 . . . . 0.0 110.665 179.097 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 38.7 t . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 118.615 -0.707 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.69 29.97 2.09 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.92 1.248 . . . . 0.0 113.758 -176.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.575 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.4 pm0 -70.69 152.19 44.1 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.896 0.878 . . . . 0.0 111.783 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.9 m -61.34 148.1 42.55 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.911 0.484 . . . . 0.0 111.442 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t -49.09 -66.61 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.906 1.682 . . . . 0.0 109.907 -173.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -138.3 19.24 2.76 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.023 2.129 . . . . 0.0 111.721 140.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.91 -19.36 0.2 Allowed Glycine 0 CA--C 1.532 1.12 0 N-CA-C 115.162 0.825 . . . . 0.0 115.162 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -99.87 173.79 6.51 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.209 1.404 . . . . 0.0 110.777 165.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.9 m -139.48 154.12 71.24 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.086 1.354 . . . . 0.0 110.939 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.45 170.45 15.95 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.553 2.835 . . . . 0.0 112.914 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.1 p 54.47 30.65 13.26 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 173.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.29 30.48 58.24 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.606 1.098 . . . . 0.0 113.399 -171.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.8 mmt -72.19 168.17 18.79 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.611 1.206 . . . . 0.0 109.782 163.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.0 m -124.13 130.85 53.24 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.081 1.752 . . . . 0.0 110.13 -173.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.9 t -73.1 102.32 3.53 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.978 0.911 . . . . 0.0 112.287 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.1 p -61.91 171.48 1.67 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 175.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -67.82 -11.27 58.2 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.246 1.418 . . . . 0.0 113.744 166.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -79.26 -4.45 50.75 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.183 0.901 . . . . 0.0 112.535 168.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.54 18.99 77.51 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.828 0.74 . . . . 0.0 112.741 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.71 146.58 46.3 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.936 1.694 . . . . 0.0 112.007 -176.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.1 m -84.09 157.46 21.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.844 1.658 . . . . 0.0 112.341 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.05 -172.55 39.09 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 128.05 2.738 . . . . 0.0 107.278 -174.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -132.39 163.68 28.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.047 1.424 . . . . 0.0 110.885 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.37 -165.98 36.07 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 114.882 0.713 . . . . 0.0 114.882 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.88 8.46 1.32 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 125.04 3.827 . . . . 0.0 115.722 -165.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.45 5.9 9.59 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.555 1.07 . . . . 0.0 113.41 168.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -133.45 -52.4 0.88 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.521 1.528 . . . . 0.0 111.733 -173.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 m -81.69 -36.3 28.86 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.675 0.39 . . . . 0.0 110.031 162.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.1 72.09 1.14 Allowed Glycine 0 CA--C 1.532 1.109 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 153.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.8 mtp-105 . . . . . 0 C--O 1.249 1.039 0 C-N-CA 127.405 2.282 . . . . 0.0 116.085 -159.962 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 91.1 t . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.0 9.32 67.9 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.306 -1.275 . . . . 0.0 115.244 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.39 157.45 6.59 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.294 1.547 . . . . 0.0 112.438 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.5 m -66.58 99.69 0.61 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 163.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t 2.73 -90.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 131.257 3.823 . . . . 0.0 111.547 -162.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 75.7 mmt-85 -131.06 41.97 3.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.774 1.23 . . . . 0.0 109.283 141.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.02 -16.36 0.08 OUTLIER Glycine 0 CA--C 1.538 1.486 0 N-CA-C 117.169 1.628 . . . . 0.0 117.169 165.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -130.77 175.77 8.76 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 120.583 2.191 . . . . 0.0 113.248 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.8 m -119.95 166.6 14.53 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 123.894 0.878 . . . . 0.0 111.018 173.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -51.57 149.85 17.46 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.27 2.647 . . . . 0.0 112.816 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.0 m -69.83 76.22 0.46 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.546 1.538 . . . . 0.0 111.206 -175.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 151.13 -19.84 0.95 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 126.113 1.816 . . . . 0.0 113.93 -171.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.5 mmt -86.5 -167.29 1.82 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.307 1.843 . . . . 0.0 111.575 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 p -147.43 162.17 39.55 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.494 1.918 . . . . 0.0 110.749 161.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.7 t -102.04 114.11 27.93 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.169 1.788 . . . . 0.0 111.997 -171.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.441 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 5.4 t -65.77 147.55 53.2 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.153 0.581 . . . . 0.0 111.747 175.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.529 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -60.74 -8.44 2.98 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.951 1.7 . . . . 0.0 114.666 175.134 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -90.7 -2.43 57.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.098 1.359 . . . . 0.0 113.792 168.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.4 18.14 31.77 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.287 -1.285 . . . . 0.0 115.542 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -127.77 152.86 47.23 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.283 1.541 . . . . 0.0 112.707 -175.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.8 m -91.11 155.97 18.24 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.57 -161.22 35.01 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.187 1.375 . . . . 0.0 111.251 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -134.77 161.72 34.39 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.76 1.624 . . . . 0.0 112.082 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.46 176.02 35.74 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.962 1.268 . . . . 0.0 112.701 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.44 -2.82 10.6 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.467 2.778 . . . . 0.0 115.257 -169.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -81.27 -16.95 51.05 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.449 1.099 . . . . 0.0 110.672 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 98.3 m-85 -123.81 -42.79 2.16 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 129.014 2.926 . . . . 0.0 111.43 -167.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.2 m -99.91 -9.2 23.08 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.339 1.455 . . . . 0.0 113.268 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.35 -174.38 41.63 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-N 118.68 0.673 . . . . 0.0 113.363 -170.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.786 2.035 . . . . 0.0 108.875 173.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.58 2.46 72.82 Favored Glycine 0 CA--C 1.536 1.374 0 N-CA-C 116.005 1.162 . . . . 0.0 116.005 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.53 163.81 6.52 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.303 1.552 . . . . 0.0 112.617 175.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.0 m -54.25 129.28 34.62 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.994 0.918 . . . . 0.0 109.48 162.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.2 t -22.47 -74.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 128.833 2.853 . . . . 0.0 113.163 -158.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -122.87 23.44 9.38 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.765 2.026 . . . . 0.0 110.077 138.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.33 -5.05 0.2 Allowed Glycine 0 CA--C 1.536 1.356 0 N-CA-C 116.171 1.229 . . . . 0.0 116.171 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -115.01 167.87 10.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.694 1.747 . . . . 0.0 112.056 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 72.9 m -152.73 173.01 4.92 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 125.912 1.685 . . . . 0.0 110.066 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -58.39 -178.0 0.11 Allowed 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 125.797 4.331 . . . . 0.0 118.894 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.6 m -43.8 105.18 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 129.016 2.926 . . . . 0.0 114.299 -178.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.74 33.26 86.31 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 123.885 0.755 . . . . 0.0 113.356 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.01 167.89 0.14 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.721 1.608 . . . . 0.0 114.985 170.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -134.69 88.29 2.42 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.002 156.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.2 t -50.55 112.51 0.71 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.186 0.995 . . . . 0.0 110.359 173.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.7 t -61.22 152.38 29.01 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.987 0.915 . . . . 0.0 111.119 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -64.1 -18.27 64.25 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -90.66 3.67 53.54 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.672 1.989 . . . . 0.0 111.929 175.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.36 6.89 47.09 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-O 118.109 -1.384 . . . . 0.0 115.831 162.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -114.62 152.77 31.31 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.638 1.719 . . . . 0.0 113.765 -169.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.6 m -79.37 152.28 30.49 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.67 -175.76 31.9 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 127.218 2.342 . . . . 0.0 109.514 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -141.65 158.15 44.18 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.927 2.091 . . . . 0.0 109.351 -175.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.44 -176.56 24.35 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 123.82 0.724 . . . . 0.0 114.67 171.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.45 -1.61 8.51 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.415 3.41 . . . . 0.0 115.854 -166.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -115.99 7.01 14.24 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.83 1.252 . . . . 0.0 111.847 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -120.39 -52.16 2.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 126.721 2.009 . . . . 0.0 109.905 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.2 m -62.36 -50.96 69.5 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 164.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.46 60.99 0.86 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.762 1.649 . . . . 0.0 112.823 162.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? . . . . . 0 C--O 1.255 1.351 1 C-N-CA 133.171 4.589 . . . . 0.0 118.407 159.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.85 7.96 12.52 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.075 1.321 . . . . 0.0 114.669 -174.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.572 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.7 pm0 -64.48 148.55 50.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.142 1.377 . . . . 0.0 111.836 172.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.0 m -64.81 139.53 58.77 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.214 0.606 . . . . 0.0 110.74 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.0 t -52.77 -66.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.262 1.825 . . . . 0.0 111.287 -165.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.3 mmt-85 -129.68 16.97 5.83 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.476 1.91 . . . . 0.0 110.269 151.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.98 -23.25 2.28 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.933 1.73 . . . . 0.0 113.007 -176.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.17 157.95 33.79 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.035 0.918 . . . . 0.0 112.225 168.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.5 m -149.24 -179.12 0.91 Allowed Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 130.0 3.32 . . . . 0.0 107.461 174.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -55.81 177.97 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.637 3.558 . . . . 0.0 117.774 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.2 m -53.77 121.77 8.57 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.851 1.66 . . . . 0.0 111.607 174.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.46 4.67 80.81 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.624 -1.098 . . . . 0.0 115.349 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.81 165.89 0.17 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 176.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.9 m -136.69 99.29 4.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.481 154.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.0 t -51.41 113.08 0.86 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.3 1.04 . . . . 0.0 110.66 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.448 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 26.3 t -67.6 160.51 27.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.294 1.438 . . . . 0.0 113.435 -169.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -57.86 -20.49 36.79 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.273 1.029 . . . . 0.0 112.712 161.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.522 ' CD2' ' HE2' ' A' ' 26' ' ' LYS . 6.1 m-90 -79.18 -2.39 40.69 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.441 1.496 . . . . 0.0 112.987 170.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.36 18.69 79.01 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.405 1.002 . . . . 0.0 113.877 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -121.44 155.45 34.84 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.849 1.66 . . . . 0.0 113.022 -172.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.98 152.42 28.0 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.288 1.835 . . . . 0.0 112.304 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.91 -170.79 30.68 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.645 1.117 . . . . 0.0 111.104 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -146.8 165.67 28.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 129.879 3.272 . . . . 0.0 109.698 -172.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.56 -170.29 38.43 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.505 1.05 . . . . 0.0 112.943 -171.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.56 3.04 7.18 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.617 2.878 . . . . 0.0 115.648 -171.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.522 ' HE2' ' CD2' ' A' ' 18' ' ' TRP . 1.6 ttpm? -98.19 11.69 36.98 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 119.534 1.061 . . . . 0.0 111.823 172.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.448 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 92.1 m-85 -147.24 -53.02 0.21 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.898 2.479 . . . . 0.0 110.179 -164.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.76 -46.53 0.49 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 131.38 -52.67 0.82 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 -152.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 49.1 tpt85 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 115.701 -2.095 . . . . 0.0 112.25 171.4 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 51.3 t . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 115.89 6.63 16.37 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.135 1.35 . . . . 0.0 114.576 -174.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.538 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.7 pm0 -64.19 148.94 48.91 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.895 1.278 . . . . 0.0 111.797 172.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.3 m -64.0 154.84 32.95 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.689 0.796 . . . . 0.0 111.005 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.9 t -45.7 -67.21 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.987 1.715 . . . . 0.0 110.191 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -138.49 23.18 2.72 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.246 2.218 . . . . 0.0 110.907 139.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.78 -11.14 0.2 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.1 0.857 . . . . 0.0 114.957 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -105.89 165.69 11.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.561 1.944 . . . . 0.0 111.312 170.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.3 m -155.56 178.52 1.63 Allowed Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 127.079 2.152 . . . . 0.0 109.24 -170.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -57.54 178.71 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.941 3.761 . . . . 0.0 118.137 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.9 m -42.87 109.13 0.12 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 128.214 2.606 . . . . 0.0 114.0 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.19 29.12 74.51 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.235 -0.759 . . . . 0.0 114.041 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.72 168.7 0.4 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 170.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -132.73 106.27 7.66 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 113.377 -1.738 . . . . 0.0 108.712 147.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.1 t -54.68 117.48 3.41 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.336 -0.852 . . . . 0.0 110.569 170.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.427 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 10.8 t -64.95 164.1 13.29 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.05 0.94 . . . . 0.0 113.091 -175.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.554 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 18.1 mp0 -60.51 -18.92 55.04 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.672 1.989 . . . . 0.0 111.5 168.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 30.5 m0 -90.97 0.75 57.46 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.739 2.016 . . . . 0.0 113.391 172.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.98 25.21 69.73 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.858 -0.968 . . . . 0.0 114.24 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -120.01 152.69 37.12 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.909 1.684 . . . . 0.0 112.527 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.3 m -81.86 151.05 27.5 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.148 1.379 . . . . 0.0 113.072 -177.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.48 -165.23 32.86 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.539 2.018 . . . . 0.0 108.471 -174.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.75 160.79 42.85 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.588 1.955 . . . . 0.0 108.907 177.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.35 -169.81 26.59 Favored Glycine 0 CA--C 1.543 1.796 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 171.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -54.64 -10.13 2.23 Favored 'Trans proline' 0 CA--C 1.538 0.713 1 C-N-CA 126.101 4.534 . . . . 0.0 119.143 -170.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.501 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -119.14 12.34 12.63 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.87 1.214 . . . . 0.0 112.636 176.138 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 57.1 m-85 -129.96 -70.48 0.64 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 127.346 2.258 . . . . 0.0 108.085 -176.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.94 -20.65 57.78 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.111 0.964 . . . . 0.0 113.331 170.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.3 -0.1 81.36 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 118.491 0.587 . . . . 0.0 113.273 -165.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? . . . . . 0 C--O 1.251 1.16 0 C-N-CA 129.521 3.128 . . . . 0.0 107.033 177.551 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.12 2.94 24.81 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.681 1.134 . . . . 0.0 113.868 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.6 mp0 -60.2 150.79 28.92 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.188 1.795 . . . . 0.0 112.213 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.9 m -69.51 156.76 38.37 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.794 -0.566 . . . . 0.0 110.774 163.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.4 t -49.18 -70.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.272 1.829 . . . . 0.0 109.613 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -141.92 17.28 2.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 127.717 2.407 . . . . 0.0 111.916 145.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 171.38 -17.84 0.06 OUTLIER Glycine 0 CA--C 1.532 1.106 0 N-CA-C 115.455 0.942 . . . . 0.0 115.455 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -121.76 179.43 4.49 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.136 1.374 . . . . 0.0 111.821 168.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.51 -173.51 0.36 Allowed Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 127.384 2.274 . . . . 0.0 109.105 173.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.02 151.97 15.17 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.063 2.508 . . . . 0.0 113.792 174.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.9 m -72.12 30.07 0.05 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 -159.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -130.45 -4.78 4.32 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 127.391 2.424 . . . . 0.0 115.029 165.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -179.67 0.15 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.055 2.542 . . . . 0.0 117.452 -176.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.07 96.08 2.83 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.493 1.117 . . . . 0.0 110.206 146.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.7 t -49.82 115.02 1.21 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.234 1.014 . . . . 0.0 111.899 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.6 t -70.04 152.56 44.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.81 1.244 . . . . 0.0 111.081 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -6.12 7.61 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 171.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -6.51 50.12 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.542 1.137 . . . . 0.0 113.159 163.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.96 23.94 60.76 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.996 0.816 . . . . 0.0 113.493 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -126.8 159.02 35.05 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.393 1.877 . . . . 0.0 112.467 -174.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.0 m -115.05 165.83 12.47 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.05 1.34 . . . . 0.0 113.218 -175.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.48 -170.65 24.33 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 -162.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -139.48 161.99 36.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.527 2.331 . . . . 0.0 109.872 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.27 -174.63 28.74 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 123.936 0.779 . . . . 0.0 113.35 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -57.96 -16.11 25.03 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 124.011 3.141 . . . . 0.0 117.551 -169.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.79 -7.14 59.53 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.544 1.066 . . . . 0.0 111.359 178.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -134.08 -58.76 0.85 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.991 2.116 . . . . 0.0 110.198 -160.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.0 m -98.42 -7.04 29.38 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.781 2.032 . . . . 0.0 113.008 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.14 -9.09 10.12 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 124.668 1.128 . . . . 0.0 114.418 -170.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.14 0 C-N-CA 128.574 2.749 . . . . 0.0 107.617 172.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 117.714 -1.136 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.18 4.77 23.68 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 119.527 1.058 . . . . 0.0 115.3 -173.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.7 pm0 -57.61 150.76 18.5 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.833 1.253 . . . . 0.0 113.045 178.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.4 m -34.17 119.76 0.42 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 128.939 2.896 . . . . 0.0 112.406 -168.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.2 t 0.92 -85.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 130.18 3.392 . . . . 0.0 112.426 -160.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -130.94 32.59 4.3 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.608 2.363 . . . . 0.0 109.171 140.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 164.37 -11.96 0.08 OUTLIER Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.864 1.697 . . . . 0.0 115.76 172.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -121.94 174.46 6.88 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.333 1.853 . . . . 0.0 113.456 -172.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.1 m -150.58 175.74 2.67 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 126.912 2.085 . . . . 0.0 109.188 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -57.39 178.41 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 125.129 3.886 . . . . 0.0 118.577 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -50.52 120.14 4.39 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.647 1.579 . . . . 0.0 112.364 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.78 32.33 74.18 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 118.761 -1.022 . . . . 0.0 113.808 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.37 166.86 2.1 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 169.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.8 m -133.81 94.26 3.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.648 1.979 . . . . 0.0 107.421 152.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -50.42 113.3 0.85 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.868 0.867 . . . . 0.0 109.381 170.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.5 t -64.95 159.45 22.89 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.023 0.916 . . . . 0.0 112.53 -169.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.44 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -48.82 -26.1 2.22 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.903 2.481 . . . . 0.0 113.552 169.873 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -100.23 3.33 43.53 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.728 2.011 . . . . 0.0 112.664 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.31 8.61 58.6 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.955 -1.47 . . . . 0.0 115.661 169.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -118.59 158.67 24.99 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.617 2.209 . . . . 0.0 113.328 -172.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.5 m -89.47 156.07 18.9 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -167.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.56 -166.43 27.75 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 128.07 2.747 . . . . 0.0 109.596 -175.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.39 170.26 21.79 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.996 1.318 . . . . 0.0 110.895 163.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 126.69 172.19 13.25 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.612 1.577 . . . . 0.0 112.63 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.24 -23.03 16.85 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 124.575 3.517 . . . . 0.0 117.545 -169.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.8 -4.54 11.6 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.487 1.115 . . . . 0.0 113.607 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -76.36 -55.9 5.13 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.634 1.174 . . . . 0.0 109.23 155.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.4 m -71.49 -44.12 65.31 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.499 1.52 . . . . 0.0 112.962 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.46 145.46 26.53 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 118.748 0.703 . . . . 0.0 112.257 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 C-N-CA 124.491 1.117 . . . . 0.0 113.053 -175.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.76 12.44 78.28 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 119.369 -0.684 . . . . 0.0 114.748 -172.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -62.37 168.81 3.27 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.355 1.462 . . . . 0.0 113.502 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 62.7 m -45.72 140.93 3.17 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.749 1.62 . . . . 0.0 112.091 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t -33.23 -67.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 127.931 2.492 . . . . 0.0 112.877 -155.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -124.16 19.66 9.07 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.402 1.881 . . . . 0.0 110.517 138.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.4 -19.2 0.81 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.732 1.158 . . . . 0.0 115.053 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.5 ptp85 -96.78 177.3 5.69 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.45 1.5 . . . . 0.0 111.559 172.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -137.57 169.37 13.25 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.798 1.239 . . . . 0.0 112.459 -172.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.23 167.99 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.613 3.542 . . . . 0.0 114.842 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 m -38.68 96.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.388 2.675 . . . . 0.0 114.628 -174.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.71 3.39 90.53 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 118.268 -1.296 . . . . 0.0 115.8 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.2 mmt -78.27 173.46 12.26 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 120.19 1.995 . . . . 0.0 112.716 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.9 m -119.3 136.28 54.32 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.609 2.364 . . . . 0.0 109.722 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.6 t -75.9 113.91 13.93 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.945 0.498 . . . . 0.0 109.738 166.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.455 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 9.2 t -62.35 151.28 37.2 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.996 0.903 . . . . 0.0 110.359 167.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.404 ' CD ' ' H ' ' A' ' 17' ' ' GLN . 17.8 mp0 -72.7 -4.93 34.24 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.557 1.543 . . . . 0.0 111.33 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -75.47 -11.19 59.98 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.486 1.914 . . . . 0.0 113.597 162.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.53 9.91 48.94 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.457 1.504 . . . . 0.0 115.195 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -131.07 147.18 52.59 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.928 1.864 . . . . 0.0 113.193 -171.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 82.6 m -82.99 149.51 26.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -169.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.02 -160.3 33.18 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.074 1.321 . . . . 0.0 111.827 176.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.6 tptt -135.94 162.1 33.78 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.395 1.478 . . . . 0.0 112.165 176.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.05 178.73 36.03 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.761 1.172 . . . . 0.0 113.862 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.34 19.29 0.53 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 125.271 3.981 . . . . 0.0 114.697 -170.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm -121.42 4.44 10.21 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.325 1.85 . . . . 0.0 111.616 169.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.455 ' CD2' ' HB2' ' A' ' 16' ' ' SER . 82.5 m-85 -130.14 -63.34 0.91 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.815 2.446 . . . . 0.0 108.876 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.1 m -71.25 -5.86 35.3 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.11 1.364 . . . . 0.0 113.56 174.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.37 166.52 34.25 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 127.676 2.56 . . . . 0.0 109.067 168.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? . . . . . 0 C--O 1.243 0.763 0 CA-C-N 117.408 0.604 . . . . 0.0 112.017 -176.4 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.8 t . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 117.061 -1.447 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.41 -45.29 6.22 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 120.462 1.483 . . . . 0.0 112.522 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 44.63 -173.68 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 128.082 2.553 . . . . 0.0 114.129 -169.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 62.2 m -58.21 116.82 3.81 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.607 -1.308 . . . . 0.0 108.185 148.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -4.67 -81.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 131.056 3.742 . . . . 0.0 113.67 -160.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -129.27 22.38 5.63 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.114 2.165 . . . . 0.0 109.807 147.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.6 -14.38 0.07 OUTLIER Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.543 1.377 . . . . 0.0 116.543 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -125.38 179.74 4.97 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 120.046 1.923 . . . . 0.0 113.029 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.4 m -124.0 157.1 64.72 Favored Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 124.635 1.174 . . . . 0.0 109.496 169.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.42 150.63 88.02 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.05 1.833 . . . . 0.0 110.78 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.5 m -65.48 88.14 0.09 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.831 1.252 . . . . 0.0 112.326 -166.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.95 -17.04 3.22 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.1 1.809 . . . . 0.0 113.491 -173.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 mmt -94.59 170.75 9.24 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.724 1.609 . . . . 0.0 109.712 158.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -142.39 161.9 36.85 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.988 1.715 . . . . 0.0 110.906 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.5 t -103.91 115.87 31.24 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.939 1.695 . . . . 0.0 112.097 -166.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.494 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 7.7 t -77.87 167.88 20.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 122.302 1.049 . . . . 0.0 113.011 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.524 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 11.1 mp0 -65.29 -16.72 63.86 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.313 2.245 . . . . 0.0 112.108 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -74.72 -5.98 46.28 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.704 2.002 . . . . 0.0 112.98 170.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.72 23.01 65.4 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.941 -0.922 . . . . 0.0 113.532 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -131.06 153.8 48.91 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.541 1.536 . . . . 0.0 112.716 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 74.5 m -84.17 160.99 20.73 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.597 1.159 . . . . 0.0 113.785 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.28 -158.8 31.88 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.919 2.199 . . . . 0.0 107.88 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -138.32 158.57 44.03 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.788 1.235 . . . . 0.0 110.8 -177.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.88 -178.14 40.55 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 123.962 0.791 . . . . 0.0 113.912 172.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.78 -13.51 6.17 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 125.07 3.847 . . . . 0.0 118.032 -167.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -96.94 -8.77 29.86 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.808 1.185 . . . . 0.0 111.956 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.494 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 92.1 m-85 -120.5 -41.79 2.58 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 128.335 2.654 . . . . 0.0 110.397 -174.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.6 m -101.24 1.62 39.07 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.708 2.003 . . . . 0.0 112.555 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.83 -88.92 0.23 Allowed Glycine 0 CA--C 1.531 1.093 0 CA-C-N 119.153 0.888 . . . . 0.0 114.895 -171.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? . . . . . 0 C--O 1.247 0.937 0 C-N-CA 124.744 1.217 . . . . 0.0 112.192 -162.475 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.4 8.76 87.08 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-O 119.189 -0.784 . . . . 0.0 114.849 -174.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -61.33 166.39 3.92 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.176 1.391 . . . . 0.0 113.344 174.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.2 m -46.78 142.16 3.51 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.796 1.638 . . . . 0.0 112.23 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.6 t -18.73 -76.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 129.555 3.142 . . . . 0.0 113.139 -163.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -124.08 25.61 7.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.173 2.189 . . . . 0.0 109.924 140.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.97 -6.39 2.04 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.482 1.515 . . . . 0.0 114.779 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -112.08 -177.92 3.29 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 127.683 2.393 . . . . 0.0 111.58 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -160.93 172.55 5.69 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 126.249 1.82 . . . . 0.0 109.59 169.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.49 178.97 6.93 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.158 2.572 . . . . 0.0 113.851 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.5 t 9.99 87.82 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 130.46 3.504 . . . . 0.0 116.06 169.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.48 34.25 74.82 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.3 0.953 . . . . 0.0 114.789 171.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.08 167.0 4.22 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 169.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.7 m -132.76 94.64 3.43 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.07 156.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -51.2 107.35 0.18 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.859 0.863 . . . . 0.0 110.734 160.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.2 p -64.79 164.55 12.08 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.709 1.204 . . . . 0.0 112.873 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.76 -21.22 60.46 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.0 0.92 . . . . 0.0 112.44 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -74.25 -10.54 59.7 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.806 1.642 . . . . 0.0 112.607 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.61 12.84 63.98 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.477 1.037 . . . . 0.0 113.802 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -124.86 142.49 51.41 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.841 1.32 . . . . 0.0 111.676 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.8 m -81.02 162.34 23.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.473 1.109 . . . . 0.0 113.289 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.86 -161.02 34.84 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 127.685 2.564 . . . . 0.0 106.857 -175.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.56 167.53 23.48 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.564 1.546 . . . . 0.0 109.309 173.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.47 -176.07 39.69 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 123.851 0.738 . . . . 0.0 114.52 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.69 9.2 0.79 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 124.83 3.686 . . . . 0.0 115.817 -165.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 tpmp? -125.64 6.8 7.52 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.287 0.949 . . . . 0.0 113.017 170.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -124.62 -54.41 1.66 Allowed 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 126.487 1.915 . . . . 0.0 109.729 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.6 m -68.89 -41.28 78.5 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.101 0.96 . . . . 0.0 109.527 164.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.35 64.9 2.43 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.96 0.791 . . . . 0.0 111.382 162.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.312 0.0 OUTLIER . . . . . 0 C--O 1.245 0.863 1 C-N-CA 132.155 4.182 . . . . 0.0 118.241 172.427 . . . . . . . . 3 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.44 13.76 82.6 Favored Glycine 0 CA--C 1.537 1.433 0 CA-C-O 119.494 -0.615 . . . . 0.0 114.472 -170.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -60.38 168.84 1.9 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.944 1.698 . . . . 0.0 113.838 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.5 m -43.52 138.33 2.52 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.439 1.896 . . . . 0.0 111.732 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.8 t -28.36 -71.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 128.832 2.853 . . . . 0.0 113.101 -154.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -122.57 19.58 10.37 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.254 1.821 . . . . 0.0 110.402 140.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.18 -20.97 0.29 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.42 1.009 . . . . 0.0 114.857 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -106.42 177.68 4.78 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 124.962 1.305 . . . . 0.0 112.335 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.482 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 53.7 m -142.25 179.81 1.13 Allowed Pre-proline 0 CA--C 1.559 1.321 0 C-N-CA 125.957 1.703 . . . . 0.0 110.353 -174.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 74.4 Cg_endo -75.97 -173.06 1.52 Allowed 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 123.676 2.917 . . . . 0.0 115.42 -177.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.1 m -41.68 108.08 0.09 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.549 2.74 . . . . 0.0 114.688 -174.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.72 29.64 75.03 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.088 0.851 . . . . 0.0 113.864 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.99 172.63 0.94 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 171.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.86 115.75 9.24 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 113.15 -1.841 . . . . 0.0 109.665 148.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.7 t -62.95 113.11 2.89 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.658 -1.276 . . . . 0.0 110.537 172.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.416 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 77.3 p -61.36 162.02 8.42 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.327 1.051 . . . . 0.0 112.778 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -71.2 -15.95 62.49 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 53.4 m0 -75.0 -9.32 58.42 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.017 1.727 . . . . 0.0 112.603 167.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.78 16.4 51.85 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.459 -1.19 . . . . 0.0 114.447 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -124.42 148.62 47.48 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.693 1.746 . . . . 0.0 112.772 -175.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 67.1 m -73.11 154.41 40.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.551 1.54 . . . . 0.0 113.259 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.26 -168.15 37.14 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.806 1.67 . . . . 0.0 109.07 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -142.01 149.6 40.22 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.754 2.022 . . . . 0.0 109.537 -175.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.76 -171.52 30.37 Favored Glycine 0 CA--C 1.542 1.78 0 N-CA-C 114.829 0.692 . . . . 0.0 114.829 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.64 -14.28 7.17 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 125.126 3.884 . . . . 0.0 118.231 -170.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -99.38 7.03 45.88 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.02 1.328 . . . . 0.0 111.693 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 90.1 m-85 -141.94 -64.31 0.43 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.875 2.07 . . . . 0.0 109.317 -167.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.3 m -79.78 -16.24 55.93 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.341 2.256 . . . . 0.0 111.963 173.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.35 -112.15 0.19 Allowed Glycine 0 CA--C 1.53 1.013 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 147.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.165 1.386 . . . . 0.0 111.224 176.419 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.418 HG13 ' H ' ' A' ' 2' ' ' GLY 0.272 7.8 p . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 117.808 -1.092 . . . . 0.0 112.398 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.418 ' H ' HG13 ' A' ' 1' ' ' VAL . . . -92.51 8.24 77.16 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-N 119.639 1.109 . . . . 0.0 115.292 -171.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 3.5 mp0 -51.62 154.08 2.08 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.585 0.707 . . . . 0.0 111.015 171.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.7 m -52.92 128.86 28.5 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 118.275 -0.869 . . . . 0.0 108.917 163.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.5 t -13.39 -79.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 129.39 3.076 . . . . 0.0 113.216 -157.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -123.8 27.67 7.19 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 127.252 2.221 . . . . 0.0 109.564 139.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.32 -2.74 0.1 OUTLIER Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.222 1.391 . . . . 0.0 116.189 176.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.6 mmt-85 -129.38 -177.46 4.26 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.157 1.783 . . . . 0.0 112.991 -172.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.2 m -143.67 158.79 56.06 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 125.073 1.349 . . . . 0.0 111.051 173.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.27 170.42 20.05 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.51 2.806 . . . . 0.0 112.947 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.6 m -44.97 99.85 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.836 2.455 . . . . 0.0 114.412 -173.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.31 -8.89 62.77 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.864 1.221 . . . . 0.0 114.899 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 45.5 mtt -90.81 164.73 13.97 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.872 1.269 . . . . 0.0 110.426 165.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.8 m -145.4 158.17 43.89 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.232 1.013 . . . . 0.0 111.805 -174.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.7 t -85.28 115.77 23.23 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.192 0.997 . . . . 0.0 111.274 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.43 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 96.4 p -70.94 165.41 23.42 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.342 1.068 . . . . 0.0 113.142 175.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.561 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 6.1 mp0 -60.33 -17.23 41.62 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.513 1.925 . . . . 0.0 113.049 175.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -80.13 -7.97 59.18 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.276 1.431 . . . . 0.0 113.277 172.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.62 13.09 83.85 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 118.701 0.682 . . . . 0.0 113.124 -168.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -105.84 141.77 36.69 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.917 1.687 . . . . 0.0 111.486 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.0 t -82.68 157.33 23.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.236 0.615 . . . . 0.0 112.089 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.63 -172.51 42.5 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.788 0.709 . . . . 0.0 112.917 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -134.17 132.52 39.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.311 1.845 . . . . 0.0 106.754 -174.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.0 179.31 15.86 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.314 0.959 . . . . 0.0 112.295 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.75 0.83 5.07 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.934 2.422 . . . . 0.0 115.846 -171.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -95.8 -8.53 34.05 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.532 1.133 . . . . 0.0 111.614 172.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 98.9 m-85 -124.03 -53.16 1.75 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.758 2.423 . . . . 0.0 110.436 -169.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 32.7 m -120.43 -16.03 8.45 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.084 2.154 . . . . 0.0 114.23 -164.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.25 -17.43 13.02 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-O 118.699 -1.056 . . . . 0.0 113.92 -159.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.145 0 C-N-CA 125.867 1.667 . . . . 0.0 112.791 -178.745 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.686 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -89.04 -42.38 5.64 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 165.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.47 141.87 55.89 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.025 0.93 . . . . 0.0 110.504 154.224 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 41.7 m -53.55 146.23 13.34 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.4 1.88 . . . . 0.0 112.012 -175.341 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.5 t -44.93 -62.43 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.576 1.951 . . . . 0.0 111.334 -160.009 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.549 ' HE ' ' HA ' ' A' ' 6' ' ' ARG . 1.7 mmp_? -135.8 29.31 3.19 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.84 1.656 . . . . 0.0 110.259 129.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.27 -35.97 0.24 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.917 0.77 . . . . 0.0 114.555 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -88.41 177.09 6.92 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.703 1.252 . . . . 0.0 111.162 172.612 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.0 m -127.69 172.92 6.03 Favored Pre-proline 0 C--O 1.24 0.595 0 C-N-CA 125.035 1.334 . . . . 0.0 110.856 176.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.57 150.24 8.93 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.988 2.459 . . . . 0.0 112.196 171.793 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.5 m -67.89 79.94 0.21 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.325 1.45 . . . . 0.0 112.624 -166.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 144.14 -17.64 2.12 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.627 2.06 . . . . 0.0 113.94 -175.675 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.6 mtt -84.56 178.77 7.58 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.552 1.676 . . . . 0.0 112.728 174.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.7 m -129.03 146.85 50.9 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.767 2.427 . . . . 0.0 110.278 173.768 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.8 t -88.69 111.64 22.19 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.761 1.625 . . . . 0.0 111.039 173.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 t -67.38 155.98 37.62 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.824 0.85 . . . . 0.0 111.217 172.687 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -9.81 48.28 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.794 -1.191 . . . . 0.0 114.138 176.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.509 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 54.0 m0 -70.08 -5.17 24.92 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.833 1.253 . . . . 0.0 113.001 164.32 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.29 14.36 68.98 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.043 1.306 . . . . 0.0 113.759 176.508 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -120.81 154.22 36.04 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.869 1.668 . . . . 0.0 113.053 -175.04 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 94.3 m -93.34 147.41 22.96 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.012 1.325 . . . . 0.0 113.848 -174.158 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.25 -161.61 32.59 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.215 0.912 . . . . 0.0 112.071 176.538 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.7 tptt -134.24 167.54 20.5 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.835 1.654 . . . . 0.0 111.763 172.399 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.91 172.78 36.01 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.994 1.283 . . . . 0.0 112.569 -174.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.77 4.19 3.27 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.842 3.028 . . . . 0.0 114.967 -170.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.509 ' HE3' ' CE2' ' A' ' 18' ' ' TRP . 1.7 tmtm? -109.14 3.71 22.18 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.066 1.303 . . . . 0.0 111.906 171.793 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -122.91 -41.22 2.36 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 126.333 1.853 . . . . 0.0 110.466 178.578 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 m -93.61 3.6 55.25 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.691 1.196 . . . . 0.0 113.592 173.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.05 -85.59 0.05 OUTLIER Glycine 0 CA--C 1.536 1.348 0 CA-C-N 119.744 1.157 . . . . 0.0 115.889 177.008 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.187 0 C-N-CA 126.601 1.96 . . . . 0.0 113.255 -171.373 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.53 9.45 64.71 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.214 0.912 . . . . 0.0 114.484 -173.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.6 pm0 -71.41 153.32 42.37 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.684 1.242 . . . . 0.0 111.974 174.176 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.6 m -69.0 164.89 21.32 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.886 1.274 . . . . 0.0 111.45 176.291 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.0 t -47.14 -68.32 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 125.762 1.625 . . . . 0.0 110.072 -176.192 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -139.64 19.15 2.52 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.145 2.178 . . . . 0.0 111.599 142.01 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.01 -14.18 0.07 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 115.656 1.023 . . . . 0.0 115.656 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -121.54 177.55 5.18 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.344 1.458 . . . . 0.0 112.12 170.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.93 -178.02 0.74 Allowed Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 126.593 1.957 . . . . 0.0 109.799 174.218 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -83.05 -174.85 2.16 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.769 2.979 . . . . 0.0 112.745 173.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.5 m 21.85 79.59 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 129.96 3.304 . . . . 0.0 116.39 161.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.2 18.68 71.43 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 115.638 1.015 . . . . 0.0 115.638 168.537 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.59 167.23 1.53 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 174.064 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.0 m -134.73 96.19 3.5 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 113.015 -1.902 . . . . 0.0 108.024 154.114 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -50.78 110.96 0.47 Allowed 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.559 -0.713 . . . . 0.0 111.655 168.113 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.416 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 43.9 t -67.09 137.29 56.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.16 1.384 . . . . 0.0 109.357 174.621 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -6.48 4.96 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -166.596 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -69.45 -9.91 55.72 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.465 1.106 . . . . 0.0 112.998 165.347 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.38 18.17 24.6 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.902 1.715 . . . . 0.0 113.932 -177.059 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -122.95 145.06 48.81 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.686 1.243 . . . . 0.0 114.04 -166.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.1 t -100.98 152.93 19.98 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.554 1.142 . . . . 0.0 113.347 -162.24 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.79 -162.78 30.58 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 127.286 2.374 . . . . 0.0 110.054 -171.017 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.22 170.69 20.65 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.811 1.644 . . . . 0.0 110.394 169.339 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.26 -176.91 25.89 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.939 1.257 . . . . 0.0 112.651 -177.407 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.95 -10.75 30.02 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.009 2.473 . . . . 0.0 114.915 -173.003 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.37 -13.94 59.82 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.494 1.043 . . . . 0.0 111.221 170.029 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.416 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 11.8 m-85 -128.98 -49.89 1.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.336 1.454 . . . . 0.0 110.932 -154.526 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.6 m -73.44 -7.76 53.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.619 1.167 . . . . 0.0 112.83 169.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.39 11.24 1.0 Allowed Glycine 0 CA--C 1.534 1.243 0 CA-C-O 117.546 -1.696 . . . . 0.0 116.681 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.236 0 CA-C-N 120.629 2.214 . . . . 0.0 114.046 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.95 4.1 3.2 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 119.614 1.097 . . . . 0.0 115.462 -175.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 4.3 pm0 -57.79 148.46 24.98 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.171 1.788 . . . . 0.0 112.495 172.781 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 m -61.73 138.51 58.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.921 0.488 . . . . 0.0 109.762 173.097 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -45.38 -66.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.643 1.977 . . . . 0.0 110.941 -162.532 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -133.58 25.09 4.07 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.991 1.716 . . . . 0.0 110.957 137.583 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.08 -34.43 0.26 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.019 0.819 . . . . 0.0 113.852 176.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -88.95 173.19 8.62 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 118.665 1.233 . . . . 0.0 112.364 174.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 19.4 m -148.35 179.74 1.12 Allowed Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 127.902 2.481 . . . . 0.0 108.444 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 49.7 Cg_endo -70.15 -175.25 1.18 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 123.685 2.923 . . . . 0.0 115.996 -178.128 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.8 m -44.11 108.04 0.1 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 128.598 2.759 . . . . 0.0 114.418 -173.644 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.08 29.75 75.59 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.87 0.748 . . . . 0.0 113.747 179.114 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.79 170.84 0.55 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 170.314 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.8 104.39 5.49 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 113.511 -1.677 . . . . 0.0 109.004 153.53 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -56.7 112.05 1.19 Allowed 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.288 -0.883 . . . . 0.0 110.719 173.006 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.483 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 81.0 p -73.56 168.07 20.05 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -173.362 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.541 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 1.4 mp0 -57.68 -20.04 31.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.544 1.938 . . . . 0.0 112.866 170.731 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.52 -4.32 55.63 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.257 1.423 . . . . 0.0 112.484 174.204 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.7 20.56 79.72 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.226 -0.763 . . . . 0.0 112.9 -170.85 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -120.24 144.89 47.52 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.028 1.731 . . . . 0.0 112.447 -175.018 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.9 m -73.34 155.48 39.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.428 1.491 . . . . 0.0 112.92 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.64 -169.38 33.43 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 126.132 1.825 . . . . 0.0 109.082 -177.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -145.29 159.58 42.82 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.417 2.287 . . . . 0.0 108.907 -175.893 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.44 -169.46 33.01 Favored Glycine 0 CA--C 1.539 1.588 0 N-CA-C 114.414 0.526 . . . . 0.0 114.414 173.312 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.66 -1.04 6.85 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 124.08 3.187 . . . . 0.0 116.733 -162.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.11 1.8 24.45 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.34 0.973 . . . . 0.0 112.71 170.427 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.483 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 86.3 m-85 -129.26 -57.08 1.16 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.47 1.908 . . . . 0.0 109.699 -167.494 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -93.42 -12.92 28.69 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.406 1.083 . . . . 0.0 113.555 169.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.68 -7.3 58.89 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-N 118.795 0.725 . . . . 0.0 113.774 -168.187 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.136 0 C-N-CA 128.666 2.787 . . . . 0.0 108.262 164.793 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.24 12.46 58.66 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.25 0.929 . . . . 0.0 114.257 -177.337 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.516 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.9 pm0 -65.9 145.15 56.27 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.663 1.231 . . . . 0.0 111.35 175.067 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.2 m -64.85 147.33 53.47 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.043 -0.411 . . . . 0.0 109.943 174.394 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.2 t -48.81 -67.1 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.725 1.21 . . . . 0.0 110.212 -174.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -137.19 23.72 3.0 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.123 2.169 . . . . 0.0 111.023 139.369 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.28 -28.8 0.34 Allowed Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.226 1.393 . . . . 0.0 113.33 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.46 151.29 42.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 117.928 0.864 . . . . 0.0 111.921 169.381 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.2 m -149.85 171.0 6.83 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 128.504 2.722 . . . . 0.0 109.792 -176.66 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.78 -176.25 2.9 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.986 3.124 . . . . 0.0 115.501 -173.118 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.8 t -45.32 119.7 2.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.97 1.708 . . . . 0.0 113.626 -173.674 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.37 29.59 75.0 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.352 0.977 . . . . 0.0 114.26 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.01 168.56 0.12 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 173.592 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -132.26 144.92 50.95 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 112.947 -1.933 . . . . 0.0 110.137 122.505 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 32.5 t -85.33 117.7 24.42 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.898 1.279 . . . . 0.0 109.356 168.668 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 t -65.9 153.2 42.66 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.328 0.651 . . . . 0.0 111.967 177.487 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -16.79 14.82 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.211 1.004 . . . . 0.0 112.518 167.42 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 27.8 m95 -76.24 -8.26 56.67 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.417 1.887 . . . . 0.0 113.119 172.286 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.92 14.15 61.31 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.467 1.032 . . . . 0.0 114.686 178.446 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -123.71 147.58 47.33 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.258 1.423 . . . . 0.0 112.804 -176.655 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 65.4 m -81.87 152.1 27.0 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.816 1.646 . . . . 0.0 112.349 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.9 -154.53 21.98 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 178.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 159.2 44.04 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.535 1.534 . . . . 0.0 109.613 176.864 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.54 -178.15 52.58 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 123.722 0.677 . . . . 0.0 113.489 178.324 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.73 2.02 2.8 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.469 3.446 . . . . 0.0 116.218 -166.216 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.73 -6.15 46.8 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 123.11 1.433 . . . . 0.0 111.031 172.692 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -132.01 -49.25 0.94 Allowed 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 127.919 2.488 . . . . 0.0 109.919 -169.491 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 67.3 m -81.53 8.79 8.73 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.646 1.978 . . . . 0.0 112.013 167.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.51 -92.09 0.09 OUTLIER Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.262 0.934 . . . . 0.0 114.233 -176.028 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 -157.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 97.9 m -38.96 127.56 1.61 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 128.486 2.715 . . . . 0.0 112.129 -173.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.5 t 1.34 -85.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 130.191 3.396 . . . . 0.0 112.192 -159.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -130.98 30.04 4.63 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.345 2.258 . . . . 0.0 109.771 142.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.97 -15.86 0.04 OUTLIER Glycine 0 CA--C 1.536 1.375 0 N-CA-C 116.656 1.422 . . . . 0.0 116.656 168.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -133.18 174.49 10.32 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 119.937 1.869 . . . . 0.0 113.662 -173.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.0 m -97.46 166.76 13.06 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.322 1.049 . . . . 0.0 111.638 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -50.68 149.58 13.68 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.94 2.427 . . . . 0.0 111.4 157.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.6 m -68.25 80.06 0.24 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.209 1.403 . . . . 0.0 111.583 -174.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 150.22 -14.81 0.98 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.723 1.63 . . . . 0.0 114.428 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.7 mtt -106.27 174.91 5.68 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.905 1.853 . . . . 0.0 111.754 175.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.5 m -126.27 130.4 50.81 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.389 1.876 . . . . 0.0 111.374 -172.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.9 t -84.0 114.82 21.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.467 0.707 . . . . 0.0 110.57 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.2 p -66.4 163.95 17.24 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -5.4 21.72 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 169.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.79 -8.87 58.61 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.152 0.887 . . . . 0.0 112.321 163.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.07 4.44 90.25 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.626 1.108 . . . . 0.0 113.701 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -109.82 148.95 30.56 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.098 1.359 . . . . 0.0 110.784 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.1 t -91.59 150.41 21.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.749 1.22 . . . . 0.0 113.153 -169.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.57 -156.69 24.59 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.01 0.814 . . . . 0.0 113.548 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -139.6 161.32 37.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.468 1.907 . . . . 0.0 112.153 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.2 -179.96 51.77 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.802 1.191 . . . . 0.0 112.798 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.7 -1.6 8.71 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.125 2.55 . . . . 0.0 115.802 -166.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.59 -6.04 58.48 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.194 0.998 . . . . 0.0 110.798 171.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -138.15 -53.47 0.63 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.104 1.762 . . . . 0.0 111.479 -165.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 63.9 m . . . . . 0 CA--C 1.541 0.608 0 C-N-CA 125.625 1.57 . . . . 0.0 113.746 176.914 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 120.842 0.353 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.3 m -62.63 135.72 57.52 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.947 0.88 . . . . 0.0 111.483 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.46 69.88 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.782 1.633 . . . . 0.0 110.381 -164.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 47.97 25.31 0.75 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.864 -155.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 128.84 -13.95 6.05 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.582 1.086 . . . . 0.0 115.544 162.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.79 171.77 7.34 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.198 1.799 . . . . 0.0 110.79 175.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 67.8 m -145.25 153.96 53.16 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.567 0.747 . . . . 0.0 112.157 -169.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.42 172.93 15.34 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.94 3.094 . . . . 0.0 112.229 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.6 m 42.4 41.69 2.34 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.603 1.961 . . . . 0.0 115.495 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.61 26.84 17.08 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.807 1.67 . . . . 0.0 114.438 -174.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.1 mtt -70.0 170.79 10.62 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.782 1.291 . . . . 0.0 110.76 172.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -122.77 140.52 52.81 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.027 1.731 . . . . 0.0 110.448 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t -71.56 116.94 12.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.488 1.115 . . . . 0.0 110.868 173.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.432 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 78.8 p -70.52 161.77 30.01 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.518 1.127 . . . . 0.0 113.133 172.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -14.67 9.49 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.415 1.486 . . . . 0.0 114.212 166.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -78.5 -11.76 59.97 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.238 1.015 . . . . 0.0 113.047 170.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.6 16.68 67.84 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-N 118.674 0.67 . . . . 0.0 113.732 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -119.32 143.63 47.28 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.576 1.551 . . . . 0.0 111.977 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.5 m -77.4 151.94 34.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.598 1.159 . . . . 0.0 112.663 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.6 -170.41 43.49 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.656 1.122 . . . . 0.0 111.24 174.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -119.4 145.65 46.04 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.698 1.199 . . . . 0.0 111.061 -173.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.98 -173.88 24.84 Favored Glycine 0 CA--C 1.542 1.74 0 N-CA-C 115.932 1.133 . . . . 0.0 115.932 166.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -71.88 12.53 0.57 Allowed 'Trans proline' 0 CA--C 1.541 0.847 1 C-N-CA 125.881 4.387 . . . . 0.0 116.282 -161.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.59 -11.87 6.71 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 167.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 75.8 m-85 -88.26 -58.06 2.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.501 1.52 . . . . 0.0 109.272 168.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.9 m . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 126.572 1.949 . . . . 0.0 110.872 177.019 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.9 mp0 . . . . . 0 CA--C 1.539 0.552 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.1 m -62.88 131.28 48.22 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.161 0.981 . . . . 0.0 110.458 168.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.09 77.36 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 128.746 2.819 . . . . 0.0 109.893 -169.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 52.94 1.32 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.99 1.716 . . . . 0.0 114.532 -158.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.47 -20.71 0.93 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-O 118.264 -1.298 . . . . 0.0 114.285 174.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -90.48 170.38 10.26 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 119.453 1.626 . . . . 0.0 111.875 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.7 m -141.73 -179.73 1.04 Allowed Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 126.245 1.818 . . . . 0.0 107.935 174.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.79 152.1 18.11 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.96 2.44 . . . . 0.0 113.997 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.7 m -68.38 93.25 0.47 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.724 0.81 . . . . 0.0 111.302 -172.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.19 -8.95 4.12 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 126.021 1.772 . . . . 0.0 114.287 -169.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.55 176.04 0.1 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 129.468 3.107 . . . . 0.0 118.413 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.7 m -135.85 111.95 9.66 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.728 2.011 . . . . 0.0 108.476 143.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.0 t -60.92 116.92 4.84 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.15 -0.969 . . . . 0.0 110.239 169.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.1 p -68.08 159.18 31.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.828 0.851 . . . . 0.0 113.183 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -54.2 -27.26 33.04 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.52 1.128 . . . . 0.0 112.581 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.452 ' CZ2' ' HE2' ' A' ' 26' ' ' LYS . 34.1 m0 -76.47 -2.53 32.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.593 1.557 . . . . 0.0 112.253 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.89 23.08 67.52 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.295 -0.725 . . . . 0.0 112.686 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.41 148.4 44.45 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.6 1.56 . . . . 0.0 112.695 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.4 m -86.51 153.29 21.96 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.07 1.748 . . . . 0.0 114.247 -178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.05 -161.92 31.87 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 127.044 2.259 . . . . 0.0 110.556 -177.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.11 157.95 43.79 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.846 2.458 . . . . 0.0 108.37 174.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.24 -174.68 18.43 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.809 1.195 . . . . 0.0 113.154 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.46 -14.8 40.73 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.95 2.434 . . . . 0.0 114.29 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.452 ' HE2' ' CZ2' ' A' ' 18' ' ' TRP . 7.3 tptp -78.87 -4.22 48.58 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.172 1.389 . . . . 0.0 111.832 174.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -137.32 -54.92 0.7 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.537 1.535 . . . . 0.0 110.684 -158.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.2 m . . . . . 0 CA--C 1.544 0.737 0 C-N-CA 125.156 1.382 . . . . 0.0 113.191 169.683 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 . . . . . 0 CA--C 1.541 0.607 0 CA-C-O 120.965 0.412 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 m -66.0 146.66 54.43 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.605 -0.684 . . . . 0.0 111.262 170.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.1 t -50.73 -69.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.093 1.757 . . . . 0.0 109.73 -173.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -138.41 21.67 2.75 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 127.591 2.356 . . . . 0.0 111.201 142.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.62 -24.36 0.3 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.856 1.217 . . . . 0.0 113.809 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.3 169.86 14.25 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.476 1.11 . . . . 0.0 112.837 165.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.1 m -137.39 176.39 2.79 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 128.733 2.813 . . . . 0.0 108.845 173.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -52.88 168.82 0.43 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.653 2.902 . . . . 0.0 115.431 175.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.9 p -54.69 106.03 0.19 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.261 1.824 . . . . 0.0 111.632 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.57 9.18 64.95 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.402 -1.221 . . . . 0.0 114.578 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 54.0 mtt -110.92 166.93 10.64 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.364 1.466 . . . . 0.0 112.067 172.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.7 m -134.32 143.35 47.65 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.906 2.082 . . . . 0.0 111.006 -173.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.6 t -84.81 115.81 22.94 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.626 1.57 . . . . 0.0 111.793 177.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.1 t -70.72 159.49 34.38 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 172.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -48.35 -24.22 1.16 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.555 2.342 . . . . 0.0 113.538 168.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -83.55 -4.47 58.58 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.132 1.773 . . . . 0.0 113.172 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.42 13.05 68.75 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.102 0.858 . . . . 0.0 114.433 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -122.0 153.33 38.71 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.677 1.591 . . . . 0.0 112.336 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.4 m -88.39 158.13 18.49 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.557 1.543 . . . . 0.0 113.426 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.22 -165.1 38.01 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -137.37 163.82 30.1 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.859 0.863 . . . . 0.0 111.185 -175.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.34 -170.25 52.16 Favored Glycine 0 CA--C 1.539 1.547 0 N-CA-C 114.756 0.663 . . . . 0.0 114.756 172.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.35 13.4 0.55 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 124.708 3.605 . . . . 0.0 115.469 -166.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.47 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -125.27 9.95 7.99 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.363 1.065 . . . . 0.0 112.44 169.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -138.69 -50.78 0.55 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 125.749 1.62 . . . . 0.0 110.862 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.1 m . . . . . 0 CA--C 1.539 0.526 0 C-N-CA 123.759 0.824 . . . . 0.0 109.026 161.359 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 . . . . . 0 CA--C 1.548 0.871 0 CA-C-O 122.082 0.944 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 41.2 m -65.23 102.27 0.64 Allowed 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.529 -1.357 . . . . 0.0 108.003 157.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -4.57 -88.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 130.641 3.577 . . . . 0.0 112.515 -156.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 67.9 mmt-85 -130.16 41.19 3.44 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.051 0.941 . . . . 0.0 109.526 143.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 157.67 -10.12 0.23 Allowed Glycine 0 CA--C 1.534 1.25 0 N-CA-C 116.254 1.262 . . . . 0.0 116.254 163.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -121.65 178.79 4.69 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 119.839 1.819 . . . . 0.0 112.883 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 39.8 m -127.59 166.78 21.05 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 124.651 1.18 . . . . 0.0 110.586 173.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.67 149.85 13.19 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.432 2.755 . . . . 0.0 112.537 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.7 m -69.49 76.27 0.4 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.542 1.537 . . . . 0.0 111.682 -171.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.38 -17.07 1.14 Allowed Glycine 0 CA--C 1.537 1.432 0 C-N-CA 126.249 1.881 . . . . 0.0 114.231 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.1 mtt -86.43 -168.59 2.29 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.674 1.737 . . . . 0.0 112.261 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.76 160.9 41.08 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.651 2.381 . . . . 0.0 110.159 162.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.1 t -98.24 120.78 39.24 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.402 1.881 . . . . 0.0 112.044 -173.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.466 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 13.1 t -76.43 159.19 30.67 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -7.92 7.07 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 160.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -71.59 -10.34 59.62 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.38 1.072 . . . . 0.0 112.436 164.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.63 13.8 82.0 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.492 1.044 . . . . 0.0 113.723 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -130.27 164.12 25.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.444 1.898 . . . . 0.0 111.495 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 78.0 m -94.32 158.24 15.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.823 1.249 . . . . 0.0 113.83 -172.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.57 -156.18 26.92 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.175 1.369 . . . . 0.0 111.102 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.7 tptt -138.34 164.47 29.21 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.839 1.656 . . . . 0.0 111.662 171.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.06 -176.18 31.59 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 124.119 0.866 . . . . 0.0 114.263 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.31 18.57 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.861 1 C-N-CA 125.745 4.296 . . . . 0.0 115.087 -168.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.49 6.46 6.92 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.889 1.276 . . . . 0.0 112.447 170.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.466 ' CD2' ' HB2' ' A' ' 16' ' ' SER . 96.3 m-85 -134.28 -48.88 0.78 Allowed 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 128.049 2.54 . . . . 0.0 109.911 -176.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.1 m . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 125.696 1.598 . . . . 0.0 111.565 173.373 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 . . . . . 0 CA--C 1.545 0.75 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.5 m -47.18 140.9 4.83 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.032 1.733 . . . . 0.0 112.094 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.8 t -30.44 -70.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 128.377 2.671 . . . . 0.0 112.908 -152.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -123.01 21.12 9.87 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.194 1.798 . . . . 0.0 110.415 138.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.07 -21.34 0.5 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.975 1.274 . . . . 0.0 114.985 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -98.78 -178.29 3.92 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.188 1.395 . . . . 0.0 111.971 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.9 m -130.95 170.43 11.24 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.737 1.215 . . . . 0.0 112.026 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.98 177.0 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 125.231 3.954 . . . . 0.0 115.386 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.7 p -53.86 90.83 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.107 2.163 . . . . 0.0 113.764 -174.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.77 -1.52 75.12 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.255 1.407 . . . . 0.0 114.661 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.29 170.27 16.87 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.369 1.585 . . . . 0.0 110.795 175.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.1 m -134.4 137.3 43.96 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.532 1.533 . . . . 0.0 110.805 -168.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 32.2 t -86.83 115.39 24.22 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.14 1.376 . . . . 0.0 110.865 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.4 t -74.44 164.88 26.08 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.628 0.728 . . . . 0.0 112.745 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -45.44 -23.13 0.18 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.948 2.499 . . . . 0.0 114.373 158.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -66.6 -16.67 64.35 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.621 1.568 . . . . 0.0 112.54 173.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.18 10.11 86.47 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.629 1.109 . . . . 0.0 113.14 -167.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -121.4 153.57 37.65 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.88 1.672 . . . . 0.0 111.269 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.1 m -84.01 155.5 22.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.116 0.967 . . . . 0.0 113.58 -177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.52 -155.44 15.77 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.142 1.829 . . . . 0.0 110.244 174.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -145.02 161.68 38.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.706 1.602 . . . . 0.0 109.965 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.79 -172.38 35.53 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.486 0.954 . . . . 0.0 115.486 172.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.19 -0.7 0.68 Allowed 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 126.11 4.54 . . . . 0.0 117.96 -172.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.486 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -125.74 9.74 7.68 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.39 0.995 . . . . 0.0 112.636 175.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -136.91 -47.07 0.59 Allowed 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 125.218 1.407 . . . . 0.0 112.409 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.441 0 CA-C-N 118.153 0.433 . . . . 0.0 110.432 159.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 CA--C 1.54 0.569 0 CA-C-O 121.801 0.81 . . . . 0.0 111.854 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.9 m -57.45 138.67 54.78 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 157.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.2 t -31.88 -68.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 128.261 2.624 . . . . 0.0 112.461 -158.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -123.32 19.11 9.8 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.491 1.916 . . . . 0.0 110.423 134.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.23 -26.78 0.32 Allowed Glycine 0 CA--C 1.54 1.597 0 C-N-CA 125.309 1.433 . . . . 0.0 114.806 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -85.23 -179.01 6.91 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.748 1.619 . . . . 0.0 111.633 172.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.7 m -134.49 142.66 43.59 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.158 0.983 . . . . 0.0 111.258 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -80.4 174.89 10.78 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.764 2.976 . . . . 0.0 111.584 172.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.1 m 37.74 46.99 0.78 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 127.672 2.389 . . . . 0.0 115.599 167.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.03 11.3 54.61 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-O 118.346 -1.252 . . . . 0.0 115.843 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.3 mmt -72.68 172.28 10.98 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.264 2.032 . . . . 0.0 112.206 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m -122.12 137.67 54.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.935 2.094 . . . . 0.0 111.006 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -86.87 117.77 25.82 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.945 0.898 . . . . 0.0 111.309 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.0 p -75.26 159.81 31.09 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.309 1.044 . . . . 0.0 113.29 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -59.2 -13.58 7.99 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.031 1.732 . . . . 0.0 113.961 167.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.474 ' CZ2' ' HE3' ' A' ' 26' ' ' LYS . 6.0 m95 -75.56 -9.33 58.48 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.838 1.255 . . . . 0.0 112.45 171.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.93 9.82 86.66 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.064 0.84 . . . . 0.0 113.106 -169.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -107.49 145.83 32.58 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.655 1.582 . . . . 0.0 111.872 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.9 t -96.42 143.83 27.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.238 1.015 . . . . 0.0 111.691 -175.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.68 -160.42 29.63 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.891 -0.506 . . . . 0.0 112.918 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -132.82 163.1 29.82 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.45 1.5 . . . . 0.0 111.999 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.65 177.68 31.05 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.64 1.114 . . . . 0.0 113.947 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.01 8.87 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 124.551 3.5 . . . . 0.0 115.246 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.474 ' HE3' ' CZ2' ' A' ' 18' ' ' TRP . 2.9 tpmp? -123.78 10.21 8.94 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.309 0.959 . . . . 0.0 112.144 169.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -125.37 -55.26 1.55 Allowed 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 126.608 1.963 . . . . 0.0 110.04 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 64.1 m . . . . . 0 CA--C 1.536 0.412 0 C-N-CA 124.049 0.939 . . . . 0.0 110.847 167.216 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 CA--C 1.539 0.529 0 CA-C-O 121.707 0.765 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.6 m -56.16 133.67 52.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 161.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.1 t -19.95 -76.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 129.2 3.0 . . . . 0.0 113.173 -160.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -122.41 25.14 9.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.804 2.042 . . . . 0.0 109.88 139.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.03 -6.92 0.45 Allowed Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.216 1.389 . . . . 0.0 115.45 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -114.13 -178.08 3.29 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.229 2.212 . . . . 0.0 112.38 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.5 m -144.75 159.93 48.97 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.661 1.584 . . . . 0.0 110.342 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.04 166.96 28.06 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.135 2.557 . . . . 0.0 113.123 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.5 m -56.63 92.71 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.12 2.168 . . . . 0.0 113.117 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.76 -8.5 6.46 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.415 1.483 . . . . 0.0 113.954 -176.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -122.03 165.54 15.87 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.56 1.944 . . . . 0.0 111.26 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.6 m -142.27 157.44 44.83 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.834 1.654 . . . . 0.0 111.047 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.3 t -83.53 118.92 24.11 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.621 0.768 . . . . 0.0 111.175 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 90.2 p -72.09 165.52 24.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.493 1.139 . . . . 0.0 113.225 175.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.546 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 5.7 mp0 -60.04 -17.13 36.8 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.355 1.862 . . . . 0.0 113.046 173.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -81.82 -7.61 59.62 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.322 1.449 . . . . 0.0 113.292 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.37 12.27 84.38 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 118.959 0.8 . . . . 0.0 113.336 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -105.07 146.03 29.67 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.791 1.637 . . . . 0.0 111.518 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.8 t -85.41 157.82 20.39 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.503 0.721 . . . . 0.0 112.095 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.36 -171.45 38.23 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.662 1.125 . . . . 0.0 111.921 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.89 175.77 9.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.176 0.988 . . . . 0.0 112.04 174.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.25 177.55 45.94 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.676 1.131 . . . . 0.0 111.755 -165.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.98 5.47 3.48 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.624 2.216 . . . . 0.0 116.097 -164.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -90.69 -8.22 50.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.265 0.939 . . . . 0.0 111.304 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.445 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 96.6 m-85 -130.92 -51.27 1.04 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.754 2.422 . . . . 0.0 111.283 -168.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -148.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 N--CA 1.468 0.472 0 CA-C-O 121.538 0.685 . . . . 0.0 111.783 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.9 m -61.34 148.1 42.55 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.911 0.484 . . . . 0.0 111.442 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t -49.09 -66.61 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.906 1.682 . . . . 0.0 109.907 -173.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -138.3 19.24 2.76 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.023 2.129 . . . . 0.0 111.721 140.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.91 -19.36 0.2 Allowed Glycine 0 CA--C 1.532 1.12 0 N-CA-C 115.162 0.825 . . . . 0.0 115.162 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -99.87 173.79 6.51 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.209 1.404 . . . . 0.0 110.777 165.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.9 m -139.48 154.12 71.24 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.086 1.354 . . . . 0.0 110.939 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.45 170.45 15.95 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.553 2.835 . . . . 0.0 112.914 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.1 p 54.47 30.65 13.26 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 173.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.29 30.48 58.24 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.606 1.098 . . . . 0.0 113.399 -171.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.8 mmt -72.19 168.17 18.79 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.611 1.206 . . . . 0.0 109.782 163.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.0 m -124.13 130.85 53.24 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.081 1.752 . . . . 0.0 110.13 -173.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.9 t -73.1 102.32 3.53 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.978 0.911 . . . . 0.0 112.287 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.1 p -61.91 171.48 1.67 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 175.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -67.82 -11.27 58.2 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.246 1.418 . . . . 0.0 113.744 166.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -79.26 -4.45 50.75 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.183 0.901 . . . . 0.0 112.535 168.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.54 18.99 77.51 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.828 0.74 . . . . 0.0 112.741 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.71 146.58 46.3 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.936 1.694 . . . . 0.0 112.007 -176.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.1 m -84.09 157.46 21.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.844 1.658 . . . . 0.0 112.341 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.05 -172.55 39.09 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 128.05 2.738 . . . . 0.0 107.278 -174.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -132.39 163.68 28.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.047 1.424 . . . . 0.0 110.885 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.37 -165.98 36.07 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 114.882 0.713 . . . . 0.0 114.882 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.88 8.46 1.32 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 125.04 3.827 . . . . 0.0 115.722 -165.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.45 5.9 9.59 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.555 1.07 . . . . 0.0 113.41 168.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -133.45 -52.4 0.88 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.521 1.528 . . . . 0.0 111.733 -173.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 CA--C 1.537 0.462 0 C-N-CA 122.675 0.39 . . . . 0.0 110.031 162.47 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 CA--C 1.541 0.618 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.5 m -66.58 99.69 0.61 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 163.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t 2.73 -90.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 131.257 3.823 . . . . 0.0 111.547 -162.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 75.7 mmt-85 -131.06 41.97 3.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.774 1.23 . . . . 0.0 109.283 141.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.02 -16.36 0.08 OUTLIER Glycine 0 CA--C 1.538 1.486 0 N-CA-C 117.169 1.628 . . . . 0.0 117.169 165.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -130.77 175.77 8.76 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 120.583 2.191 . . . . 0.0 113.248 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.8 m -119.95 166.6 14.53 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 123.894 0.878 . . . . 0.0 111.018 173.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -51.57 149.85 17.46 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.27 2.647 . . . . 0.0 112.816 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.0 m -69.83 76.22 0.46 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.546 1.538 . . . . 0.0 111.206 -175.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 151.13 -19.84 0.95 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 126.113 1.816 . . . . 0.0 113.93 -171.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.5 mmt -86.5 -167.29 1.82 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.307 1.843 . . . . 0.0 111.575 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 p -147.43 162.17 39.55 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.494 1.918 . . . . 0.0 110.749 161.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.7 t -102.04 114.11 27.93 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.169 1.788 . . . . 0.0 111.997 -171.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.441 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 5.4 t -65.77 147.55 53.2 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.153 0.581 . . . . 0.0 111.747 175.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.529 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -60.74 -8.44 2.98 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.951 1.7 . . . . 0.0 114.666 175.134 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -90.7 -2.43 57.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.098 1.359 . . . . 0.0 113.792 168.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.4 18.14 31.77 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.287 -1.285 . . . . 0.0 115.542 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -127.77 152.86 47.23 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.283 1.541 . . . . 0.0 112.707 -175.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.8 m -91.11 155.97 18.24 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.57 -161.22 35.01 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.187 1.375 . . . . 0.0 111.251 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -134.77 161.72 34.39 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.76 1.624 . . . . 0.0 112.082 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.46 176.02 35.74 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.962 1.268 . . . . 0.0 112.701 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.44 -2.82 10.6 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.467 2.778 . . . . 0.0 115.257 -169.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -81.27 -16.95 51.05 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.449 1.099 . . . . 0.0 110.672 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 98.3 m-85 -123.81 -42.79 2.16 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 129.014 2.926 . . . . 0.0 111.43 -167.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.2 m . . . . . 0 CA--C 1.541 0.625 0 C-N-CA 125.339 1.455 . . . . 0.0 113.268 -179.35 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 121.645 0.736 . . . . 0.0 112.617 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.0 m -54.25 129.28 34.62 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.994 0.918 . . . . 0.0 109.48 162.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.2 t -22.47 -74.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 128.833 2.853 . . . . 0.0 113.163 -158.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -122.87 23.44 9.38 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.765 2.026 . . . . 0.0 110.077 138.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.33 -5.05 0.2 Allowed Glycine 0 CA--C 1.536 1.356 0 N-CA-C 116.171 1.229 . . . . 0.0 116.171 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -115.01 167.87 10.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.694 1.747 . . . . 0.0 112.056 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 72.9 m -152.73 173.01 4.92 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 125.912 1.685 . . . . 0.0 110.066 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -58.39 -178.0 0.11 Allowed 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 125.797 4.331 . . . . 0.0 118.894 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.6 m -43.8 105.18 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 129.016 2.926 . . . . 0.0 114.299 -178.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.74 33.26 86.31 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 123.885 0.755 . . . . 0.0 113.356 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.01 167.89 0.14 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.721 1.608 . . . . 0.0 114.985 170.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -134.69 88.29 2.42 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.002 156.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.2 t -50.55 112.51 0.71 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.186 0.995 . . . . 0.0 110.359 173.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.7 t -61.22 152.38 29.01 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.987 0.915 . . . . 0.0 111.119 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -64.1 -18.27 64.25 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -90.66 3.67 53.54 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.672 1.989 . . . . 0.0 111.929 175.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.36 6.89 47.09 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-O 118.109 -1.384 . . . . 0.0 115.831 162.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -114.62 152.77 31.31 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.638 1.719 . . . . 0.0 113.765 -169.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.6 m -79.37 152.28 30.49 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.67 -175.76 31.9 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 127.218 2.342 . . . . 0.0 109.514 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -141.65 158.15 44.18 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.927 2.091 . . . . 0.0 109.351 -175.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.44 -176.56 24.35 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 123.82 0.724 . . . . 0.0 114.67 171.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.45 -1.61 8.51 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.415 3.41 . . . . 0.0 115.854 -166.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -115.99 7.01 14.24 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.83 1.252 . . . . 0.0 111.847 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -120.39 -52.16 2.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 126.721 2.009 . . . . 0.0 109.905 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.2 m . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 164.739 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 121.217 0.532 . . . . 0.0 111.836 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.0 m -64.81 139.53 58.77 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.214 0.606 . . . . 0.0 110.74 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.0 t -52.77 -66.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.262 1.825 . . . . 0.0 111.287 -165.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.3 mmt-85 -129.68 16.97 5.83 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.476 1.91 . . . . 0.0 110.269 151.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.98 -23.25 2.28 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.933 1.73 . . . . 0.0 113.007 -176.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.17 157.95 33.79 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.035 0.918 . . . . 0.0 112.225 168.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.5 m -149.24 -179.12 0.91 Allowed Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 130.0 3.32 . . . . 0.0 107.461 174.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -55.81 177.97 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.637 3.558 . . . . 0.0 117.774 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.2 m -53.77 121.77 8.57 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.851 1.66 . . . . 0.0 111.607 174.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.46 4.67 80.81 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.624 -1.098 . . . . 0.0 115.349 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.81 165.89 0.17 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 176.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.9 m -136.69 99.29 4.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.481 154.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.0 t -51.41 113.08 0.86 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.3 1.04 . . . . 0.0 110.66 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.448 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 26.3 t -67.6 160.51 27.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.294 1.438 . . . . 0.0 113.435 -169.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -57.86 -20.49 36.79 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.273 1.029 . . . . 0.0 112.712 161.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.522 ' CD2' ' HE2' ' A' ' 26' ' ' LYS . 6.1 m-90 -79.18 -2.39 40.69 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.441 1.496 . . . . 0.0 112.987 170.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.36 18.69 79.01 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.405 1.002 . . . . 0.0 113.877 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -121.44 155.45 34.84 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.849 1.66 . . . . 0.0 113.022 -172.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.98 152.42 28.0 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.288 1.835 . . . . 0.0 112.304 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.91 -170.79 30.68 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.645 1.117 . . . . 0.0 111.104 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -146.8 165.67 28.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 129.879 3.272 . . . . 0.0 109.698 -172.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.56 -170.29 38.43 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.505 1.05 . . . . 0.0 112.943 -171.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.56 3.04 7.18 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.617 2.878 . . . . 0.0 115.648 -171.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.522 ' HE2' ' CD2' ' A' ' 18' ' ' TRP . 1.6 ttpm? -98.19 11.69 36.98 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 119.534 1.061 . . . . 0.0 111.823 172.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.448 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 92.1 m-85 -147.24 -53.02 0.21 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.898 2.479 . . . . 0.0 110.179 -164.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 121.587 0.708 . . . . 0.0 111.797 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.3 m -64.0 154.84 32.95 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.689 0.796 . . . . 0.0 111.005 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.9 t -45.7 -67.21 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.987 1.715 . . . . 0.0 110.191 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -138.49 23.18 2.72 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.246 2.218 . . . . 0.0 110.907 139.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.78 -11.14 0.2 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.1 0.857 . . . . 0.0 114.957 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -105.89 165.69 11.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.561 1.944 . . . . 0.0 111.312 170.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.3 m -155.56 178.52 1.63 Allowed Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 127.079 2.152 . . . . 0.0 109.24 -170.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -57.54 178.71 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.941 3.761 . . . . 0.0 118.137 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.9 m -42.87 109.13 0.12 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 128.214 2.606 . . . . 0.0 114.0 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.19 29.12 74.51 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.235 -0.759 . . . . 0.0 114.041 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.72 168.7 0.4 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 170.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -132.73 106.27 7.66 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 113.377 -1.738 . . . . 0.0 108.712 147.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.1 t -54.68 117.48 3.41 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.336 -0.852 . . . . 0.0 110.569 170.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.427 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 10.8 t -64.95 164.1 13.29 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.05 0.94 . . . . 0.0 113.091 -175.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.554 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 18.1 mp0 -60.51 -18.92 55.04 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.672 1.989 . . . . 0.0 111.5 168.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 30.5 m0 -90.97 0.75 57.46 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.739 2.016 . . . . 0.0 113.391 172.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.98 25.21 69.73 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.858 -0.968 . . . . 0.0 114.24 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -120.01 152.69 37.12 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.909 1.684 . . . . 0.0 112.527 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.3 m -81.86 151.05 27.5 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.148 1.379 . . . . 0.0 113.072 -177.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.48 -165.23 32.86 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.539 2.018 . . . . 0.0 108.471 -174.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.75 160.79 42.85 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.588 1.955 . . . . 0.0 108.907 177.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.35 -169.81 26.59 Favored Glycine 0 CA--C 1.543 1.796 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 171.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -54.64 -10.13 2.23 Favored 'Trans proline' 0 CA--C 1.538 0.713 1 C-N-CA 126.101 4.534 . . . . 0.0 119.143 -170.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.501 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -119.14 12.34 12.63 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.87 1.214 . . . . 0.0 112.636 176.138 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 57.1 m-85 -129.96 -70.48 0.64 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 127.346 2.258 . . . . 0.0 108.085 -176.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.539 0.548 0 C-N-CA 124.111 0.964 . . . . 0.0 113.331 170.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.6 mp0 . . . . . 0 CA--C 1.542 0.656 0 CA-C-O 121.102 0.477 . . . . 0.0 112.213 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.9 m -69.51 156.76 38.37 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.794 -0.566 . . . . 0.0 110.774 163.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.4 t -49.18 -70.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.272 1.829 . . . . 0.0 109.613 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -141.92 17.28 2.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 127.717 2.407 . . . . 0.0 111.916 145.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 171.38 -17.84 0.06 OUTLIER Glycine 0 CA--C 1.532 1.106 0 N-CA-C 115.455 0.942 . . . . 0.0 115.455 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -121.76 179.43 4.49 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.136 1.374 . . . . 0.0 111.821 168.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.51 -173.51 0.36 Allowed Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 127.384 2.274 . . . . 0.0 109.105 173.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.02 151.97 15.17 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.063 2.508 . . . . 0.0 113.792 174.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.9 m -72.12 30.07 0.05 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 -159.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -130.45 -4.78 4.32 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 127.391 2.424 . . . . 0.0 115.029 165.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -179.67 0.15 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.055 2.542 . . . . 0.0 117.452 -176.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.07 96.08 2.83 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.493 1.117 . . . . 0.0 110.206 146.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.7 t -49.82 115.02 1.21 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.234 1.014 . . . . 0.0 111.899 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.6 t -70.04 152.56 44.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.81 1.244 . . . . 0.0 111.081 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -6.12 7.61 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 171.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -6.51 50.12 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.542 1.137 . . . . 0.0 113.159 163.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.96 23.94 60.76 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.996 0.816 . . . . 0.0 113.493 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -126.8 159.02 35.05 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.393 1.877 . . . . 0.0 112.467 -174.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.0 m -115.05 165.83 12.47 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.05 1.34 . . . . 0.0 113.218 -175.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.48 -170.65 24.33 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 -162.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -139.48 161.99 36.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.527 2.331 . . . . 0.0 109.872 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.27 -174.63 28.74 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 123.936 0.779 . . . . 0.0 113.35 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -57.96 -16.11 25.03 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 124.011 3.141 . . . . 0.0 117.551 -169.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.79 -7.14 59.53 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.544 1.066 . . . . 0.0 111.359 178.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -134.08 -58.76 0.85 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.991 2.116 . . . . 0.0 110.198 -160.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.0 m . . . . . 0 CA--C 1.539 0.546 0 C-N-CA 126.781 2.032 . . . . 0.0 113.008 -177.506 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.4 m -34.17 119.76 0.42 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 128.939 2.896 . . . . 0.0 112.406 -168.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.2 t 0.92 -85.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 130.18 3.392 . . . . 0.0 112.426 -160.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -130.94 32.59 4.3 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.608 2.363 . . . . 0.0 109.171 140.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 164.37 -11.96 0.08 OUTLIER Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.864 1.697 . . . . 0.0 115.76 172.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -121.94 174.46 6.88 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.333 1.853 . . . . 0.0 113.456 -172.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.1 m -150.58 175.74 2.67 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 126.912 2.085 . . . . 0.0 109.188 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -57.39 178.41 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 125.129 3.886 . . . . 0.0 118.577 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -50.52 120.14 4.39 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.647 1.579 . . . . 0.0 112.364 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.78 32.33 74.18 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 118.761 -1.022 . . . . 0.0 113.808 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.37 166.86 2.1 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 169.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.8 m -133.81 94.26 3.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.648 1.979 . . . . 0.0 107.421 152.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -50.42 113.3 0.85 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.868 0.867 . . . . 0.0 109.381 170.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.5 t -64.95 159.45 22.89 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.023 0.916 . . . . 0.0 112.53 -169.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.44 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -48.82 -26.1 2.22 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.903 2.481 . . . . 0.0 113.552 169.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -100.23 3.33 43.53 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.728 2.011 . . . . 0.0 112.664 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.31 8.61 58.6 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.955 -1.47 . . . . 0.0 115.661 169.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -118.59 158.67 24.99 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.617 2.209 . . . . 0.0 113.328 -172.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.5 m -89.47 156.07 18.9 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -167.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.56 -166.43 27.75 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 128.07 2.747 . . . . 0.0 109.596 -175.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.39 170.26 21.79 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.996 1.318 . . . . 0.0 110.895 163.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 126.69 172.19 13.25 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.612 1.577 . . . . 0.0 112.63 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.24 -23.03 16.85 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 124.575 3.517 . . . . 0.0 117.545 -169.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.8 -4.54 11.6 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.487 1.115 . . . . 0.0 113.607 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -76.36 -55.9 5.13 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.634 1.174 . . . . 0.0 109.23 155.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.4 m . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 125.499 1.52 . . . . 0.0 112.962 -179.205 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 . . . . . 0 CA--C 1.545 0.769 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 62.7 m -45.72 140.93 3.17 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.749 1.62 . . . . 0.0 112.091 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t -33.23 -67.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 127.931 2.492 . . . . 0.0 112.877 -155.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -124.16 19.66 9.07 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.402 1.881 . . . . 0.0 110.517 138.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.4 -19.2 0.81 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.732 1.158 . . . . 0.0 115.053 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.5 ptp85 -96.78 177.3 5.69 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.45 1.5 . . . . 0.0 111.559 172.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -137.57 169.37 13.25 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.798 1.239 . . . . 0.0 112.459 -172.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.23 167.99 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.613 3.542 . . . . 0.0 114.842 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 m -38.68 96.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.388 2.675 . . . . 0.0 114.628 -174.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.71 3.39 90.53 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 118.268 -1.296 . . . . 0.0 115.8 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.2 mmt -78.27 173.46 12.26 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 120.19 1.995 . . . . 0.0 112.716 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.9 m -119.3 136.28 54.32 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.609 2.364 . . . . 0.0 109.722 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.6 t -75.9 113.91 13.93 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.945 0.498 . . . . 0.0 109.738 166.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.455 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 9.2 t -62.35 151.28 37.2 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.996 0.903 . . . . 0.0 110.359 167.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.404 ' CD ' ' H ' ' A' ' 17' ' ' GLN . 17.8 mp0 -72.7 -4.93 34.24 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.557 1.543 . . . . 0.0 111.33 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -75.47 -11.19 59.98 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.486 1.914 . . . . 0.0 113.597 162.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.53 9.91 48.94 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.457 1.504 . . . . 0.0 115.195 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -131.07 147.18 52.59 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.928 1.864 . . . . 0.0 113.193 -171.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 82.6 m -82.99 149.51 26.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -169.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.02 -160.3 33.18 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.074 1.321 . . . . 0.0 111.827 176.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.6 tptt -135.94 162.1 33.78 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.395 1.478 . . . . 0.0 112.165 176.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.05 178.73 36.03 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.761 1.172 . . . . 0.0 113.862 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.34 19.29 0.53 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 125.271 3.981 . . . . 0.0 114.697 -170.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm -121.42 4.44 10.21 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.325 1.85 . . . . 0.0 111.616 169.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.455 ' CD2' ' HB2' ' A' ' 16' ' ' SER . 82.5 m-85 -130.14 -63.34 0.91 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.815 2.446 . . . . 0.0 108.876 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.1 m . . . . . 0 CA--C 1.545 0.76 0 C-N-CA 125.11 1.364 . . . . 0.0 113.56 174.245 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 CA--C 1.551 0.994 0 CA-C-O 123.018 1.39 . . . . 0.0 114.129 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 62.2 m -58.21 116.82 3.81 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.607 -1.308 . . . . 0.0 108.185 148.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -4.67 -81.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 131.056 3.742 . . . . 0.0 113.67 -160.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -129.27 22.38 5.63 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.114 2.165 . . . . 0.0 109.807 147.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.6 -14.38 0.07 OUTLIER Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.543 1.377 . . . . 0.0 116.543 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -125.38 179.74 4.97 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 120.046 1.923 . . . . 0.0 113.029 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.4 m -124.0 157.1 64.72 Favored Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 124.635 1.174 . . . . 0.0 109.496 169.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.42 150.63 88.02 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.05 1.833 . . . . 0.0 110.78 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.5 m -65.48 88.14 0.09 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.831 1.252 . . . . 0.0 112.326 -166.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.95 -17.04 3.22 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.1 1.809 . . . . 0.0 113.491 -173.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 mmt -94.59 170.75 9.24 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.724 1.609 . . . . 0.0 109.712 158.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -142.39 161.9 36.85 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.988 1.715 . . . . 0.0 110.906 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.5 t -103.91 115.87 31.24 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.939 1.695 . . . . 0.0 112.097 -166.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.494 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 7.7 t -77.87 167.88 20.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 122.302 1.049 . . . . 0.0 113.011 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.524 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 11.1 mp0 -65.29 -16.72 63.86 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.313 2.245 . . . . 0.0 112.108 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -74.72 -5.98 46.28 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.704 2.002 . . . . 0.0 112.98 170.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.72 23.01 65.4 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.941 -0.922 . . . . 0.0 113.532 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -131.06 153.8 48.91 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.541 1.536 . . . . 0.0 112.716 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 74.5 m -84.17 160.99 20.73 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.597 1.159 . . . . 0.0 113.785 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.28 -158.8 31.88 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.919 2.199 . . . . 0.0 107.88 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -138.32 158.57 44.03 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.788 1.235 . . . . 0.0 110.8 -177.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.88 -178.14 40.55 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 123.962 0.791 . . . . 0.0 113.912 172.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.78 -13.51 6.17 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 125.07 3.847 . . . . 0.0 118.032 -167.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -96.94 -8.77 29.86 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.808 1.185 . . . . 0.0 111.956 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.494 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 92.1 m-85 -120.5 -41.79 2.58 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 128.335 2.654 . . . . 0.0 110.397 -174.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.6 m . . . . . 0 CA--C 1.547 0.84 0 C-N-CA 126.708 2.003 . . . . 0.0 112.555 179.962 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.2 m -46.78 142.16 3.51 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.796 1.638 . . . . 0.0 112.23 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.6 t -18.73 -76.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 129.555 3.142 . . . . 0.0 113.139 -163.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -124.08 25.61 7.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.173 2.189 . . . . 0.0 109.924 140.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.97 -6.39 2.04 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.482 1.515 . . . . 0.0 114.779 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -112.08 -177.92 3.29 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 127.683 2.393 . . . . 0.0 111.58 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -160.93 172.55 5.69 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 126.249 1.82 . . . . 0.0 109.59 169.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.49 178.97 6.93 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.158 2.572 . . . . 0.0 113.851 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.5 t 9.99 87.82 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 130.46 3.504 . . . . 0.0 116.06 169.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.48 34.25 74.82 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.3 0.953 . . . . 0.0 114.789 171.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.08 167.0 4.22 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 169.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.7 m -132.76 94.64 3.43 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.07 156.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -51.2 107.35 0.18 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.859 0.863 . . . . 0.0 110.734 160.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.2 p -64.79 164.55 12.08 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.709 1.204 . . . . 0.0 112.873 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.76 -21.22 60.46 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.0 0.92 . . . . 0.0 112.44 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -74.25 -10.54 59.7 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.806 1.642 . . . . 0.0 112.607 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.61 12.84 63.98 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.477 1.037 . . . . 0.0 113.802 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -124.86 142.49 51.41 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.841 1.32 . . . . 0.0 111.676 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.8 m -81.02 162.34 23.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.473 1.109 . . . . 0.0 113.289 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.86 -161.02 34.84 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 127.685 2.564 . . . . 0.0 106.857 -175.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.56 167.53 23.48 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.564 1.546 . . . . 0.0 109.309 173.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.47 -176.07 39.69 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 123.851 0.738 . . . . 0.0 114.52 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.69 9.2 0.79 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 124.83 3.686 . . . . 0.0 115.817 -165.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 tpmp? -125.64 6.8 7.52 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.287 0.949 . . . . 0.0 113.017 170.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -124.62 -54.41 1.66 Allowed 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 126.487 1.915 . . . . 0.0 109.729 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.6 m . . . . . 0 CA--C 1.536 0.408 0 C-N-CA 124.101 0.96 . . . . 0.0 109.527 164.811 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 . . . . . 0 CA--C 1.545 0.787 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.5 m -43.52 138.33 2.52 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.439 1.896 . . . . 0.0 111.732 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.8 t -28.36 -71.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 128.832 2.853 . . . . 0.0 113.101 -154.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -122.57 19.58 10.37 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.254 1.821 . . . . 0.0 110.402 140.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.18 -20.97 0.29 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.42 1.009 . . . . 0.0 114.857 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -106.42 177.68 4.78 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 124.962 1.305 . . . . 0.0 112.335 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.482 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 53.7 m -142.25 179.81 1.13 Allowed Pre-proline 0 CA--C 1.559 1.321 0 C-N-CA 125.957 1.703 . . . . 0.0 110.353 -174.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 74.4 Cg_endo -75.97 -173.06 1.52 Allowed 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 123.676 2.917 . . . . 0.0 115.42 -177.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.1 m -41.68 108.08 0.09 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.549 2.74 . . . . 0.0 114.688 -174.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.72 29.64 75.03 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.088 0.851 . . . . 0.0 113.864 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.99 172.63 0.94 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 171.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.86 115.75 9.24 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 113.15 -1.841 . . . . 0.0 109.665 148.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.7 t -62.95 113.11 2.89 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.658 -1.276 . . . . 0.0 110.537 172.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.416 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 77.3 p -61.36 162.02 8.42 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.327 1.051 . . . . 0.0 112.778 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -71.2 -15.95 62.49 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 53.4 m0 -75.0 -9.32 58.42 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.017 1.727 . . . . 0.0 112.603 167.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.78 16.4 51.85 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.459 -1.19 . . . . 0.0 114.447 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -124.42 148.62 47.48 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.693 1.746 . . . . 0.0 112.772 -175.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 67.1 m -73.11 154.41 40.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.551 1.54 . . . . 0.0 113.259 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.26 -168.15 37.14 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.806 1.67 . . . . 0.0 109.07 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -142.01 149.6 40.22 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.754 2.022 . . . . 0.0 109.537 -175.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.76 -171.52 30.37 Favored Glycine 0 CA--C 1.542 1.78 0 N-CA-C 114.829 0.692 . . . . 0.0 114.829 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.64 -14.28 7.17 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 125.126 3.884 . . . . 0.0 118.231 -170.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -99.38 7.03 45.88 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.02 1.328 . . . . 0.0 111.693 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 90.1 m-85 -141.94 -64.31 0.43 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.875 2.07 . . . . 0.0 109.317 -167.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.3 m . . . . . 0 CA--C 1.538 0.498 0 C-N-CA 127.341 2.256 . . . . 0.0 111.963 173.584 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 121.585 0.707 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.7 m -52.92 128.86 28.5 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 118.275 -0.869 . . . . 0.0 108.917 163.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.5 t -13.39 -79.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 129.39 3.076 . . . . 0.0 113.216 -157.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -123.8 27.67 7.19 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 127.252 2.221 . . . . 0.0 109.564 139.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.32 -2.74 0.1 OUTLIER Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.222 1.391 . . . . 0.0 116.189 176.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.6 mmt-85 -129.38 -177.46 4.26 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.157 1.783 . . . . 0.0 112.991 -172.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.2 m -143.67 158.79 56.06 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 125.073 1.349 . . . . 0.0 111.051 173.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.27 170.42 20.05 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.51 2.806 . . . . 0.0 112.947 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.6 m -44.97 99.85 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.836 2.455 . . . . 0.0 114.412 -173.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.31 -8.89 62.77 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.864 1.221 . . . . 0.0 114.899 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 45.5 mtt -90.81 164.73 13.97 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.872 1.269 . . . . 0.0 110.426 165.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.8 m -145.4 158.17 43.89 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.232 1.013 . . . . 0.0 111.805 -174.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.7 t -85.28 115.77 23.23 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.192 0.997 . . . . 0.0 111.274 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.43 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 96.4 p -70.94 165.41 23.42 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.342 1.068 . . . . 0.0 113.142 175.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.561 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 6.1 mp0 -60.33 -17.23 41.62 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.513 1.925 . . . . 0.0 113.049 175.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -80.13 -7.97 59.18 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.276 1.431 . . . . 0.0 113.277 172.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.62 13.09 83.85 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 118.701 0.682 . . . . 0.0 113.124 -168.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -105.84 141.77 36.69 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.917 1.687 . . . . 0.0 111.486 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.0 t -82.68 157.33 23.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.236 0.615 . . . . 0.0 112.089 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.63 -172.51 42.5 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.788 0.709 . . . . 0.0 112.917 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -134.17 132.52 39.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.311 1.845 . . . . 0.0 106.754 -174.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.0 179.31 15.86 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.314 0.959 . . . . 0.0 112.295 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.75 0.83 5.07 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.934 2.422 . . . . 0.0 115.846 -171.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -95.8 -8.53 34.05 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.532 1.133 . . . . 0.0 111.614 172.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 98.9 m-85 -124.03 -53.16 1.75 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.758 2.423 . . . . 0.0 110.436 -169.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 32.7 m . . . . . 0 CA--C 1.536 0.422 0 C-N-CA 127.084 2.154 . . . . 0.0 114.23 -164.687 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.624 0 CA-C-O 120.983 0.421 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 41.7 m -53.55 146.23 13.34 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.4 1.88 . . . . 0.0 112.012 -175.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.5 t -44.93 -62.43 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.576 1.951 . . . . 0.0 111.334 -160.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.549 ' HE ' ' HA ' ' A' ' 6' ' ' ARG . 1.7 mmp_? -135.8 29.31 3.19 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.84 1.656 . . . . 0.0 110.259 129.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.27 -35.97 0.24 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.917 0.77 . . . . 0.0 114.555 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -88.41 177.09 6.92 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.703 1.252 . . . . 0.0 111.162 172.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.0 m -127.69 172.92 6.03 Favored Pre-proline 0 C--O 1.24 0.595 0 C-N-CA 125.035 1.334 . . . . 0.0 110.856 176.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.57 150.24 8.93 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.988 2.459 . . . . 0.0 112.196 171.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.5 m -67.89 79.94 0.21 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.325 1.45 . . . . 0.0 112.624 -166.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 144.14 -17.64 2.12 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.627 2.06 . . . . 0.0 113.94 -175.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.6 mtt -84.56 178.77 7.58 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.552 1.676 . . . . 0.0 112.728 174.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.7 m -129.03 146.85 50.9 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.767 2.427 . . . . 0.0 110.278 173.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.8 t -88.69 111.64 22.19 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.761 1.625 . . . . 0.0 111.039 173.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 t -67.38 155.98 37.62 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.824 0.85 . . . . 0.0 111.217 172.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -9.81 48.28 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.794 -1.191 . . . . 0.0 114.138 176.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.509 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 54.0 m0 -70.08 -5.17 24.92 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.833 1.253 . . . . 0.0 113.001 164.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.29 14.36 68.98 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.043 1.306 . . . . 0.0 113.759 176.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -120.81 154.22 36.04 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.869 1.668 . . . . 0.0 113.053 -175.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 94.3 m -93.34 147.41 22.96 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.012 1.325 . . . . 0.0 113.848 -174.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.25 -161.61 32.59 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.215 0.912 . . . . 0.0 112.071 176.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.7 tptt -134.24 167.54 20.5 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.835 1.654 . . . . 0.0 111.763 172.399 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.91 172.78 36.01 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.994 1.283 . . . . 0.0 112.569 -174.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.77 4.19 3.27 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.842 3.028 . . . . 0.0 114.967 -170.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.509 ' HE3' ' CE2' ' A' ' 18' ' ' TRP . 1.7 tmtm? -109.14 3.71 22.18 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.066 1.303 . . . . 0.0 111.906 171.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -122.91 -41.22 2.36 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 126.333 1.853 . . . . 0.0 110.466 178.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 m . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 124.691 1.196 . . . . 0.0 113.592 173.764 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 CA--C 1.539 0.521 0 CA-C-O 122.028 0.918 . . . . 0.0 111.974 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.6 m -69.0 164.89 21.32 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.886 1.274 . . . . 0.0 111.45 176.291 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.0 t -47.14 -68.32 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 125.762 1.625 . . . . 0.0 110.072 -176.192 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -139.64 19.15 2.52 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.145 2.178 . . . . 0.0 111.599 142.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.01 -14.18 0.07 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 115.656 1.023 . . . . 0.0 115.656 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -121.54 177.55 5.18 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.344 1.458 . . . . 0.0 112.12 170.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.93 -178.02 0.74 Allowed Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 126.593 1.957 . . . . 0.0 109.799 174.218 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -83.05 -174.85 2.16 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.769 2.979 . . . . 0.0 112.745 173.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.5 m 21.85 79.59 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 129.96 3.304 . . . . 0.0 116.39 161.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.2 18.68 71.43 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 115.638 1.015 . . . . 0.0 115.638 168.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.59 167.23 1.53 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 174.064 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.0 m -134.73 96.19 3.5 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 113.015 -1.902 . . . . 0.0 108.024 154.114 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -50.78 110.96 0.47 Allowed 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.559 -0.713 . . . . 0.0 111.655 168.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.416 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 43.9 t -67.09 137.29 56.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.16 1.384 . . . . 0.0 109.357 174.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -6.48 4.96 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -166.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -69.45 -9.91 55.72 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.465 1.106 . . . . 0.0 112.998 165.347 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.38 18.17 24.6 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.902 1.715 . . . . 0.0 113.932 -177.059 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -122.95 145.06 48.81 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.686 1.243 . . . . 0.0 114.04 -166.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.1 t -100.98 152.93 19.98 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.554 1.142 . . . . 0.0 113.347 -162.24 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.79 -162.78 30.58 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 127.286 2.374 . . . . 0.0 110.054 -171.017 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.22 170.69 20.65 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.811 1.644 . . . . 0.0 110.394 169.339 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.26 -176.91 25.89 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.939 1.257 . . . . 0.0 112.651 -177.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.95 -10.75 30.02 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.009 2.473 . . . . 0.0 114.915 -173.003 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.37 -13.94 59.82 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.494 1.043 . . . . 0.0 111.221 170.029 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.416 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 11.8 m-85 -128.98 -49.89 1.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.336 1.454 . . . . 0.0 110.932 -154.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.6 m . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 124.619 1.167 . . . . 0.0 112.83 169.993 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 121.425 0.631 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 m -61.73 138.51 58.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.921 0.488 . . . . 0.0 109.762 173.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -45.38 -66.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.643 1.977 . . . . 0.0 110.941 -162.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -133.58 25.09 4.07 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.991 1.716 . . . . 0.0 110.957 137.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.08 -34.43 0.26 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.019 0.819 . . . . 0.0 113.852 176.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -88.95 173.19 8.62 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 118.665 1.233 . . . . 0.0 112.364 174.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 19.4 m -148.35 179.74 1.12 Allowed Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 127.902 2.481 . . . . 0.0 108.444 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 49.7 Cg_endo -70.15 -175.25 1.18 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 123.685 2.923 . . . . 0.0 115.996 -178.128 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.8 m -44.11 108.04 0.1 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 128.598 2.759 . . . . 0.0 114.418 -173.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.08 29.75 75.59 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.87 0.748 . . . . 0.0 113.747 179.114 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.79 170.84 0.55 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 170.314 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.8 104.39 5.49 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 113.511 -1.677 . . . . 0.0 109.004 153.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -56.7 112.05 1.19 Allowed 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.288 -0.883 . . . . 0.0 110.719 173.006 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.483 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 81.0 p -73.56 168.07 20.05 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -173.362 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.541 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 1.4 mp0 -57.68 -20.04 31.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.544 1.938 . . . . 0.0 112.866 170.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.52 -4.32 55.63 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.257 1.423 . . . . 0.0 112.484 174.204 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.7 20.56 79.72 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.226 -0.763 . . . . 0.0 112.9 -170.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -120.24 144.89 47.52 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.028 1.731 . . . . 0.0 112.447 -175.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.9 m -73.34 155.48 39.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.428 1.491 . . . . 0.0 112.92 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.64 -169.38 33.43 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 126.132 1.825 . . . . 0.0 109.082 -177.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -145.29 159.58 42.82 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.417 2.287 . . . . 0.0 108.907 -175.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.44 -169.46 33.01 Favored Glycine 0 CA--C 1.539 1.588 0 N-CA-C 114.414 0.526 . . . . 0.0 114.414 173.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.66 -1.04 6.85 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 124.08 3.187 . . . . 0.0 116.733 -162.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.11 1.8 24.45 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.34 0.973 . . . . 0.0 112.71 170.427 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.483 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 86.3 m-85 -129.26 -57.08 1.16 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.47 1.908 . . . . 0.0 109.699 -167.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.614 0 C-N-CA 124.406 1.083 . . . . 0.0 113.555 169.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 . . . . . 0 N--CA 1.469 0.495 0 CA-C-O 121.101 0.477 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.2 m -64.85 147.33 53.47 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.043 -0.411 . . . . 0.0 109.943 174.394 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.2 t -48.81 -67.1 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.725 1.21 . . . . 0.0 110.212 -174.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -137.19 23.72 3.0 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.123 2.169 . . . . 0.0 111.023 139.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.28 -28.8 0.34 Allowed Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.226 1.393 . . . . 0.0 113.33 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.46 151.29 42.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 117.928 0.864 . . . . 0.0 111.921 169.381 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.2 m -149.85 171.0 6.83 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 128.504 2.722 . . . . 0.0 109.792 -176.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.78 -176.25 2.9 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.986 3.124 . . . . 0.0 115.501 -173.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.8 t -45.32 119.7 2.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.97 1.708 . . . . 0.0 113.626 -173.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.37 29.59 75.0 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.352 0.977 . . . . 0.0 114.26 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.01 168.56 0.12 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 173.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -132.26 144.92 50.95 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 112.947 -1.933 . . . . 0.0 110.137 122.505 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 32.5 t -85.33 117.7 24.42 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.898 1.279 . . . . 0.0 109.356 168.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 t -65.9 153.2 42.66 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.328 0.651 . . . . 0.0 111.967 177.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -16.79 14.82 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.211 1.004 . . . . 0.0 112.518 167.42 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 27.8 m95 -76.24 -8.26 56.67 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.417 1.887 . . . . 0.0 113.119 172.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.92 14.15 61.31 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.467 1.032 . . . . 0.0 114.686 178.446 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -123.71 147.58 47.33 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.258 1.423 . . . . 0.0 112.804 -176.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 65.4 m -81.87 152.1 27.0 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.816 1.646 . . . . 0.0 112.349 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.9 -154.53 21.98 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 178.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 159.2 44.04 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.535 1.534 . . . . 0.0 109.613 176.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.54 -178.15 52.58 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 123.722 0.677 . . . . 0.0 113.489 178.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.73 2.02 2.8 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.469 3.446 . . . . 0.0 116.218 -166.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.73 -6.15 46.8 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 123.11 1.433 . . . . 0.0 111.031 172.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -132.01 -49.25 0.94 Allowed 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 127.919 2.488 . . . . 0.0 109.919 -169.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 67.3 m . . . . . 0 CA--C 1.548 0.886 0 C-N-CA 126.646 1.978 . . . . 0.0 112.013 167.991 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 118.463 -0.779 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.35 4.2 82.18 Favored Glycine 0 CA--C 1.534 1.273 0 N-CA-C 116.268 1.267 . . . . 0.0 116.268 -170.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 3.2 pm0 -55.05 150.31 10.66 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.605 1.203 . . . . 0.0 112.62 174.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 97.9 m -38.96 127.56 1.61 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 128.486 2.715 . . . . 0.0 112.129 -173.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.5 t 1.34 -85.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 130.191 3.396 . . . . 0.0 112.192 -159.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -130.98 30.04 4.63 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.345 2.258 . . . . 0.0 109.771 142.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.97 -15.86 0.04 OUTLIER Glycine 0 CA--C 1.536 1.375 0 N-CA-C 116.656 1.422 . . . . 0.0 116.656 168.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -133.18 174.49 10.32 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 119.937 1.869 . . . . 0.0 113.662 -173.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.0 m -97.46 166.76 13.06 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.322 1.049 . . . . 0.0 111.638 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -50.68 149.58 13.68 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.94 2.427 . . . . 0.0 111.4 157.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.6 m -68.25 80.06 0.24 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.209 1.403 . . . . 0.0 111.583 -174.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 150.22 -14.81 0.98 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.723 1.63 . . . . 0.0 114.428 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.7 mtt -106.27 174.91 5.68 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.905 1.853 . . . . 0.0 111.754 175.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.5 m -126.27 130.4 50.81 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.389 1.876 . . . . 0.0 111.374 -172.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.9 t -84.0 114.82 21.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.467 0.707 . . . . 0.0 110.57 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.2 p -66.4 163.95 17.24 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -5.4 21.72 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 169.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.79 -8.87 58.61 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.152 0.887 . . . . 0.0 112.321 163.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.07 4.44 90.25 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.626 1.108 . . . . 0.0 113.701 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -109.82 148.95 30.56 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.098 1.359 . . . . 0.0 110.784 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.1 t -91.59 150.41 21.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.749 1.22 . . . . 0.0 113.153 -169.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.57 -156.69 24.59 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.01 0.814 . . . . 0.0 113.548 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -139.6 161.32 37.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.468 1.907 . . . . 0.0 112.153 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.2 -179.96 51.77 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.802 1.191 . . . . 0.0 112.798 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.7 -1.6 8.71 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.125 2.55 . . . . 0.0 115.802 -166.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.59 -6.04 58.48 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.194 0.998 . . . . 0.0 110.798 171.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -138.15 -53.47 0.63 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.104 1.762 . . . . 0.0 111.479 -165.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 63.9 m -90.7 -9.3 47.28 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.625 1.57 . . . . 0.0 113.746 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.09 -3.38 22.05 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 124.394 0.997 . . . . 0.0 114.692 -170.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.106 0 C-N-CA 128.451 2.7 . . . . 0.0 109.561 174.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.02 2.88 55.97 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.325 0.964 . . . . 0.0 114.288 -172.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -58.66 147.99 30.76 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.454 1.502 . . . . 0.0 111.352 174.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.3 m -62.63 135.72 57.52 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.947 0.88 . . . . 0.0 111.483 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.46 69.88 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.782 1.633 . . . . 0.0 110.381 -164.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 47.97 25.31 0.75 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.864 -155.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 128.84 -13.95 6.05 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.582 1.086 . . . . 0.0 115.544 162.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.79 171.77 7.34 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.198 1.799 . . . . 0.0 110.79 175.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 67.8 m -145.25 153.96 53.16 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.567 0.747 . . . . 0.0 112.157 -169.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.42 172.93 15.34 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.94 3.094 . . . . 0.0 112.229 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.6 m 42.4 41.69 2.34 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.603 1.961 . . . . 0.0 115.495 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.61 26.84 17.08 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.807 1.67 . . . . 0.0 114.438 -174.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.1 mtt -70.0 170.79 10.62 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.782 1.291 . . . . 0.0 110.76 172.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -122.77 140.52 52.81 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.027 1.731 . . . . 0.0 110.448 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t -71.56 116.94 12.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.488 1.115 . . . . 0.0 110.868 173.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.432 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 78.8 p -70.52 161.77 30.01 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.518 1.127 . . . . 0.0 113.133 172.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -14.67 9.49 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.415 1.486 . . . . 0.0 114.212 166.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -78.5 -11.76 59.97 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.238 1.015 . . . . 0.0 113.047 170.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.6 16.68 67.84 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-N 118.674 0.67 . . . . 0.0 113.732 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -119.32 143.63 47.28 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.576 1.551 . . . . 0.0 111.977 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.5 m -77.4 151.94 34.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.598 1.159 . . . . 0.0 112.663 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.6 -170.41 43.49 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.656 1.122 . . . . 0.0 111.24 174.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -119.4 145.65 46.04 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.698 1.199 . . . . 0.0 111.061 -173.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.98 -173.88 24.84 Favored Glycine 0 CA--C 1.542 1.74 0 N-CA-C 115.932 1.133 . . . . 0.0 115.932 166.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -71.88 12.53 0.57 Allowed 'Trans proline' 0 CA--C 1.541 0.847 1 C-N-CA 125.881 4.387 . . . . 0.0 116.282 -161.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.59 -11.87 6.71 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 167.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 75.8 m-85 -88.26 -58.06 2.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.501 1.52 . . . . 0.0 109.272 168.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.9 m -78.41 -45.47 22.26 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.572 1.949 . . . . 0.0 110.872 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.17 110.85 3.64 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 167.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? . . . . . 0 C--O 1.249 1.067 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -158.716 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.25 23.62 8.04 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.848 1.213 . . . . 0.0 114.599 -175.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.9 mp0 -60.88 145.31 50.64 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.222 1.409 . . . . 0.0 112.079 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.1 m -62.88 131.28 48.22 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.161 0.981 . . . . 0.0 110.458 168.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.09 77.36 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 128.746 2.819 . . . . 0.0 109.893 -169.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 52.94 1.32 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.99 1.716 . . . . 0.0 114.532 -158.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.47 -20.71 0.93 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-O 118.264 -1.298 . . . . 0.0 114.285 174.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -90.48 170.38 10.26 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 119.453 1.626 . . . . 0.0 111.875 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.7 m -141.73 -179.73 1.04 Allowed Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 126.245 1.818 . . . . 0.0 107.935 174.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.79 152.1 18.11 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.96 2.44 . . . . 0.0 113.997 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.7 m -68.38 93.25 0.47 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.724 0.81 . . . . 0.0 111.302 -172.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.19 -8.95 4.12 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 126.021 1.772 . . . . 0.0 114.287 -169.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.55 176.04 0.1 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 129.468 3.107 . . . . 0.0 118.413 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.7 m -135.85 111.95 9.66 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.728 2.011 . . . . 0.0 108.476 143.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.0 t -60.92 116.92 4.84 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.15 -0.969 . . . . 0.0 110.239 169.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.1 p -68.08 159.18 31.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.828 0.851 . . . . 0.0 113.183 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -54.2 -27.26 33.04 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.52 1.128 . . . . 0.0 112.581 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.452 ' CZ2' ' HE2' ' A' ' 26' ' ' LYS . 34.1 m0 -76.47 -2.53 32.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.593 1.557 . . . . 0.0 112.253 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.89 23.08 67.52 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.295 -0.725 . . . . 0.0 112.686 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.41 148.4 44.45 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.6 1.56 . . . . 0.0 112.695 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.4 m -86.51 153.29 21.96 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.07 1.748 . . . . 0.0 114.247 -178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.05 -161.92 31.87 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 127.044 2.259 . . . . 0.0 110.556 -177.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.11 157.95 43.79 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.846 2.458 . . . . 0.0 108.37 174.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.24 -174.68 18.43 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.809 1.195 . . . . 0.0 113.154 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.46 -14.8 40.73 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.95 2.434 . . . . 0.0 114.29 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.452 ' HE2' ' CZ2' ' A' ' 18' ' ' TRP . 7.3 tptp -78.87 -4.22 48.58 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.172 1.389 . . . . 0.0 111.832 174.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -137.32 -54.92 0.7 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.537 1.535 . . . . 0.0 110.684 -158.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.2 m -81.83 -4.99 57.81 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.156 1.382 . . . . 0.0 113.191 169.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.2 -82.62 0.46 Allowed Glycine 0 C--N 1.343 0.935 0 C-N-CA 124.955 1.264 . . . . 0.0 112.972 -172.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.601 -172.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.84 7.4 61.37 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 119.225 -0.764 . . . . 0.0 114.299 -173.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -60.55 150.44 31.56 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.301 1.44 . . . . 0.0 111.45 172.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 m -66.0 146.66 54.43 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.605 -0.684 . . . . 0.0 111.262 170.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.1 t -50.73 -69.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.093 1.757 . . . . 0.0 109.73 -173.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -138.41 21.67 2.75 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 127.591 2.356 . . . . 0.0 111.201 142.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.62 -24.36 0.3 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.856 1.217 . . . . 0.0 113.809 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.3 169.86 14.25 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.476 1.11 . . . . 0.0 112.837 165.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.1 m -137.39 176.39 2.79 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 128.733 2.813 . . . . 0.0 108.845 173.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -52.88 168.82 0.43 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.653 2.902 . . . . 0.0 115.431 175.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.9 p -54.69 106.03 0.19 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.261 1.824 . . . . 0.0 111.632 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.57 9.18 64.95 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.402 -1.221 . . . . 0.0 114.578 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 54.0 mtt -110.92 166.93 10.64 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.364 1.466 . . . . 0.0 112.067 172.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.7 m -134.32 143.35 47.65 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.906 2.082 . . . . 0.0 111.006 -173.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.6 t -84.81 115.81 22.94 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.626 1.57 . . . . 0.0 111.793 177.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.1 t -70.72 159.49 34.38 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 172.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -48.35 -24.22 1.16 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.555 2.342 . . . . 0.0 113.538 168.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -83.55 -4.47 58.58 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.132 1.773 . . . . 0.0 113.172 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.42 13.05 68.75 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.102 0.858 . . . . 0.0 114.433 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -122.0 153.33 38.71 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.677 1.591 . . . . 0.0 112.336 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.4 m -88.39 158.13 18.49 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.557 1.543 . . . . 0.0 113.426 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.22 -165.1 38.01 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -137.37 163.82 30.1 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.859 0.863 . . . . 0.0 111.185 -175.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.34 -170.25 52.16 Favored Glycine 0 CA--C 1.539 1.547 0 N-CA-C 114.756 0.663 . . . . 0.0 114.756 172.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.35 13.4 0.55 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 124.708 3.605 . . . . 0.0 115.469 -166.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.47 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -125.27 9.95 7.99 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.363 1.065 . . . . 0.0 112.44 169.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -138.69 -50.78 0.55 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 125.749 1.62 . . . . 0.0 110.862 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.1 m -73.2 -43.76 60.81 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.759 0.824 . . . . 0.0 109.026 161.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.94 63.96 2.36 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 157.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.3 0.0 OUTLIER . . . . . 0 C--O 1.253 1.287 0 C-N-CA 128.489 2.715 . . . . 0.0 117.396 -164.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.95 -7.03 53.56 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 129.117 3.246 . . . . 0.0 114.935 -1.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 57.45 -176.66 0.06 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.506 1.522 . . . . 0.0 112.263 -170.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 41.2 m -65.23 102.27 0.64 Allowed 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.529 -1.357 . . . . 0.0 108.003 157.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -4.57 -88.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 130.641 3.577 . . . . 0.0 112.515 -156.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 67.9 mmt-85 -130.16 41.19 3.44 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.051 0.941 . . . . 0.0 109.526 143.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 157.67 -10.12 0.23 Allowed Glycine 0 CA--C 1.534 1.25 0 N-CA-C 116.254 1.262 . . . . 0.0 116.254 163.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -121.65 178.79 4.69 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 119.839 1.819 . . . . 0.0 112.883 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 39.8 m -127.59 166.78 21.05 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 124.651 1.18 . . . . 0.0 110.586 173.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.67 149.85 13.19 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.432 2.755 . . . . 0.0 112.537 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.7 m -69.49 76.27 0.4 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.542 1.537 . . . . 0.0 111.682 -171.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.38 -17.07 1.14 Allowed Glycine 0 CA--C 1.537 1.432 0 C-N-CA 126.249 1.881 . . . . 0.0 114.231 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.1 mtt -86.43 -168.59 2.29 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.674 1.737 . . . . 0.0 112.261 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.76 160.9 41.08 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.651 2.381 . . . . 0.0 110.159 162.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.1 t -98.24 120.78 39.24 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.402 1.881 . . . . 0.0 112.044 -173.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.466 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 13.1 t -76.43 159.19 30.67 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -7.92 7.07 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 160.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -71.59 -10.34 59.62 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.38 1.072 . . . . 0.0 112.436 164.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.63 13.8 82.0 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.492 1.044 . . . . 0.0 113.723 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -130.27 164.12 25.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.444 1.898 . . . . 0.0 111.495 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 78.0 m -94.32 158.24 15.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.823 1.249 . . . . 0.0 113.83 -172.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.57 -156.18 26.92 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.175 1.369 . . . . 0.0 111.102 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.7 tptt -138.34 164.47 29.21 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.839 1.656 . . . . 0.0 111.662 171.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.06 -176.18 31.59 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 124.119 0.866 . . . . 0.0 114.263 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.31 18.57 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.861 1 C-N-CA 125.745 4.296 . . . . 0.0 115.087 -168.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.49 6.46 6.92 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.889 1.276 . . . . 0.0 112.447 170.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.466 ' CD2' ' HB2' ' A' ' 16' ' ' SER . 96.3 m-85 -134.28 -48.88 0.78 Allowed 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 128.049 2.54 . . . . 0.0 109.911 -176.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.1 m -95.25 5.54 51.46 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.696 1.598 . . . . 0.0 111.565 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.11 156.71 26.88 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.524 2.011 . . . . 0.0 110.353 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 C-N-CA 125.238 1.415 . . . . 0.0 112.251 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 118.146 -0.931 . . . . 0.0 113.046 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.25 -0.57 0.29 Allowed Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.429 1.014 . . . . 0.0 115.627 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -60.13 165.25 3.52 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 127.682 2.393 . . . . 0.0 113.66 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.5 m -47.18 140.9 4.83 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.032 1.733 . . . . 0.0 112.094 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.8 t -30.44 -70.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 128.377 2.671 . . . . 0.0 112.908 -152.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -123.01 21.12 9.87 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.194 1.798 . . . . 0.0 110.415 138.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.07 -21.34 0.5 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.975 1.274 . . . . 0.0 114.985 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -98.78 -178.29 3.92 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.188 1.395 . . . . 0.0 111.971 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.9 m -130.95 170.43 11.24 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.737 1.215 . . . . 0.0 112.026 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.98 177.0 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 125.231 3.954 . . . . 0.0 115.386 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.7 p -53.86 90.83 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.107 2.163 . . . . 0.0 113.764 -174.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.77 -1.52 75.12 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.255 1.407 . . . . 0.0 114.661 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.29 170.27 16.87 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.369 1.585 . . . . 0.0 110.795 175.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.1 m -134.4 137.3 43.96 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.532 1.533 . . . . 0.0 110.805 -168.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 32.2 t -86.83 115.39 24.22 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.14 1.376 . . . . 0.0 110.865 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.4 t -74.44 164.88 26.08 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.628 0.728 . . . . 0.0 112.745 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -45.44 -23.13 0.18 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.948 2.499 . . . . 0.0 114.373 158.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -66.6 -16.67 64.35 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.621 1.568 . . . . 0.0 112.54 173.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.18 10.11 86.47 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.629 1.109 . . . . 0.0 113.14 -167.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -121.4 153.57 37.65 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.88 1.672 . . . . 0.0 111.269 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.1 m -84.01 155.5 22.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.116 0.967 . . . . 0.0 113.58 -177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.52 -155.44 15.77 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.142 1.829 . . . . 0.0 110.244 174.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -145.02 161.68 38.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.706 1.602 . . . . 0.0 109.965 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.79 -172.38 35.53 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.486 0.954 . . . . 0.0 115.486 172.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.19 -0.7 0.68 Allowed 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 126.11 4.54 . . . . 0.0 117.96 -172.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.486 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -125.74 9.74 7.68 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.39 0.995 . . . . 0.0 112.636 175.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -136.91 -47.07 0.59 Allowed 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 125.218 1.407 . . . . 0.0 112.409 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.38 -33.77 28.61 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.153 0.433 . . . . 0.0 110.432 159.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.15 64.2 1.65 Allowed Glycine 0 CA--C 1.532 1.15 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 151.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 C-N-CA 127.227 2.211 . . . . 0.0 115.544 -162.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.86 -7.1 58.92 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.34 1.448 . . . . 0.0 115.109 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.24 160.01 5.49 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.748 1.274 . . . . 0.0 111.854 173.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.9 m -57.45 138.67 54.78 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 157.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.2 t -31.88 -68.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 128.261 2.624 . . . . 0.0 112.461 -158.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -123.32 19.11 9.8 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.491 1.916 . . . . 0.0 110.423 134.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.23 -26.78 0.32 Allowed Glycine 0 CA--C 1.54 1.597 0 C-N-CA 125.309 1.433 . . . . 0.0 114.806 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -85.23 -179.01 6.91 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.748 1.619 . . . . 0.0 111.633 172.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.7 m -134.49 142.66 43.59 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.158 0.983 . . . . 0.0 111.258 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -80.4 174.89 10.78 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.764 2.976 . . . . 0.0 111.584 172.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.1 m 37.74 46.99 0.78 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 127.672 2.389 . . . . 0.0 115.599 167.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.03 11.3 54.61 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-O 118.346 -1.252 . . . . 0.0 115.843 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.3 mmt -72.68 172.28 10.98 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.264 2.032 . . . . 0.0 112.206 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m -122.12 137.67 54.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.935 2.094 . . . . 0.0 111.006 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -86.87 117.77 25.82 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.945 0.898 . . . . 0.0 111.309 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.0 p -75.26 159.81 31.09 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.309 1.044 . . . . 0.0 113.29 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -59.2 -13.58 7.99 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.031 1.732 . . . . 0.0 113.961 167.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.474 ' CZ2' ' HE3' ' A' ' 26' ' ' LYS . 6.0 m95 -75.56 -9.33 58.48 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.838 1.255 . . . . 0.0 112.45 171.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.93 9.82 86.66 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.064 0.84 . . . . 0.0 113.106 -169.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -107.49 145.83 32.58 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.655 1.582 . . . . 0.0 111.872 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.9 t -96.42 143.83 27.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.238 1.015 . . . . 0.0 111.691 -175.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.68 -160.42 29.63 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.891 -0.506 . . . . 0.0 112.918 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -132.82 163.1 29.82 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.45 1.5 . . . . 0.0 111.999 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.65 177.68 31.05 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.64 1.114 . . . . 0.0 113.947 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.01 8.87 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 124.551 3.5 . . . . 0.0 115.246 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.474 ' HE3' ' CZ2' ' A' ' 18' ' ' TRP . 2.9 tpmp? -123.78 10.21 8.94 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.309 0.959 . . . . 0.0 112.144 169.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -125.37 -55.26 1.55 Allowed 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 126.608 1.963 . . . . 0.0 110.04 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 64.1 m -75.01 -36.41 61.96 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.049 0.939 . . . . 0.0 110.847 167.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.29 71.74 1.48 Allowed Glycine 0 CA--C 1.529 0.913 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 155.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? . . . . . 0 C--O 1.248 0.994 0 C-N-CA 128.312 2.645 . . . . 0.0 113.957 -168.229 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 86.7 t . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.4 -8.33 48.04 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.619 1.581 . . . . 0.0 114.785 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.41 157.39 6.7 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.592 1.196 . . . . 0.0 111.685 173.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.6 m -56.16 133.67 52.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 161.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.1 t -19.95 -76.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 129.2 3.0 . . . . 0.0 113.173 -160.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -122.41 25.14 9.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.804 2.042 . . . . 0.0 109.88 139.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.03 -6.92 0.45 Allowed Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.216 1.389 . . . . 0.0 115.45 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -114.13 -178.08 3.29 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.229 2.212 . . . . 0.0 112.38 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.5 m -144.75 159.93 48.97 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.661 1.584 . . . . 0.0 110.342 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.04 166.96 28.06 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.135 2.557 . . . . 0.0 113.123 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.5 m -56.63 92.71 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.12 2.168 . . . . 0.0 113.117 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.76 -8.5 6.46 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.415 1.483 . . . . 0.0 113.954 -176.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -122.03 165.54 15.87 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.56 1.944 . . . . 0.0 111.26 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.6 m -142.27 157.44 44.83 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.834 1.654 . . . . 0.0 111.047 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.3 t -83.53 118.92 24.11 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.621 0.768 . . . . 0.0 111.175 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 90.2 p -72.09 165.52 24.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.493 1.139 . . . . 0.0 113.225 175.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.546 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 5.7 mp0 -60.04 -17.13 36.8 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.355 1.862 . . . . 0.0 113.046 173.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -81.82 -7.61 59.62 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.322 1.449 . . . . 0.0 113.292 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.37 12.27 84.38 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 118.959 0.8 . . . . 0.0 113.336 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -105.07 146.03 29.67 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.791 1.637 . . . . 0.0 111.518 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.8 t -85.41 157.82 20.39 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.503 0.721 . . . . 0.0 112.095 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.36 -171.45 38.23 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.662 1.125 . . . . 0.0 111.921 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.89 175.77 9.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.176 0.988 . . . . 0.0 112.04 174.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.25 177.55 45.94 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.676 1.131 . . . . 0.0 111.755 -165.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.98 5.47 3.48 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.624 2.216 . . . . 0.0 116.097 -164.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -90.69 -8.22 50.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.265 0.939 . . . . 0.0 111.304 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.445 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 96.6 m-85 -130.92 -51.27 1.04 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.754 2.422 . . . . 0.0 111.283 -168.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.95 -1.58 0.96 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -148.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.07 -62.1 0.76 Allowed Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.515 -0.741 . . . . 0.0 111.51 -160.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? . . . . . 0 C--O 1.249 1.041 0 C-N-CA 126.207 1.803 . . . . 0.0 110.665 179.097 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 38.7 t . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 118.615 -0.707 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.69 29.97 2.09 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.92 1.248 . . . . 0.0 113.758 -176.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.575 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.4 pm0 -70.69 152.19 44.1 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.896 0.878 . . . . 0.0 111.783 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.9 m -61.34 148.1 42.55 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.911 0.484 . . . . 0.0 111.442 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t -49.09 -66.61 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.906 1.682 . . . . 0.0 109.907 -173.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -138.3 19.24 2.76 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.023 2.129 . . . . 0.0 111.721 140.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.91 -19.36 0.2 Allowed Glycine 0 CA--C 1.532 1.12 0 N-CA-C 115.162 0.825 . . . . 0.0 115.162 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -99.87 173.79 6.51 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.209 1.404 . . . . 0.0 110.777 165.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.9 m -139.48 154.12 71.24 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.086 1.354 . . . . 0.0 110.939 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.45 170.45 15.95 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.553 2.835 . . . . 0.0 112.914 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.1 p 54.47 30.65 13.26 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 173.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.29 30.48 58.24 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.606 1.098 . . . . 0.0 113.399 -171.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.8 mmt -72.19 168.17 18.79 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.611 1.206 . . . . 0.0 109.782 163.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.0 m -124.13 130.85 53.24 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.081 1.752 . . . . 0.0 110.13 -173.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.9 t -73.1 102.32 3.53 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.978 0.911 . . . . 0.0 112.287 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.1 p -61.91 171.48 1.67 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 175.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -67.82 -11.27 58.2 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.246 1.418 . . . . 0.0 113.744 166.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -79.26 -4.45 50.75 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.183 0.901 . . . . 0.0 112.535 168.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.54 18.99 77.51 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.828 0.74 . . . . 0.0 112.741 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.71 146.58 46.3 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.936 1.694 . . . . 0.0 112.007 -176.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.1 m -84.09 157.46 21.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.844 1.658 . . . . 0.0 112.341 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.05 -172.55 39.09 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 128.05 2.738 . . . . 0.0 107.278 -174.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -132.39 163.68 28.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.047 1.424 . . . . 0.0 110.885 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.37 -165.98 36.07 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 114.882 0.713 . . . . 0.0 114.882 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.88 8.46 1.32 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 125.04 3.827 . . . . 0.0 115.722 -165.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.45 5.9 9.59 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.555 1.07 . . . . 0.0 113.41 168.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -133.45 -52.4 0.88 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.521 1.528 . . . . 0.0 111.733 -173.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 m -81.69 -36.3 28.86 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.675 0.39 . . . . 0.0 110.031 162.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.1 72.09 1.14 Allowed Glycine 0 CA--C 1.532 1.109 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 153.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.8 mtp-105 . . . . . 0 C--O 1.249 1.039 0 C-N-CA 127.405 2.282 . . . . 0.0 116.085 -159.962 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 91.1 t . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.0 9.32 67.9 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.306 -1.275 . . . . 0.0 115.244 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.39 157.45 6.59 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.294 1.547 . . . . 0.0 112.438 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.5 m -66.58 99.69 0.61 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 163.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t 2.73 -90.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 131.257 3.823 . . . . 0.0 111.547 -162.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 75.7 mmt-85 -131.06 41.97 3.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.774 1.23 . . . . 0.0 109.283 141.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.02 -16.36 0.08 OUTLIER Glycine 0 CA--C 1.538 1.486 0 N-CA-C 117.169 1.628 . . . . 0.0 117.169 165.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -130.77 175.77 8.76 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 120.583 2.191 . . . . 0.0 113.248 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.8 m -119.95 166.6 14.53 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 123.894 0.878 . . . . 0.0 111.018 173.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -51.57 149.85 17.46 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.27 2.647 . . . . 0.0 112.816 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.0 m -69.83 76.22 0.46 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.546 1.538 . . . . 0.0 111.206 -175.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 151.13 -19.84 0.95 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 126.113 1.816 . . . . 0.0 113.93 -171.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.5 mmt -86.5 -167.29 1.82 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.307 1.843 . . . . 0.0 111.575 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 p -147.43 162.17 39.55 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.494 1.918 . . . . 0.0 110.749 161.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.7 t -102.04 114.11 27.93 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.169 1.788 . . . . 0.0 111.997 -171.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.441 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 5.4 t -65.77 147.55 53.2 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.153 0.581 . . . . 0.0 111.747 175.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.529 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -60.74 -8.44 2.98 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.951 1.7 . . . . 0.0 114.666 175.134 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -90.7 -2.43 57.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.098 1.359 . . . . 0.0 113.792 168.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.4 18.14 31.77 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.287 -1.285 . . . . 0.0 115.542 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -127.77 152.86 47.23 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.283 1.541 . . . . 0.0 112.707 -175.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.8 m -91.11 155.97 18.24 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.57 -161.22 35.01 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.187 1.375 . . . . 0.0 111.251 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -134.77 161.72 34.39 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.76 1.624 . . . . 0.0 112.082 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.46 176.02 35.74 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.962 1.268 . . . . 0.0 112.701 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.44 -2.82 10.6 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.467 2.778 . . . . 0.0 115.257 -169.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -81.27 -16.95 51.05 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.449 1.099 . . . . 0.0 110.672 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 98.3 m-85 -123.81 -42.79 2.16 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 129.014 2.926 . . . . 0.0 111.43 -167.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.2 m -99.91 -9.2 23.08 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.339 1.455 . . . . 0.0 113.268 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.35 -174.38 41.63 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-N 118.68 0.673 . . . . 0.0 113.363 -170.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.786 2.035 . . . . 0.0 108.875 173.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.58 2.46 72.82 Favored Glycine 0 CA--C 1.536 1.374 0 N-CA-C 116.005 1.162 . . . . 0.0 116.005 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.53 163.81 6.52 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.303 1.552 . . . . 0.0 112.617 175.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.0 m -54.25 129.28 34.62 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.994 0.918 . . . . 0.0 109.48 162.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.2 t -22.47 -74.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 128.833 2.853 . . . . 0.0 113.163 -158.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -122.87 23.44 9.38 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.765 2.026 . . . . 0.0 110.077 138.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.33 -5.05 0.2 Allowed Glycine 0 CA--C 1.536 1.356 0 N-CA-C 116.171 1.229 . . . . 0.0 116.171 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -115.01 167.87 10.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.694 1.747 . . . . 0.0 112.056 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 72.9 m -152.73 173.01 4.92 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 125.912 1.685 . . . . 0.0 110.066 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -58.39 -178.0 0.11 Allowed 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 125.797 4.331 . . . . 0.0 118.894 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.6 m -43.8 105.18 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 129.016 2.926 . . . . 0.0 114.299 -178.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.74 33.26 86.31 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 123.885 0.755 . . . . 0.0 113.356 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.01 167.89 0.14 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.721 1.608 . . . . 0.0 114.985 170.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -134.69 88.29 2.42 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.002 156.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.2 t -50.55 112.51 0.71 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.186 0.995 . . . . 0.0 110.359 173.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.7 t -61.22 152.38 29.01 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.987 0.915 . . . . 0.0 111.119 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -64.1 -18.27 64.25 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -90.66 3.67 53.54 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.672 1.989 . . . . 0.0 111.929 175.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.36 6.89 47.09 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-O 118.109 -1.384 . . . . 0.0 115.831 162.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -114.62 152.77 31.31 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.638 1.719 . . . . 0.0 113.765 -169.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.6 m -79.37 152.28 30.49 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.67 -175.76 31.9 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 127.218 2.342 . . . . 0.0 109.514 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -141.65 158.15 44.18 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.927 2.091 . . . . 0.0 109.351 -175.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.44 -176.56 24.35 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 123.82 0.724 . . . . 0.0 114.67 171.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.45 -1.61 8.51 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.415 3.41 . . . . 0.0 115.854 -166.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -115.99 7.01 14.24 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.83 1.252 . . . . 0.0 111.847 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -120.39 -52.16 2.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 126.721 2.009 . . . . 0.0 109.905 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.2 m -62.36 -50.96 69.5 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 164.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.46 60.99 0.86 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.762 1.649 . . . . 0.0 112.823 162.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? . . . . . 0 C--O 1.255 1.351 1 C-N-CA 133.171 4.589 . . . . 0.0 118.407 159.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.85 7.96 12.52 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.075 1.321 . . . . 0.0 114.669 -174.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.572 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.7 pm0 -64.48 148.55 50.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.142 1.377 . . . . 0.0 111.836 172.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.0 m -64.81 139.53 58.77 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.214 0.606 . . . . 0.0 110.74 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.0 t -52.77 -66.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.262 1.825 . . . . 0.0 111.287 -165.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.3 mmt-85 -129.68 16.97 5.83 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.476 1.91 . . . . 0.0 110.269 151.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.98 -23.25 2.28 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.933 1.73 . . . . 0.0 113.007 -176.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.17 157.95 33.79 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.035 0.918 . . . . 0.0 112.225 168.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.5 m -149.24 -179.12 0.91 Allowed Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 130.0 3.32 . . . . 0.0 107.461 174.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -55.81 177.97 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.637 3.558 . . . . 0.0 117.774 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.2 m -53.77 121.77 8.57 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.851 1.66 . . . . 0.0 111.607 174.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.46 4.67 80.81 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.624 -1.098 . . . . 0.0 115.349 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.81 165.89 0.17 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 176.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.9 m -136.69 99.29 4.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.481 154.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.0 t -51.41 113.08 0.86 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.3 1.04 . . . . 0.0 110.66 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.448 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 26.3 t -67.6 160.51 27.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.294 1.438 . . . . 0.0 113.435 -169.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -57.86 -20.49 36.79 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.273 1.029 . . . . 0.0 112.712 161.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.522 ' CD2' ' HE2' ' A' ' 26' ' ' LYS . 6.1 m-90 -79.18 -2.39 40.69 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.441 1.496 . . . . 0.0 112.987 170.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.36 18.69 79.01 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.405 1.002 . . . . 0.0 113.877 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -121.44 155.45 34.84 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.849 1.66 . . . . 0.0 113.022 -172.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.98 152.42 28.0 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.288 1.835 . . . . 0.0 112.304 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.91 -170.79 30.68 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.645 1.117 . . . . 0.0 111.104 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -146.8 165.67 28.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 129.879 3.272 . . . . 0.0 109.698 -172.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.56 -170.29 38.43 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.505 1.05 . . . . 0.0 112.943 -171.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.56 3.04 7.18 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.617 2.878 . . . . 0.0 115.648 -171.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.522 ' HE2' ' CD2' ' A' ' 18' ' ' TRP . 1.6 ttpm? -98.19 11.69 36.98 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 119.534 1.061 . . . . 0.0 111.823 172.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.448 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 92.1 m-85 -147.24 -53.02 0.21 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.898 2.479 . . . . 0.0 110.179 -164.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.76 -46.53 0.49 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 131.38 -52.67 0.82 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 -152.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 49.1 tpt85 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 115.701 -2.095 . . . . 0.0 112.25 171.4 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 51.3 t . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 115.89 6.63 16.37 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.135 1.35 . . . . 0.0 114.576 -174.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.538 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.7 pm0 -64.19 148.94 48.91 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.895 1.278 . . . . 0.0 111.797 172.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.3 m -64.0 154.84 32.95 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.689 0.796 . . . . 0.0 111.005 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.9 t -45.7 -67.21 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.987 1.715 . . . . 0.0 110.191 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -138.49 23.18 2.72 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.246 2.218 . . . . 0.0 110.907 139.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.78 -11.14 0.2 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.1 0.857 . . . . 0.0 114.957 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -105.89 165.69 11.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.561 1.944 . . . . 0.0 111.312 170.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.3 m -155.56 178.52 1.63 Allowed Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 127.079 2.152 . . . . 0.0 109.24 -170.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -57.54 178.71 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.941 3.761 . . . . 0.0 118.137 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.9 m -42.87 109.13 0.12 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 128.214 2.606 . . . . 0.0 114.0 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.19 29.12 74.51 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.235 -0.759 . . . . 0.0 114.041 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.72 168.7 0.4 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 170.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -132.73 106.27 7.66 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 113.377 -1.738 . . . . 0.0 108.712 147.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.1 t -54.68 117.48 3.41 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.336 -0.852 . . . . 0.0 110.569 170.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.427 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 10.8 t -64.95 164.1 13.29 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.05 0.94 . . . . 0.0 113.091 -175.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.554 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 18.1 mp0 -60.51 -18.92 55.04 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.672 1.989 . . . . 0.0 111.5 168.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 30.5 m0 -90.97 0.75 57.46 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.739 2.016 . . . . 0.0 113.391 172.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.98 25.21 69.73 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.858 -0.968 . . . . 0.0 114.24 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -120.01 152.69 37.12 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.909 1.684 . . . . 0.0 112.527 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.3 m -81.86 151.05 27.5 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.148 1.379 . . . . 0.0 113.072 -177.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.48 -165.23 32.86 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.539 2.018 . . . . 0.0 108.471 -174.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.75 160.79 42.85 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.588 1.955 . . . . 0.0 108.907 177.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.35 -169.81 26.59 Favored Glycine 0 CA--C 1.543 1.796 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 171.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -54.64 -10.13 2.23 Favored 'Trans proline' 0 CA--C 1.538 0.713 1 C-N-CA 126.101 4.534 . . . . 0.0 119.143 -170.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.501 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -119.14 12.34 12.63 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.87 1.214 . . . . 0.0 112.636 176.138 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 57.1 m-85 -129.96 -70.48 0.64 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 127.346 2.258 . . . . 0.0 108.085 -176.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.94 -20.65 57.78 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.111 0.964 . . . . 0.0 113.331 170.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.3 -0.1 81.36 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 118.491 0.587 . . . . 0.0 113.273 -165.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? . . . . . 0 C--O 1.251 1.16 0 C-N-CA 129.521 3.128 . . . . 0.0 107.033 177.551 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.12 2.94 24.81 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.681 1.134 . . . . 0.0 113.868 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.6 mp0 -60.2 150.79 28.92 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.188 1.795 . . . . 0.0 112.213 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.9 m -69.51 156.76 38.37 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.794 -0.566 . . . . 0.0 110.774 163.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.4 t -49.18 -70.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.272 1.829 . . . . 0.0 109.613 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -141.92 17.28 2.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 127.717 2.407 . . . . 0.0 111.916 145.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 171.38 -17.84 0.06 OUTLIER Glycine 0 CA--C 1.532 1.106 0 N-CA-C 115.455 0.942 . . . . 0.0 115.455 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -121.76 179.43 4.49 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.136 1.374 . . . . 0.0 111.821 168.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.51 -173.51 0.36 Allowed Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 127.384 2.274 . . . . 0.0 109.105 173.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.02 151.97 15.17 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.063 2.508 . . . . 0.0 113.792 174.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.9 m -72.12 30.07 0.05 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 -159.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -130.45 -4.78 4.32 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 127.391 2.424 . . . . 0.0 115.029 165.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -179.67 0.15 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.055 2.542 . . . . 0.0 117.452 -176.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.07 96.08 2.83 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.493 1.117 . . . . 0.0 110.206 146.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.7 t -49.82 115.02 1.21 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.234 1.014 . . . . 0.0 111.899 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.6 t -70.04 152.56 44.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.81 1.244 . . . . 0.0 111.081 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -6.12 7.61 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 171.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -6.51 50.12 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.542 1.137 . . . . 0.0 113.159 163.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.96 23.94 60.76 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.996 0.816 . . . . 0.0 113.493 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -126.8 159.02 35.05 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.393 1.877 . . . . 0.0 112.467 -174.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.0 m -115.05 165.83 12.47 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.05 1.34 . . . . 0.0 113.218 -175.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.48 -170.65 24.33 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 -162.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -139.48 161.99 36.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.527 2.331 . . . . 0.0 109.872 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.27 -174.63 28.74 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 123.936 0.779 . . . . 0.0 113.35 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -57.96 -16.11 25.03 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 124.011 3.141 . . . . 0.0 117.551 -169.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.79 -7.14 59.53 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.544 1.066 . . . . 0.0 111.359 178.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -134.08 -58.76 0.85 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.991 2.116 . . . . 0.0 110.198 -160.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.0 m -98.42 -7.04 29.38 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.781 2.032 . . . . 0.0 113.008 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.14 -9.09 10.12 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 124.668 1.128 . . . . 0.0 114.418 -170.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.14 0 C-N-CA 128.574 2.749 . . . . 0.0 107.617 172.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 117.714 -1.136 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.18 4.77 23.68 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 119.527 1.058 . . . . 0.0 115.3 -173.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.7 pm0 -57.61 150.76 18.5 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.833 1.253 . . . . 0.0 113.045 178.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.4 m -34.17 119.76 0.42 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 128.939 2.896 . . . . 0.0 112.406 -168.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.2 t 0.92 -85.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 130.18 3.392 . . . . 0.0 112.426 -160.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -130.94 32.59 4.3 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.608 2.363 . . . . 0.0 109.171 140.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 164.37 -11.96 0.08 OUTLIER Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.864 1.697 . . . . 0.0 115.76 172.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -121.94 174.46 6.88 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.333 1.853 . . . . 0.0 113.456 -172.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.1 m -150.58 175.74 2.67 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 126.912 2.085 . . . . 0.0 109.188 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -57.39 178.41 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 125.129 3.886 . . . . 0.0 118.577 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -50.52 120.14 4.39 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.647 1.579 . . . . 0.0 112.364 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.78 32.33 74.18 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 118.761 -1.022 . . . . 0.0 113.808 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.37 166.86 2.1 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 169.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.8 m -133.81 94.26 3.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.648 1.979 . . . . 0.0 107.421 152.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -50.42 113.3 0.85 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.868 0.867 . . . . 0.0 109.381 170.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.5 t -64.95 159.45 22.89 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.023 0.916 . . . . 0.0 112.53 -169.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.44 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -48.82 -26.1 2.22 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.903 2.481 . . . . 0.0 113.552 169.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -100.23 3.33 43.53 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.728 2.011 . . . . 0.0 112.664 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.31 8.61 58.6 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.955 -1.47 . . . . 0.0 115.661 169.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -118.59 158.67 24.99 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.617 2.209 . . . . 0.0 113.328 -172.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.5 m -89.47 156.07 18.9 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -167.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.56 -166.43 27.75 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 128.07 2.747 . . . . 0.0 109.596 -175.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.39 170.26 21.79 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.996 1.318 . . . . 0.0 110.895 163.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 126.69 172.19 13.25 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.612 1.577 . . . . 0.0 112.63 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.24 -23.03 16.85 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 124.575 3.517 . . . . 0.0 117.545 -169.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.8 -4.54 11.6 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.487 1.115 . . . . 0.0 113.607 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -76.36 -55.9 5.13 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.634 1.174 . . . . 0.0 109.23 155.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.4 m -71.49 -44.12 65.31 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.499 1.52 . . . . 0.0 112.962 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.46 145.46 26.53 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 118.748 0.703 . . . . 0.0 112.257 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 C-N-CA 124.491 1.117 . . . . 0.0 113.053 -175.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.76 12.44 78.28 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 119.369 -0.684 . . . . 0.0 114.748 -172.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -62.37 168.81 3.27 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.355 1.462 . . . . 0.0 113.502 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 62.7 m -45.72 140.93 3.17 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.749 1.62 . . . . 0.0 112.091 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t -33.23 -67.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 127.931 2.492 . . . . 0.0 112.877 -155.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -124.16 19.66 9.07 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.402 1.881 . . . . 0.0 110.517 138.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.4 -19.2 0.81 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.732 1.158 . . . . 0.0 115.053 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.5 ptp85 -96.78 177.3 5.69 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.45 1.5 . . . . 0.0 111.559 172.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -137.57 169.37 13.25 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.798 1.239 . . . . 0.0 112.459 -172.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.23 167.99 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.613 3.542 . . . . 0.0 114.842 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 m -38.68 96.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.388 2.675 . . . . 0.0 114.628 -174.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.71 3.39 90.53 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 118.268 -1.296 . . . . 0.0 115.8 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.2 mmt -78.27 173.46 12.26 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 120.19 1.995 . . . . 0.0 112.716 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.9 m -119.3 136.28 54.32 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.609 2.364 . . . . 0.0 109.722 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.6 t -75.9 113.91 13.93 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.945 0.498 . . . . 0.0 109.738 166.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.455 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 9.2 t -62.35 151.28 37.2 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.996 0.903 . . . . 0.0 110.359 167.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.404 ' CD ' ' H ' ' A' ' 17' ' ' GLN . 17.8 mp0 -72.7 -4.93 34.24 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.557 1.543 . . . . 0.0 111.33 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -75.47 -11.19 59.98 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.486 1.914 . . . . 0.0 113.597 162.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.53 9.91 48.94 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.457 1.504 . . . . 0.0 115.195 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -131.07 147.18 52.59 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.928 1.864 . . . . 0.0 113.193 -171.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 82.6 m -82.99 149.51 26.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -169.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.02 -160.3 33.18 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.074 1.321 . . . . 0.0 111.827 176.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.6 tptt -135.94 162.1 33.78 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.395 1.478 . . . . 0.0 112.165 176.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.05 178.73 36.03 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.761 1.172 . . . . 0.0 113.862 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.34 19.29 0.53 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 125.271 3.981 . . . . 0.0 114.697 -170.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm -121.42 4.44 10.21 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.325 1.85 . . . . 0.0 111.616 169.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.455 ' CD2' ' HB2' ' A' ' 16' ' ' SER . 82.5 m-85 -130.14 -63.34 0.91 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.815 2.446 . . . . 0.0 108.876 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.1 m -71.25 -5.86 35.3 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.11 1.364 . . . . 0.0 113.56 174.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.37 166.52 34.25 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 127.676 2.56 . . . . 0.0 109.067 168.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? . . . . . 0 C--O 1.243 0.763 0 CA-C-N 117.408 0.604 . . . . 0.0 112.017 -176.4 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.8 t . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 117.061 -1.447 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.41 -45.29 6.22 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 120.462 1.483 . . . . 0.0 112.522 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 44.63 -173.68 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 128.082 2.553 . . . . 0.0 114.129 -169.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 62.2 m -58.21 116.82 3.81 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.607 -1.308 . . . . 0.0 108.185 148.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -4.67 -81.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 131.056 3.742 . . . . 0.0 113.67 -160.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -129.27 22.38 5.63 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.114 2.165 . . . . 0.0 109.807 147.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.6 -14.38 0.07 OUTLIER Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.543 1.377 . . . . 0.0 116.543 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -125.38 179.74 4.97 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 120.046 1.923 . . . . 0.0 113.029 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.4 m -124.0 157.1 64.72 Favored Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 124.635 1.174 . . . . 0.0 109.496 169.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.42 150.63 88.02 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.05 1.833 . . . . 0.0 110.78 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.5 m -65.48 88.14 0.09 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.831 1.252 . . . . 0.0 112.326 -166.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.95 -17.04 3.22 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.1 1.809 . . . . 0.0 113.491 -173.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 mmt -94.59 170.75 9.24 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.724 1.609 . . . . 0.0 109.712 158.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -142.39 161.9 36.85 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.988 1.715 . . . . 0.0 110.906 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.5 t -103.91 115.87 31.24 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.939 1.695 . . . . 0.0 112.097 -166.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.494 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 7.7 t -77.87 167.88 20.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 122.302 1.049 . . . . 0.0 113.011 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.524 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 11.1 mp0 -65.29 -16.72 63.86 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.313 2.245 . . . . 0.0 112.108 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -74.72 -5.98 46.28 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.704 2.002 . . . . 0.0 112.98 170.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.72 23.01 65.4 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.941 -0.922 . . . . 0.0 113.532 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -131.06 153.8 48.91 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.541 1.536 . . . . 0.0 112.716 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 74.5 m -84.17 160.99 20.73 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.597 1.159 . . . . 0.0 113.785 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.28 -158.8 31.88 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.919 2.199 . . . . 0.0 107.88 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -138.32 158.57 44.03 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.788 1.235 . . . . 0.0 110.8 -177.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.88 -178.14 40.55 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 123.962 0.791 . . . . 0.0 113.912 172.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.78 -13.51 6.17 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 125.07 3.847 . . . . 0.0 118.032 -167.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -96.94 -8.77 29.86 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.808 1.185 . . . . 0.0 111.956 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.494 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 92.1 m-85 -120.5 -41.79 2.58 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 128.335 2.654 . . . . 0.0 110.397 -174.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.6 m -101.24 1.62 39.07 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.708 2.003 . . . . 0.0 112.555 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.83 -88.92 0.23 Allowed Glycine 0 CA--C 1.531 1.093 0 CA-C-N 119.153 0.888 . . . . 0.0 114.895 -171.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? . . . . . 0 C--O 1.247 0.937 0 C-N-CA 124.744 1.217 . . . . 0.0 112.192 -162.475 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.4 8.76 87.08 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-O 119.189 -0.784 . . . . 0.0 114.849 -174.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -61.33 166.39 3.92 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.176 1.391 . . . . 0.0 113.344 174.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.2 m -46.78 142.16 3.51 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.796 1.638 . . . . 0.0 112.23 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.6 t -18.73 -76.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 129.555 3.142 . . . . 0.0 113.139 -163.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -124.08 25.61 7.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.173 2.189 . . . . 0.0 109.924 140.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.97 -6.39 2.04 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.482 1.515 . . . . 0.0 114.779 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -112.08 -177.92 3.29 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 127.683 2.393 . . . . 0.0 111.58 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -160.93 172.55 5.69 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 126.249 1.82 . . . . 0.0 109.59 169.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.49 178.97 6.93 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.158 2.572 . . . . 0.0 113.851 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.5 t 9.99 87.82 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 130.46 3.504 . . . . 0.0 116.06 169.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.48 34.25 74.82 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.3 0.953 . . . . 0.0 114.789 171.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.08 167.0 4.22 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 169.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.7 m -132.76 94.64 3.43 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.07 156.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -51.2 107.35 0.18 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.859 0.863 . . . . 0.0 110.734 160.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.2 p -64.79 164.55 12.08 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.709 1.204 . . . . 0.0 112.873 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.76 -21.22 60.46 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.0 0.92 . . . . 0.0 112.44 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -74.25 -10.54 59.7 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.806 1.642 . . . . 0.0 112.607 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.61 12.84 63.98 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.477 1.037 . . . . 0.0 113.802 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -124.86 142.49 51.41 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.841 1.32 . . . . 0.0 111.676 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.8 m -81.02 162.34 23.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.473 1.109 . . . . 0.0 113.289 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.86 -161.02 34.84 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 127.685 2.564 . . . . 0.0 106.857 -175.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.56 167.53 23.48 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.564 1.546 . . . . 0.0 109.309 173.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.47 -176.07 39.69 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 123.851 0.738 . . . . 0.0 114.52 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.69 9.2 0.79 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 124.83 3.686 . . . . 0.0 115.817 -165.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 tpmp? -125.64 6.8 7.52 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.287 0.949 . . . . 0.0 113.017 170.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -124.62 -54.41 1.66 Allowed 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 126.487 1.915 . . . . 0.0 109.729 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.6 m -68.89 -41.28 78.5 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.101 0.96 . . . . 0.0 109.527 164.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.35 64.9 2.43 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.96 0.791 . . . . 0.0 111.382 162.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.312 0.0 OUTLIER . . . . . 0 C--O 1.245 0.863 1 C-N-CA 132.155 4.182 . . . . 0.0 118.241 172.427 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.44 13.76 82.6 Favored Glycine 0 CA--C 1.537 1.433 0 CA-C-O 119.494 -0.615 . . . . 0.0 114.472 -170.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -60.38 168.84 1.9 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.944 1.698 . . . . 0.0 113.838 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.5 m -43.52 138.33 2.52 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.439 1.896 . . . . 0.0 111.732 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.8 t -28.36 -71.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 128.832 2.853 . . . . 0.0 113.101 -154.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -122.57 19.58 10.37 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.254 1.821 . . . . 0.0 110.402 140.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.18 -20.97 0.29 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.42 1.009 . . . . 0.0 114.857 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -106.42 177.68 4.78 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 124.962 1.305 . . . . 0.0 112.335 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.482 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 53.7 m -142.25 179.81 1.13 Allowed Pre-proline 0 CA--C 1.559 1.321 0 C-N-CA 125.957 1.703 . . . . 0.0 110.353 -174.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 74.4 Cg_endo -75.97 -173.06 1.52 Allowed 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 123.676 2.917 . . . . 0.0 115.42 -177.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.1 m -41.68 108.08 0.09 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.549 2.74 . . . . 0.0 114.688 -174.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.72 29.64 75.03 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.088 0.851 . . . . 0.0 113.864 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.99 172.63 0.94 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 171.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.86 115.75 9.24 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 113.15 -1.841 . . . . 0.0 109.665 148.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.7 t -62.95 113.11 2.89 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.658 -1.276 . . . . 0.0 110.537 172.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.416 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 77.3 p -61.36 162.02 8.42 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.327 1.051 . . . . 0.0 112.778 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -71.2 -15.95 62.49 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 53.4 m0 -75.0 -9.32 58.42 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.017 1.727 . . . . 0.0 112.603 167.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.78 16.4 51.85 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.459 -1.19 . . . . 0.0 114.447 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -124.42 148.62 47.48 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.693 1.746 . . . . 0.0 112.772 -175.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 67.1 m -73.11 154.41 40.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.551 1.54 . . . . 0.0 113.259 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.26 -168.15 37.14 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.806 1.67 . . . . 0.0 109.07 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -142.01 149.6 40.22 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.754 2.022 . . . . 0.0 109.537 -175.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.76 -171.52 30.37 Favored Glycine 0 CA--C 1.542 1.78 0 N-CA-C 114.829 0.692 . . . . 0.0 114.829 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.64 -14.28 7.17 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 125.126 3.884 . . . . 0.0 118.231 -170.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -99.38 7.03 45.88 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.02 1.328 . . . . 0.0 111.693 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 90.1 m-85 -141.94 -64.31 0.43 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.875 2.07 . . . . 0.0 109.317 -167.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.3 m -79.78 -16.24 55.93 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.341 2.256 . . . . 0.0 111.963 173.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.35 -112.15 0.19 Allowed Glycine 0 CA--C 1.53 1.013 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 147.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.165 1.386 . . . . 0.0 111.224 176.419 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.418 HG13 ' H ' ' A' ' 2' ' ' GLY 0.272 7.8 p . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 117.808 -1.092 . . . . 0.0 112.398 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.418 ' H ' HG13 ' A' ' 1' ' ' VAL . . . -92.51 8.24 77.16 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-N 119.639 1.109 . . . . 0.0 115.292 -171.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 3.5 mp0 -51.62 154.08 2.08 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.585 0.707 . . . . 0.0 111.015 171.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.7 m -52.92 128.86 28.5 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 118.275 -0.869 . . . . 0.0 108.917 163.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.5 t -13.39 -79.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 129.39 3.076 . . . . 0.0 113.216 -157.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -123.8 27.67 7.19 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 127.252 2.221 . . . . 0.0 109.564 139.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.32 -2.74 0.1 OUTLIER Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.222 1.391 . . . . 0.0 116.189 176.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.6 mmt-85 -129.38 -177.46 4.26 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.157 1.783 . . . . 0.0 112.991 -172.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.2 m -143.67 158.79 56.06 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 125.073 1.349 . . . . 0.0 111.051 173.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.27 170.42 20.05 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.51 2.806 . . . . 0.0 112.947 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.6 m -44.97 99.85 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.836 2.455 . . . . 0.0 114.412 -173.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.31 -8.89 62.77 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.864 1.221 . . . . 0.0 114.899 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 45.5 mtt -90.81 164.73 13.97 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.872 1.269 . . . . 0.0 110.426 165.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.8 m -145.4 158.17 43.89 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.232 1.013 . . . . 0.0 111.805 -174.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.7 t -85.28 115.77 23.23 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.192 0.997 . . . . 0.0 111.274 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.43 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 96.4 p -70.94 165.41 23.42 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.342 1.068 . . . . 0.0 113.142 175.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.561 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 6.1 mp0 -60.33 -17.23 41.62 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.513 1.925 . . . . 0.0 113.049 175.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -80.13 -7.97 59.18 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.276 1.431 . . . . 0.0 113.277 172.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.62 13.09 83.85 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 118.701 0.682 . . . . 0.0 113.124 -168.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -105.84 141.77 36.69 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.917 1.687 . . . . 0.0 111.486 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.0 t -82.68 157.33 23.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.236 0.615 . . . . 0.0 112.089 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.63 -172.51 42.5 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.788 0.709 . . . . 0.0 112.917 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -134.17 132.52 39.9 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.311 1.845 . . . . 0.0 106.754 -174.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.0 179.31 15.86 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.314 0.959 . . . . 0.0 112.295 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.75 0.83 5.07 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.934 2.422 . . . . 0.0 115.846 -171.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -95.8 -8.53 34.05 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.532 1.133 . . . . 0.0 111.614 172.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 98.9 m-85 -124.03 -53.16 1.75 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.758 2.423 . . . . 0.0 110.436 -169.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 32.7 m -120.43 -16.03 8.45 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.084 2.154 . . . . 0.0 114.23 -164.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.25 -17.43 13.02 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-O 118.699 -1.056 . . . . 0.0 113.92 -159.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.145 0 C-N-CA 125.867 1.667 . . . . 0.0 112.791 -178.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.686 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -89.04 -42.38 5.64 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 165.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.47 141.87 55.89 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.025 0.93 . . . . 0.0 110.504 154.224 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 41.7 m -53.55 146.23 13.34 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.4 1.88 . . . . 0.0 112.012 -175.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.5 t -44.93 -62.43 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.576 1.951 . . . . 0.0 111.334 -160.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.549 ' HE ' ' HA ' ' A' ' 6' ' ' ARG . 1.7 mmp_? -135.8 29.31 3.19 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.84 1.656 . . . . 0.0 110.259 129.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.27 -35.97 0.24 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.917 0.77 . . . . 0.0 114.555 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -88.41 177.09 6.92 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.703 1.252 . . . . 0.0 111.162 172.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.0 m -127.69 172.92 6.03 Favored Pre-proline 0 C--O 1.24 0.595 0 C-N-CA 125.035 1.334 . . . . 0.0 110.856 176.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.57 150.24 8.93 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.988 2.459 . . . . 0.0 112.196 171.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.5 m -67.89 79.94 0.21 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.325 1.45 . . . . 0.0 112.624 -166.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 144.14 -17.64 2.12 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.627 2.06 . . . . 0.0 113.94 -175.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.6 mtt -84.56 178.77 7.58 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.552 1.676 . . . . 0.0 112.728 174.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.7 m -129.03 146.85 50.9 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.767 2.427 . . . . 0.0 110.278 173.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.8 t -88.69 111.64 22.19 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.761 1.625 . . . . 0.0 111.039 173.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 t -67.38 155.98 37.62 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.824 0.85 . . . . 0.0 111.217 172.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -9.81 48.28 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.794 -1.191 . . . . 0.0 114.138 176.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.509 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 54.0 m0 -70.08 -5.17 24.92 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.833 1.253 . . . . 0.0 113.001 164.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.29 14.36 68.98 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.043 1.306 . . . . 0.0 113.759 176.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -120.81 154.22 36.04 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.869 1.668 . . . . 0.0 113.053 -175.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 94.3 m -93.34 147.41 22.96 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.012 1.325 . . . . 0.0 113.848 -174.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.25 -161.61 32.59 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.215 0.912 . . . . 0.0 112.071 176.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.7 tptt -134.24 167.54 20.5 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.835 1.654 . . . . 0.0 111.763 172.399 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.91 172.78 36.01 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.994 1.283 . . . . 0.0 112.569 -174.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.77 4.19 3.27 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.842 3.028 . . . . 0.0 114.967 -170.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.509 ' HE3' ' CE2' ' A' ' 18' ' ' TRP . 1.7 tmtm? -109.14 3.71 22.18 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.066 1.303 . . . . 0.0 111.906 171.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -122.91 -41.22 2.36 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 126.333 1.853 . . . . 0.0 110.466 178.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 m -93.61 3.6 55.25 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.691 1.196 . . . . 0.0 113.592 173.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.05 -85.59 0.05 OUTLIER Glycine 0 CA--C 1.536 1.348 0 CA-C-N 119.744 1.157 . . . . 0.0 115.889 177.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.187 0 C-N-CA 126.601 1.96 . . . . 0.0 113.255 -171.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.53 9.45 64.71 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.214 0.912 . . . . 0.0 114.484 -173.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.6 pm0 -71.41 153.32 42.37 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.684 1.242 . . . . 0.0 111.974 174.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.6 m -69.0 164.89 21.32 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.886 1.274 . . . . 0.0 111.45 176.291 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.0 t -47.14 -68.32 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 125.762 1.625 . . . . 0.0 110.072 -176.192 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -139.64 19.15 2.52 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.145 2.178 . . . . 0.0 111.599 142.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.01 -14.18 0.07 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 115.656 1.023 . . . . 0.0 115.656 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -121.54 177.55 5.18 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.344 1.458 . . . . 0.0 112.12 170.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.93 -178.02 0.74 Allowed Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 126.593 1.957 . . . . 0.0 109.799 174.218 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -83.05 -174.85 2.16 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.769 2.979 . . . . 0.0 112.745 173.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.5 m 21.85 79.59 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 129.96 3.304 . . . . 0.0 116.39 161.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.2 18.68 71.43 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 115.638 1.015 . . . . 0.0 115.638 168.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.59 167.23 1.53 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 174.064 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.0 m -134.73 96.19 3.5 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 113.015 -1.902 . . . . 0.0 108.024 154.114 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -50.78 110.96 0.47 Allowed 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.559 -0.713 . . . . 0.0 111.655 168.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.416 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 43.9 t -67.09 137.29 56.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.16 1.384 . . . . 0.0 109.357 174.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -6.48 4.96 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -166.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -69.45 -9.91 55.72 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.465 1.106 . . . . 0.0 112.998 165.347 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.38 18.17 24.6 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.902 1.715 . . . . 0.0 113.932 -177.059 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -122.95 145.06 48.81 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.686 1.243 . . . . 0.0 114.04 -166.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.1 t -100.98 152.93 19.98 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.554 1.142 . . . . 0.0 113.347 -162.24 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.79 -162.78 30.58 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 127.286 2.374 . . . . 0.0 110.054 -171.017 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.22 170.69 20.65 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.811 1.644 . . . . 0.0 110.394 169.339 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.26 -176.91 25.89 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.939 1.257 . . . . 0.0 112.651 -177.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.95 -10.75 30.02 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.009 2.473 . . . . 0.0 114.915 -173.003 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.37 -13.94 59.82 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.494 1.043 . . . . 0.0 111.221 170.029 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.416 ' CD1' ' HB2' ' A' ' 16' ' ' SER . 11.8 m-85 -128.98 -49.89 1.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.336 1.454 . . . . 0.0 110.932 -154.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.6 m -73.44 -7.76 53.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.619 1.167 . . . . 0.0 112.83 169.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.39 11.24 1.0 Allowed Glycine 0 CA--C 1.534 1.243 0 CA-C-O 117.546 -1.696 . . . . 0.0 116.681 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.236 0 CA-C-N 120.629 2.214 . . . . 0.0 114.046 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.95 4.1 3.2 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 119.614 1.097 . . . . 0.0 115.462 -175.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 4.3 pm0 -57.79 148.46 24.98 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.171 1.788 . . . . 0.0 112.495 172.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 m -61.73 138.51 58.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.921 0.488 . . . . 0.0 109.762 173.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -45.38 -66.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.643 1.977 . . . . 0.0 110.941 -162.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -133.58 25.09 4.07 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.991 1.716 . . . . 0.0 110.957 137.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.08 -34.43 0.26 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.019 0.819 . . . . 0.0 113.852 176.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -88.95 173.19 8.62 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 118.665 1.233 . . . . 0.0 112.364 174.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 19.4 m -148.35 179.74 1.12 Allowed Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 127.902 2.481 . . . . 0.0 108.444 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 49.7 Cg_endo -70.15 -175.25 1.18 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 123.685 2.923 . . . . 0.0 115.996 -178.128 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.8 m -44.11 108.04 0.1 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 128.598 2.759 . . . . 0.0 114.418 -173.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.08 29.75 75.59 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.87 0.748 . . . . 0.0 113.747 179.114 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.79 170.84 0.55 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 170.314 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.8 104.39 5.49 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 113.511 -1.677 . . . . 0.0 109.004 153.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -56.7 112.05 1.19 Allowed 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.288 -0.883 . . . . 0.0 110.719 173.006 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.483 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 81.0 p -73.56 168.07 20.05 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -173.362 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.541 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 1.4 mp0 -57.68 -20.04 31.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.544 1.938 . . . . 0.0 112.866 170.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.52 -4.32 55.63 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.257 1.423 . . . . 0.0 112.484 174.204 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.7 20.56 79.72 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.226 -0.763 . . . . 0.0 112.9 -170.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -120.24 144.89 47.52 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.028 1.731 . . . . 0.0 112.447 -175.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.9 m -73.34 155.48 39.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.428 1.491 . . . . 0.0 112.92 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.64 -169.38 33.43 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 126.132 1.825 . . . . 0.0 109.082 -177.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -145.29 159.58 42.82 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.417 2.287 . . . . 0.0 108.907 -175.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.44 -169.46 33.01 Favored Glycine 0 CA--C 1.539 1.588 0 N-CA-C 114.414 0.526 . . . . 0.0 114.414 173.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.66 -1.04 6.85 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 124.08 3.187 . . . . 0.0 116.733 -162.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.11 1.8 24.45 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.34 0.973 . . . . 0.0 112.71 170.427 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.483 ' CD1' ' HB3' ' A' ' 16' ' ' SER . 86.3 m-85 -129.26 -57.08 1.16 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.47 1.908 . . . . 0.0 109.699 -167.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -93.42 -12.92 28.69 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.406 1.083 . . . . 0.0 113.555 169.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.68 -7.3 58.89 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-N 118.795 0.725 . . . . 0.0 113.774 -168.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.136 0 C-N-CA 128.666 2.787 . . . . 0.0 108.262 164.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.24 12.46 58.66 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.25 0.929 . . . . 0.0 114.257 -177.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.516 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.9 pm0 -65.9 145.15 56.27 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.663 1.231 . . . . 0.0 111.35 175.067 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.2 m -64.85 147.33 53.47 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.043 -0.411 . . . . 0.0 109.943 174.394 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.2 t -48.81 -67.1 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.725 1.21 . . . . 0.0 110.212 -174.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -137.19 23.72 3.0 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.123 2.169 . . . . 0.0 111.023 139.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.28 -28.8 0.34 Allowed Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.226 1.393 . . . . 0.0 113.33 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.46 151.29 42.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 117.928 0.864 . . . . 0.0 111.921 169.381 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.2 m -149.85 171.0 6.83 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 128.504 2.722 . . . . 0.0 109.792 -176.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.78 -176.25 2.9 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.986 3.124 . . . . 0.0 115.501 -173.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.8 t -45.32 119.7 2.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.97 1.708 . . . . 0.0 113.626 -173.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.37 29.59 75.0 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.352 0.977 . . . . 0.0 114.26 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.01 168.56 0.12 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 173.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -132.26 144.92 50.95 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 112.947 -1.933 . . . . 0.0 110.137 122.505 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 32.5 t -85.33 117.7 24.42 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.898 1.279 . . . . 0.0 109.356 168.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 t -65.9 153.2 42.66 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.328 0.651 . . . . 0.0 111.967 177.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -16.79 14.82 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.211 1.004 . . . . 0.0 112.518 167.42 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 27.8 m95 -76.24 -8.26 56.67 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.417 1.887 . . . . 0.0 113.119 172.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.92 14.15 61.31 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.467 1.032 . . . . 0.0 114.686 178.446 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -123.71 147.58 47.33 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.258 1.423 . . . . 0.0 112.804 -176.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 65.4 m -81.87 152.1 27.0 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.816 1.646 . . . . 0.0 112.349 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.9 -154.53 21.98 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 178.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 159.2 44.04 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.535 1.534 . . . . 0.0 109.613 176.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.54 -178.15 52.58 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 123.722 0.677 . . . . 0.0 113.489 178.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.73 2.02 2.8 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.469 3.446 . . . . 0.0 116.218 -166.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.73 -6.15 46.8 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 123.11 1.433 . . . . 0.0 111.031 172.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -132.01 -49.25 0.94 Allowed 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 127.919 2.488 . . . . 0.0 109.919 -169.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 67.3 m -81.53 8.79 8.73 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.646 1.978 . . . . 0.0 112.013 167.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.51 -92.09 0.09 OUTLIER Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.262 0.934 . . . . 0.0 114.233 -176.028 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 -157.448 . . . . . . . . 1 1 . 1 stop_ save_